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Abstract 
Background and aims 
In the United Kingdom one third of all breast cancers are diagnosed in 
women aged 70 or over. Older women with breast cancer are less likely to 
be offered or receive standard treatment.    
Aim  
The overarching aim of this study was to establish the information needs and 
decision-making preferences of older women diagnosed with primary, 
operable, oestrogen receptor positive breast cancer and faced with a choice 
of surgery or primary endocrine therapy (PET).  
Research design and methods 
This exploratory, sequential mixed methods study comprised a critical review 
of the literature, qualitative interviews and a quantitative questionnaire. The 
findings were interpreted and integrated in line with the mixed method ethos.  
Key Findings 
The findings are underpinned by varied and complex internal and external 
influences. It is accepted that with increasing age cognitive functioning is 
compromised and poor health literacy is common.  Although, the views of 
HCPs influenced treatment decisions, contrary to previously reported studies 
older women in this study wanted active involvement in the decision-making 
process and demonstrated confidence when making treatment choices. In 
terms of the content and format of information, unsurprisingly women 
preferred tailored information delivered face to face by the specialist HCP. In 
terms of written information women wanted brevity and simplicity. Visual 
displays of numeric data were unpopular and were found to be confusing for 
most women.  
Conclusions and recommendations 
Information and decision support needs varied among this group of women. 
Understanding how older women define ' involvement in treatment decision-
making' would enhance the development of appropriate decision support. 
Further work is required in the development of data collection tools, 
particularly questionnaires, appropriate for an older, frail population. 
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Article-based PhD 
This thesis is written as an 'Article-based (AB) PhD'. 
Although the format is substantially different to the traditional monograph 
PhD the regulations and assessment criteria for award remain the same.  
An AB PhD includes between three and five articles that are produced by the 
candidate during the period of their candidature.  
The articles, together with an introductory chapter, an explanation of the 
research question, the methodology and methods and a concluding chapter 
describe a coherent programme of research undertaken by the candidate. 
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Structure of this PhD thesis 
This section aims to inform the reader of the structure of this thesis and 
provide a brief outline of the contents of each chapter.  
Overview 
The thesis begins by providing  an overview of the wider 6 year programme 
of work funded by the National Institute of Health Research entitled 'Bridging 
the Age Gap in Breast Cancer: Improving Outcomes for Older Women.  
(NIHR Programme Grant: RP-PG-1209-10071, Project leads: Lynda Wyld, 
Malcolm Reed and Karen Collins, 2012-2018) 
This section will demonstrate how the work presented in this thesis is nested 
within and contributes to the overall aims the main study.  
Chapter 1  
Chapter 1 provides the context to the PhD. The incidence of primary breast 
cancer and current UK survival rates for breast cancer. Any differences 
between younger and older women (>70 years of age) are evidenced. An 
overview of standard breast cancer treatments and how advances in both 
surgical and non-surgical treatments have given rise to the possibility of a 
choice of breast cancer treatment are discussed. This is followed by a 
discussion of the information needs and decision-making preferences of 
older women when faced with a choice of breast cancer treatments, 
specifically with the choice of surgery or PET for operable breast cancer. 
This chapter thereafter establishes the gap in knowledge and outlines the 
aims and objectives of the PhD.  
Chapter 2 
Chapter 2 contains the first article entitled: 'Information Needs of Older 
Women Faced with a Choice of Primary Endocrine Therapy or Surgery 
for Early-Stage Breast Cancer: A Literature Review'. This article forms 
the background of this PhD and provides the rationale for undertaking this 
study. This chapter also contains a critical commentary of the article and an 
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update of the current literature (since the original search in January 2013 to 
the time of submission of this PhD in 2017). 
Chapter 3 
This chapter provides a detailed examination of the methodological approach 
adopted within this thesis, namely mixed methods. It outlines the 
philosophical stance of mixed methods and a justification for the design 
chosen. 
Chapter 4 
Chapter 4 outlines the methods used within this PhD. It details the sequential 
mixed methods design comprising of both qualitative (semi-structured 
interviews) and quantitative methods (postal survey) and provides the 
rationale for using this approach. Details of the study sample, eligibility, 
participant recruitment and access, the development of the interview 
schedule and questionnaire survey, data collection methods, data handling 
and  data analysis are all discussed. Finally details of the research ethical 
approval and local governance approvals are described  
Chapter 5 
Chapter 5 contains the second published article entitled: 'The information 
and decision support needs of older women (>75 yrs) facing treatment 
choices for breast cancer: a qualitative study'. This article reports the 
findings from the qualitative semi-structured interviews undertaken and forms 
the qualitative component of this mixed methods study. The author presents 
a critical commentary on the article using the NICE (2012) qualitative 
appraisal tool as a framework. This chapter also contains a reflexive account 
of the extent to which the values, actions and experience of the researcher 
impacted on the author’s role as a researcher.  
Chapter 6 
Chapter 6 contains the third article entitled; 'Information needs and 
decision-making preferences of older women offered a choice between 
surgery and primary endocrine therapy for early breast cancer.' This 
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article reports the findings from a questionnaire survey and forms the 
quantitative component of this mixed methods study. The author presents a 
critical commentary on the article in order to expand upon and add further 
detail that it was not possible to address in the published article. 
Chapter 7 
This article contains the fourth published article entitled; 'The balance of 
clinician and patient input into treatment decision-making in older 
women with operable breast cancer'. This paper provides a deeper 
exploration and understanding of older women's decision-making using data 
from the qualitative semi-structured interviews in this PhD and data from the 
main Bridging the Age Gap in Breast Cancer (BTAG) study. As in previous 
chapters the author presents a critical commentary to expand on elements 
that it was not possible to address in the published article. 
Chapter 8 
This chapter integrates the findings of the various PhD components and 
provides a mixed methods summary of the literature review, the semi-
structured interviews and the questionnaire using a triangulation protocol. 
The findings from this mixed methods integration are reviewed.  
Chapter 9 
This chapter revisits the research questions and the aims of the study and 
summarises the findings before examining them in the light of previous 
literature. Strengths and limitations of the study will be addressed. 
Conclusions and Recommendations 
This thesis will conclude by outlining the contribution to current clinical, 
methodological and theoretical knowledge this study has made and what 
further work may be necessary to further understand the information and 
decision preferences of older women faced with a choice of treatment for 
their primary operable breast cancer 
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Preface 
This article based PhD is nested in a wider 6 year programme of work 
funded by the National Institute of Health Research entitled 'Bridging the Age 
Gap in Breast Cancer: Improving Outcomes for Older Women'  (BTAG). 
Overview of the Bridging the Age Gap in Breast Cancer 
Programme of Research 
Breast cancer affects 13000 UK women over age 70 annually and causes 
the deaths of 6733 per year. Patients over 70 years of age have seen less 
than half of the reduction in cancer mortality compared to younger women.  
This is, in part, due to sub-optimal treatment  as a result of concerns about 
poor treatment tolerance.  Older women have not benefitted from the 
advances in chemotherapy (and trastuzumab) and many do not undergo 
surgery, being offered instead anti-oestrogen tablets.  The use of anti-
oestrogens as sole treatment for otherwise operable breast cancer is called 
Primary Endocrine Therapy (PET).  PET is a good alternative to surgery in 
older frailer women as they have equivalent overall survival rates, although 
rates of local disease control are inferior.  At present there is no guidance for 
Health Care Professionals (HCPs) on the level of frailty or ill health in older 
women with breast cancer, which suggests that PET may be a superior 
option to surgery.  There is little research to guide best practice in older 
patients.  There is also little known about the information and support needs 
of older women with breast cancers, or their preferences for engagement in 
cancer treatment decision-making.  Such information and the production of 
national evidence-based guidance, is needed to optimise the treatment of 
older women and bridge the age gap in cancer outcomes.  
The BTAG programme comprises 6 main components: 
1. Prospective multicentre cohort study to determine current UK practice and 
permit analysis of optimal care using state of the art data modelling 
techniques.  
2. Retrospective registry and Hospital Episode Statistics (HES) data modelling 
study to supplement the data from the cohort study and give longer term 
follow-up on outcomes than that provided by the cohort study. 
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3. Clinician practice variance study to determine how UK practice varies by 
centre and assess the impact of clinician preference. 
4. Development of a decision support tool for older women to assist older 
women in making evidence based choices about their preferred care 
This PhD is contained within this element of the wider programme of 
research. 
5. A pragmatic cluster randomised controlled trial (RCT) to test and validate a 
combined clinician facing web-based breast cancer outcomes algorithm and 
a decision support intervention (DESI) to support shared decision-making in 
older women faced with the choice of either PET or surgery.  
6. A process evaluation running alongside the RCT to evaluate the process and 
outcomes of the DESI (including validation of measures, intervention 
implementation and effect, acceptability of the intervention and the facilitators 
and barriers to embedding the intervention into everyday clinical 
practice).These component parts are summarised diagrammatically in Figure 
1 below. An executive summary of the parent study 'Bridging the Age Gap in 
Breast Cancer is provided in Appendix 1 
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Figure 0.1: Components of the BTAG Programme 
 
  
 This 
PhD 
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Summary of the PHD 
This mixed methods exploratory sequential study is embedded within a wider 
NIHR Programme Grant summarised above (The Bridging the Age Gap 
Breast Cancer Study (BTAG)). Specifically this article based PHD will 
provide a clinical, methodological and theoretical contribution to the current 
evidence base. It comprises of a critical review of the current literature, in-
depth qualitative interviews and a quantitative questionnaire which has 
acquired data focused on the information of older women with breast cancer 
and their preferences for engagement in cancer treatment decision-making. 
This data informed the development of a decision support intervention for 
older women with operable breast cancer when faced with a choice of 
surgery or PET. 
Scope of this PhD 
During July 2012, the researcher was employed as a research fellow on the 
BTAG study outlined above. The researcher role within the BTAG 
programme was primarily focused on the development of a patient decision 
support intervention. This involved the development of the protocol and 
subsequently responsibility for gaining ethical approvals and research and 
development governance for all the study sites involved in this phase of the 
study. The researcher was responsible for undertaking the literature review, 
participant recruitment and data collection and analysis focused on 
establishing the information needs and decision-making preferences of older 
women with operable breast cancer when faced with a choice between 
surgery or PET. Initially this phase of the study was purely qualitative using 
interviews as a sole means of data collection. However, in order to quantify 
the findings of the interview data it was decided that by incorporating a 
quantitative component and thus undertaking a mixed methods study would 
increase applicability, confirmability and permit stronger inferences to be 
made (Teddlie & Tashakkori 2009). A questionnaire was therefore developed 
and data collected and analysed. This was then integrated with the 
qualitative data analysis and the insights derived from the literature review. 
To the researcher's knowledge, there are no other published studies that 
have examined the information needs and decision-making preferences of 
10 
 
older women diagnosed with primary breast cancer and who are faced with a 
choice of surgery or PET, thus this PHD will provide a new methodological 
and theoretical contribution to the existing literature. 
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1. Chapter 1: Introduction 
This chapter provides the context for this article based PhD thesis. It 
provides an outline of the incidence and survival outcomes of breast cancer 
and the standard treatment available to women with primary breast cancer. It 
is not the intention of this chapter to provide an in-depth account of the 
treatment of breast cancer but to provide the context of the PhD. The 
development of each treatment option is outlined before examining how 
these developments have culminated in treatment options being available to 
both the HCP and the patient.  Consideration was given to the changing view 
of the patient as an active partner in health care decisions and how this has 
led to changing practice in breast cancer treatment in older women. This 
chapter will conclude by identifying the gap in knowledge which this thesis 
will address. 
1.1. Background 
Globally breast cancer is the most common cancer affecting women (WHO 
2017) and is the leading cause of cancer death among females, accounting 
for 23% of the total cancer cases and 14% of cancer deaths worldwide 
(Jemal et al. 2011). In the UK, breast cancer it is the third most common type 
in England and the most common cancer in women (ONS 2010). One in 
eight women will develop breast cancer at some point in their lives, with age 
being the strongest risk factor (Cancer Research UK, 2012). Eighty percent 
of breast cancers occur in the over 50's and almost a third in the over 70s 
(Moller, Flatt & Moran 2011). 
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Figure 1.1: Number of female breast cancer cases per year by age at diagnosis (2012-
2014)  
 
Reproduced from the Cancer Research UK 
1.2. Stages of Breast Cancer 
When there is uncontrolled, abnormal growth and division of cells in either 
the lobules or the ducts of the breast which spreads to the surrounding tissue 
invasive breast cancer occurs. Breast cancers are staged according to The 
Union Internationale Contre le Cancer (UICC) staging system. Stages 1-3 
(known as early breast cancer) refer to breast cancer which is confined  
locally to the breast tissue and the lymph glands in the axilla.  Stages 1 and 2 
are referred to as early breast cancer and is always operable.  Stage 3 is 
sometimes referred to as locally advanced breast cancer and is sometimes 
operable and sometimes curable, but not always. Stage 4 disease has 
spread via the bloodstream and lymphatic system to other parts of the body 
(Hermaneck, Henson, Hutter & Sabin1987) and is often called secondary or 
metastatic breast cancer. Stage 4 disease is not curable and treatment is 
rarely surgical and is usually with palliative intent. This study is concerned 
with older women (≥75 years) with operable breast cancer i.e. all in stages 1 
and 2 and those patients with stage 3 disease who have surgical options and 
the potential for cure. 
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1.3. Breast Cancer Treatment Options (non age specific) 
1.3.1. Surgery 
William Halsted's radical mastectomy was initially 'considered to be the ideal 
cancer operation' and the only effective treatment for breast cancer (Halsted 
1894). Described in 1894, this operation included resection of the breast, 
pectoral muscles, and regional lymphatics. This operation was based on the 
accepted science of the time that breast cancer spread slowly and only 
entered the bloodstream at a later phase of the disease, therefore performing 
this type of operation 'would remove all the cancer in the body' (Fisher 2005; 
Lerner 2013).  
Despite the poor cosmetic appearance and the associated lymphoedema 
this was standard surgery for almost 70 years. A number of developments in 
the understanding of cancer biology and growing reports of recurrence of 
cancer following mastectomy led some to perform a modified mastectomy, 
which left the pectoral muscles intact (Patey & Dyson 1948) or a lumpectomy, 
(or breast conserving surgery (BCS) as it is now more commonly referred to), 
which took only the tumour and a small amount adjacent normal breast 
tissue (Crile 1972). This treatment was variously accompanied by adjuvant 
therapies including chemotherapy and radiotherapy (Fisher et al. 1968, 
Atkins, Hayward, Klugman & Wayte 1972) for selected patients. Evidence 
from a randomized controlled trial published in 1985 demonstrated that BCS 
plus radiotherapy was an effective alternative treatment to mastectomy for 
some cases breast cancer (Fisher et al. 1985).  
Today surgery, either mastectomy or, where appropriate, BCS, commonly 
accompanied by adjuvant or neo-adjuvant therapies is considered standard 
treatment.  The technicalities of breast surgery are outwith the scope of this 
PhD suffice to say that they may also now include mastectomy and 
reconstruction, oncoplastic reshaping of the breast to extend the indications 
for breast conservation.  In addition about 40% of women have axillary nodal 
disease at presentation.  Until 15-20 years ago, all women with breast cancer 
underwent axillary node clearance as part of their surgery.  In modern 
practice, whilst axillary clearance is still often used in women with definite 
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nodal disease at diagnosis, for those whose axillae appear clinically normal, 
sentinel node biopsy is now the standard of care (Krag et al. 2007).  In recent 
years options for axillary radiotherapy in place of surgery are being adopted 
following trial data (Donker et al. 2014) 
1.4. Adjuvant therapy 
Adjuvant therapy is additional cancer treatment given after the primary 
treatment to lower the risk of cancer recurrence locally or systemically. This 
may include radiotherapy, hormone therapy, chemotherapy and targeted 
therapy, (also known as biological therapy). 
1.4.1. Radiotherapy 
The introduction of X-rays at the end of the 18th century opened the doors 
for the development of radiotherapy and mammography. The discovery of 
radium allowed the introduction of interstitial radiation for breast cancer 
therapy (Cooper 1942). Pfahler & Parry (1930) reported favourable five year 
results of routine post-operative radio-therapy for stage II breast cancer but it 
was McWhirter's1948 study (McWhirter 1948) that provided the initial 
evidence required to support it as routine practice following breast surgery. 
McWhirter (1948) followed a simple mastectomy with three weeks of 
radiation to the axilla and chest wall. The results were impressive with a 62% 
five year cure rate compared to current radical mastectomy only cures rates 
which ranged between 35-45% at the time. More recently the Early Breast 
Cancer Trialists' Collaborative Group (EBCTCG 2006) have updated their 
meta-analysis of long-term outcome in women with early stage breast cancer 
and they conclude that radiotherapy is effective in eradicating much of the 
microscopic local disease foci that may persist following surgery. It also 
states that when not used after surgery local disease recurrence can 
metastasize increasing the possibility of dying from breast cancer. 
Radiotherapy is not without its side effects. These range from minor skin 
irritation to fibrosis of the skin and underlying tissue, to the more serious 
cardiac damage resulting in reduced cardiac function (Gagliardi et al. 2010; 
Olivotto et al. 2013). Following BCS it is known that true recurrences of 
breast cancer (as opposed to second primary cancers) usually occur in the 
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same breast quadrant (Salvadori 1999) therefore the question of whether 
whole breast irradiation (WBI) is necessary has been investigated. When 
compared to WBI, irradiating a smaller area of the breast, partial breast 
irradiation (PBI) has the advantages of reduced fibrosis of the breast and 
underlying tissues, thereby reducing the risk of cardiac damage (Borger et al 
1994) without affecting local recurrence rates or overall survival in selected 
sub groups of patients.  
Partial breast irradiation is an attractive option for patients as it requires 
fewer treatment sessions, a factor known to influence the surgical choice of 
women with early breast cancer. Forty-seven percent of mastectomy patients 
would have been more likely to choose BCS if a shorter duration of 
radiotherapy had been offered to them (Rippy et al. 2014). However, there is 
conflicting evidence surrounding the improvement in cosmetic outcome of 
the breast following PBI. Polgar, Fodor, Major, Sulyok & Kasler (2013), 
suggested an improved appearance and no difference in recurrence at 10 
year follow up with the use of PBI compared to WBI. Currently in the UK PBI 
is not given as part of routine practice. More recently intra-operative 
radiotherapy (IORT) has been investigated and although overall survival is 
unaffected on relatively short term follow up, local recurrence rates are 
considerably higher when compared with whole breast irradiation (Vaidya, et 
al. (2014).  Consequently IORT is not yet recommended for use outside of 
trials in the UK, although is currently the subject of a NICE review which may 
recommend its adoption in some sub-groups of patients (NICE Draft 
Guidelines, Feb 2017).    
The impact that radiotherapy has on improving local disease control and 
survival is not in question but further investigation is required to understand 
the variation in treatment effect between individuals and to identify the 
optimal dosage, frequency, timing and method of application of radiotherapy 
(Clarke et al.2005 & EBCTCG, 2011). Larger fractions over a shorter period 
are being investigated with radiotherapy regime durations dropping from 7 
weeks, to 5 weeks and now 3 weeks (the current norm), with trials ongoing 
looking at a single week (The Fast Forward Trial) (Brunt et al. 2016). 
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Targeting is also better with CT guided target volume delineation to spare the 
heart (Latty, Stuart, Wang & Ahern 2015).  
1.4.2. Systemic therapies in the treatment of breast cancer 
There are three broad categories of drug strategies used in the treatment of 
breast cancer; hormone therapy, chemotherapy and targeted therapy.  Again 
an overview is presented as detailed review is out with the scope of this 
thesis. 
1.4.3. Hormone therapy 
Some hormones cause certain cancers to grow. Hormone therapy, also 
known as endocrine therapy, aims to remove hormones or block their action 
to prevent tumours from growing. Where cancer cells are known to be 
hormone receptive, (ER+), hormone therapy (known as endocrine therapy) is 
used to reduce the production of hormones or block their action. Oestrogen, 
is known to encourage growth in some breast cancers therefore anti-
oestrogen drugs, such as tamoxifen are given to pre-menopausal patients 
with early breast cancer to block oestrogen from stimulating further growth. 
In postmenopausal women with oestrogen dependent breast cancer an 
aromatase inhibitor, e.g. anastrozole, letrozole or exemestane is used to 
prevent the production of oestrogen.  In high risk pre menopausal women, 
ovarian suppression therapies may also be added.   
Hormone therapies may produce side effects to a lesser or greater degree. 
The most common side effects being vasomotor symptoms including hot 
flushes and night sweats (Carpenter, Johnson & Wagner 2002). The 
symptoms mimic those of the menopause but the symptoms can be more 
severe than women going through 'natural' menopause (Carpenter 2002). 
Five years is the usual treatment duration for hormone therapy but patients 
may discontinue earlier when the side effects have too greater an impact on 
their quality of life (Gibson 2009; Loibl 2011; Zhu, Bensoussan, McNicol, 
Chen & Lu 2013). Recent data from the ATLAS and ATTOM trials have 
suggested that antioestrogen therapies for higher risk women should be 
extended to 10 years (Cuzick et al. 2010; Davies et al. 2013; Gray et al. 
2013). 
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The Early Breast Cancer Trialists Collaborative Group (EBCTCG) (2006) 
overview of tamoxifen in early breast cancer suggests that the survival 
benefit of 5 years is approximately 25%.  Aromatase inhibitor therapies have 
a slightly better side effect profile and reduce disease free but not overall 
survival relative to tamoxifen (Cuzick et al. 2010)  
1.4.4. Chemotherapy 
Chemotherapy is a systemic treatment for breast cancer using a combination 
of different cytotoxic drugs that aim to destroy or prevent further growth of 
the malignant tumour. In breast cancer, the decision to use chemotherapy 
depends on the size, grade, the oestrogen receptor (ER) status, human 
epidermal growth factor type 2 receptor (HER2) status and the general 
health of the patient. More recently multigene arrays have been used to 
make chemotherapy decisions (Oncotype DX) (Sparano et al. 2015). 
Patients with a grade 3 tumour i.e. a fast growing, poorly differentiated 
tumour and/or HER2 positive are more likely to be offered or receive 
chemotherapy after surgery. Used as a neo-adjuvant therapy, chemotherapy 
aims to shrink the tumour thereby making surgery less extensive (Fisher et al. 
1998).  
Chemotherapy is known to have significant side effects (Partridge, Burstein, 
Winer 2001). Short-term side effects such as fatigue, vomiting, hair loss, 
depression, myelosuppression, thromboembolism, myalgia and neuropathy 
occur during the course of treatment and usual end shortly after treatment 
completion (Shapiro & Recht 2001; Zhang, Liu, Li & Tripathy 2007; Frisk, 
Kallstrom, Wall, Fredrikson & Hammar 2012). Long-term side effects, such 
as weight gain, cardiac dysfunction, leukaemia and cognitive impairment 
appear later in treatment or after completion and may last for many years 
(Shapiro & Recht 2001; Ramalingam 2002). 
1.4.5. Targeted therapy 
In addition to chemotherapy a targeted therapy may also be used to treat 
women with HER-2 positive breast cancer. Trastuzumab is the targeted 
therapy used to treat women with the subtype of early breast cancer that 
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expresses high levels of the HER 2 receptor (Slamon et al. 2001; Vogel et al. 
2002; Piccart-Gebhart et al. 2005; Romond et al. 2005; Slamon et al. 2011). 
Common side effects of hair loss and vomiting in chemotherapy are not 
present in targeted therapy but they do include flu-like symptoms and in 
some patients, severe diarrhoea and possible cardiac problems (Metzger, 
Saini, Azim & Awada. 2012; Breast Cancer Campaign). 
1.5. Breast Cancer Treatment in Older Women 
Older women experience worse survival for breast cancer when compared to 
younger women with relative five year survival rates reducing from 89% for 
45-49 year olds to 69% for women ≥80 years (Coleman et al. 2011).  
Figure 1.2: Average number of breast cancer deaths per year and age-specific 
mortality rates, Females, UK, 2012-2014  
 
Reproduced from Cancer Research UK 
1.5.1. Treatment Guidelines 
Published guidelines give minimum standards for the diagnosis and 
treatment of non-metastatic breast cancer (NICE 2009; Gnant, Thomssen & 
Harbeck 2015). Older women are less likely to be diagnosed via triple 
assessment or have a needle biopsy so the exact nature of the breast cancer 
(ER receptor status) is not always clear leading to less efficient and effective 
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treatment (Busch 1996; Wyld , Garg, Kumar, Brown & Reed 2004; Lavelle et 
al. 2007). 
1.6. Surgery 
There is evidence demonstrating that older women in the UK are less likely 
to receive primary surgery (the standard treatment), radiotherapy or 
chemotherapy and are more likely to receive endocrine therapy as a sole 
treatment (Bouchardy et al. 2003; Moneypenny 2004; Wyld, et al. 2004; 
Lavelle et al. 2007; Bastiaannet, et al. 2010; Lavelle et al. 2012; Morgan, 
Wyld, Collins & Reed 2014a). Tumour characteristics i.e. large tumour or 
grade of tumour, co-morbidities or poor general health making the patient 
unfit for surgery or the patient declining surgery (Lavelle 2014) have been 
cited as possible explanations for reduced surgery rates.  However, to date 
there is limited evidence to support these claims.  
Lavelle and colleagues (2007a) suggest that when women present with 
tumours equivalent to those in younger women they do not receive 
equivalent treatment, (Lavelle et al. 2007a). Similarly when patients are 
deemed 'unfit for surgery' there is little quantifiable evidence to support this. 
After accounting for the effect of tumour characteristics, co-morbidity and 
health status, Lavelle and colleagues (2007 b) concluded that women aged 
80 years and over, were less likely to have surgery. Further work examining 
the significance of co-morbidities in the lower surgery rates in older women 
concluded that co-morbidities could only account for some of the variation 
but that increasing age predicted lack of primary surgery (Audisio et al. 2004; 
Lavelle 2012). Co-morbidity was found to predict non-standard treatment in 
other studies (Ballard-Barbash, Potsky, Harlan, Nayfield & Kessler et al. 
1996; Giordano, Hortobagyi, Kau, Theriault & Bondy. 2005; Audisio et al. 
2004; Naeim et al. 2006). Despite the differences, increasing age is identified, 
across all studies, as a predictor of under-treatment. 
1.7. Primary Endocrine Therapy 
Primary endocrine therapy (PET), namely tamoxifen, was introduced in the 
early 80s as a stand-alone treatment for early operable breast cancer in 
older patients. (Preece,Wood, Mackie & Cushieri 1982; Bradbeer & Kyngdon, 
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1983). The results were encouraging with 75% of the breast cancers either 
shrinking or growth being halted. The introduction of ER status testing in the 
1980's enabled the identification of patients who were more likely to respond 
to PET (Hind & Wyld 2004; McCarty, Miller, Cox, Konrath, & McCarty 1985). 
The use of PET has proved to be a popular treatment choice, particularly in 
the UK with 42% of women over the age of 70 (Wyld et al. 2004) and 55% of 
women over 80 (Moneypenny 2004) treated with PET. Rates in the rest of 
Europe vary widely ranging from 3% in Italy to 32% in Sweden.  In the USA, 
PET is not a common option for older women. This may be due to a more 
defensive medical practice and also surgical fees cannot be charged by 
surgeons for prescribing tamoxifen which will be a major disincentive to PET 
(Morgan et al. 2014a). 
Under-representation of older women in breast cancer treatment trials (SIGN 
2005; NICE 2009) raises debate about the extent to which the findings of 
studies and the subsequent guidelines can be applied to treatment of older 
(not defined) women with early breast cancer (Balducci, Extermann & 
Carreca. 2001; Ring et al. 2010). Despite this, primary surgery is 
recommended as standard treatment in older women (Cancer Reform 
Strategy Department of Health 2007, Biganzoli et al. 2012).  
In support of this recommendation the findings from a systematic review 
comparing surgery and endocrine therapy with endocrine therapy alone in 
women ≥70 years,  Hind and colleagues (2006) concluded that there was 
poorer progression free survival in those who received endocrine therapy 
alone. This was further supported by Morgan, Wyld and Reed (2014b). 
1.8. Adjuvant Therapy 
A similar picture emerges when radiotherapy and chemotherapy are 
examined. Increasing age strongly predicts the non-receipt of radiotherapy 
following breast conserving surgery, even when patient preference is taken 
into account (Busch et al. 1996; Mandelblatt et al. 2000). There is some 
justification for radiotherapy omission in women who have a short predicted 
life expectancy and low risk tumours (ER positive, small, excised with clear 
margins) and the recent PRIME trial demonstrated that whilst there is a small 
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increase in rates of local recurrence in such cases, survival rates are the 
same (Kunkler, Williams, Jack, Cameron & Dixon 2015). 
Despite international guidelines recommending chemotherapy should be 
considered for fit older women with high risk cancers and evidence showing 
that chemotherapy given to older women (≥70 yrs) with primary breast 
cancer has the potential to reduce local recurrence by 12% and death by 
13% chemotherapy is received less often by this group of women 
(Mandelblatt et al. 2000; Ring 2010).   There is some justification for more 
cautious use in older women as trial data to show benefits are lacking in this 
age group and adverse effects, including treatment related deaths from 
neutropenic sepsis, are more common in women over 70 (Muss et al. 2007; 
Giordano et al. 2005) 
1.9. Improving Health Care Outcomes and Increasing Patient 
Autonomy 
Over the past four decades there has been a gradual shift in direction from a 
paternalistic style of health care to one of greater patient involvement.  'No 
decision about me, without me' was the mantra of Andrew Lansley, a 
previous Secretary of State for Health, in the 2010 White paper 'Equity and 
Excellence: Liberating the NHS' (Department of Health 2010). This paper 
built on earlier papers, (Working for patients1989, Patients Charter 1991, 
Choosing Health: making healthier choices easier 2004) which aimed to 
make shared decision-making and patient treatment and health care choice 
the norm. More recently cancer strategies have been developed that aim to 
improve prevention, earlier detection and diagnosis of cancer, promote 
survival rates treatment delivery, patient experience and end of life care for 
all cancer patients. (Achieving World Class Outcomes-a cancer strategy for 
England 2015-2020). In 2015 NHS England, announced the establishment of 
an independent taskforce to implement the NHS Five Year Forward View 
(2014). This strategy places the patient experience on a par with clinical 
outcomes such as survival. This plan also commits to the empowerment of 
patients by providing information about their condition and possible treatment 
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to enable them to make more informed decisions about the treatment 
choices they make.  
NICE guidance (2004) highlighted the importance of the providing people 
with cancer, high quality, up-to-date, tailored information and support. In the 
Macmillan report 'Cancer in the UK 2014: State of the nation' it states that: 
"To achieve the best results and enhance experience, people affected 
by cancer should be listened to and engaged as full partners in a 
collaborative relationship of shared decision-making. Good 
information is a vital step on the way towards creating a culture of 
shared decision-making. Without support to interpret information, 
there is a risk that people affected by cancer will not understand the 
information they are given or find it overwhelming and unhelpful."   
 
  ('Cancer in the UK 2014: State of the nation pg 31) 
Providing tailored information to support decision-making for older women 
requires consideration of age-related factors such as frailty, comorbidities 
and potentially compromised vision and hearing and cognition.  
1.10. The Impact of Patient Choice on Non-standard Treatment 
The UK national cancer reform strategy states that 'patient choice' or 'poor 
health' are the only two legitimate reasons non-standard treatment should be 
given (Department of Health 2007). Patient choice is cited as one reason 
why older women may be receiving non-standard or sub-optimal treatment 
for breast cancer (Wyld et al. 2004; Lavelle et al. 2014). Very few studies 
have investigated the impact of patient choice on breast cancer treatment 
received by older women (Lavelle et al  2014; Sowerbutts et al. 2015) There 
is also little research that examines the way in which older patients with 
breast cancer make treatment decisions or how this can be supported.   
Tang and colleagues (2011) undertook a review of 268 women with the aim 
of profiling the characteristics of older women (>70 years) with operable 
primary breast cancer and the relationship with patient treatment decision-
making. The authors report that given a 'genuine choice' (defined as a 'free' 
choice of treatment options given to patients based on the judgement of joint 
assessment by the clinical team who considered age and medical fitness) 
over half of the women (56%) chose PET as the sole treatment in preference 
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to surgery. This group of women were on average seven years older and had 
more co-morbidities than those who chose surgery. In contrast, Lavelle and 
colleagues examined the impact of patient choice on rates of surgery and 
concluded that the lower rates of surgery among women 85 years and older 
could not be explained by patient choice alone (Lavelle 2014). However, the 
pattern of decreased surgery rates was not so significant in women 70-74 
years.  Women who reported themselves to be 'passive' in the treatment 
decision-making process, i.e. leaving the treatment decision to the HCP,  
were just as likely to receive surgery as those who considered themselves as 
'active' in the process. Receipt of adjuvant radiotherapy was also examined 
by Tang and colleagues (2009). They reported offering adjuvant radiotherapy 
to 82% (n=55) of older women who had BCS with 68% (n=44) going on to 
accept it. The reason given for non-acceptance of radiotherapy was that the 
patients’ preferred to 'watch and wait' as they were also receiving adjuvant 
anti-oestrogens. A breakdown by age, related to those who were offered or 
received radiotherapy, was not given.  In contrast to the Tang study, Lavelle 
and colleagues reported that 95% of women age 80 years and older, in their 
study, did not receive radiotherapy and noted that as age increased the odds 
of receiving radiotherapy decreased (Lavelle 2014).  
Chemotherapy in the treatment of older women with operable breast cancer 
is under-utilised (Ring 2010). Again it follows a pattern of increasing age and 
decreased use. Studies examining the reasons for low usage report that 
clinicians base recommendations on the basis of age and not on medical 
assessment of fitness (Protiere, Viens, Rousseau & Moatti 2010; Ring 2010). 
Clinicians are also more likely to cite co-morbidities and frailty as reasons not 
to offer chemotherapy however there is only recorded evidence to justify 
omission of treatment in two-thirds of cases (All Party Parliamentary Group 
Breast Cancer Report 2013). The impact of patient choice on chemotherapy 
rates in older women with breast cancer is a poorly researched area and one 
which Ring and colleagues highlight as requiring attention (Ring et al. 2010). 
1.11. Factors Affecting Patient Treatment Decision-Making 
Age, race, culture, media, prior experience of cancer and its treatment, body 
image, HCP interactions, HCP preferences, information received and level of 
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education have all been cited as influencing decision-making in breast 
cancer (Hawley et al. 2007; Bleicher, Abrahamse, Hawley, Katz & Morrow. 
2008; Singh et al. 2010; Hamaker et al. 2013, Morgan et al. 2014b).  
The influence of age on breast cancer decision-making is unclear with some 
reports of older women preferring a passive role within the clinical 
consultation (Davison, Degner, & Morgan, 1995; Degner 1997; Wallberg et al. 
2000; Jenkins, Fallowfield, & Saul 2001; Lobb, Kenny, Butow & Tattersall 
2001; Levinson, Kao, Kuby & Thisted 2005; Ciambrone 2006; Bleicher et al. 
2007; O'Leary et al. 2007; Husain 2008) whilst others have  reported a 
preference for an active role (Cassileth, Zupkis, Sutton-Smith & March et al. 
1980; Guadagnoli & Ward 1998; Kenny, Robertson, Ellis, Elston & Blarney. 
1998; Crooks 2001; Bruera,  Willey, Lynn Palmer & Rosales. 2002; Schou, 
Ekeberg, Ruland & Karesen 2002; Janz, et al. 2004; Caldon, Walters, & 
Reed, 2008; Collins et al. 2009) still others reporting age is unrelated to role 
preference (Hack, Degner & Dyck 1994; Bleicher et al. 2008). 
The influence of race, culture and ethnicity on decision-making is also 
unclear. There is evidence to show non-white women feel they were less 
involved in decision-making and experienced more decision regret than white 
women (Degner et al. 1997; Keating et al. 2003 Lantz et al. 2005; Katz et al. 
2005; Janz et al. 2008). Polacek, Ramos & Ferrer (2007) suggest the 
evidence is unclear because researchers are not engaging the most affected 
people.  
Across a number of patient populations a higher level of education is 
associated with patient preference for involvement in decision-making 
(Degner, Sloan & Venkatesh 1997; Giordana et al. 2008, O'Donnell & 
Hunnskaar 2007). A pooled analysis by Singh and colleagues (2010) 
demonstrated that when education level was corrected, race and age were 
not factors in preference for involvement in decision-making.   
There is evidence to suggest that doctors influence the treatment decision-
making in breast cancer (Katz, Lanz & Zemencuk, 2001; Morrow et al. 2001; 
Molenaar et al. 2004; Gort, Broekhuis, Otter & Klazinga. 2007; Morrow et al. 
2009). Influence can be exerted in a very overt way by making the decision 
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for the patient without patient input to more subtle means, such as, the 
control of information, rushing clinical discussions and deliberately steering 
conversation to achieve the HCPs preference (Canter 2001). Despite many 
patients reporting they made their own treatment decision it is possible this is 
simply a product of the HCPs managing the treatment discussion and their 
decision simply reflects the HCPs preference (Hamaker 2013).   
In an article by O'Brien and colleagues (2011) of younger women (mean age 
50-62 across the study phases) verbal and non-verbal facilitators and 
barriers to women's involvement in treatment decision-making were identified 
both from the perspective of the patient and the HCP. Patients' identified the 
need for the HCP to explain why they were being invited to participate in the 
decision-making process, explain the risk of cancer recurrence, enhance the 
patients' understanding of the information provided, give an explanation of 
the treatment options, allow time for treatment decision-making, give a 
recommendation or guidance about options and make the women feel at 
ease to facilitate their involvement. Most, but not all, of these items were also 
identified by the HCPs, the exceptions being, the need to make the patient 
feel comfortable and giving a rationale for the treatment options. Perceived 
barriers to women's’ involvement were lack of interest by the HCP in the 
women's concerns and not being 'invited' to participate (O'Brien et al 2013). 
The significance of the HCP in the decision-making process was explored in 
this study and is reported in chapter 7. An opportunity arose which allowed 
an examination of the differing perspectives on decision-making of both the 
patient and a number of HCPs including, 20 breast surgeons, 13 breast care 
nurses and 1 geriatrician based within the breast clinics engaged in this 
study.      
Evidence has consistently demonstrated that patient involvement in 
treatment decision-making leads to improved satisfaction with treatment and 
psychological outcomes and reduced 'decisional regret' following treatment 
for breast cancer (Bottomley & Jones 1997; Steginga, Occhipinti, Wilson & 
Dunn 1998; Reaby 1998; Mandelblatt et al. 2003; Andersen, Bowen, Morea, 
Stein & Baker 2009 ). Involvement in decision-making is frequently described 
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in relation to patient preference for the style of decision-making within a 
clinical consultation. Three preferences for patient decision-making have 
been identified; active, collaborative or passive decision-making. 'Active' 
decision-makers are those who prefer to make their own health care 
decisions; 'collaborative' are those who wish to share the decision-making; 
and 'passive' refers to those who defer decision-making to others, frequently 
the HCP (Strull 1984; Degner & Sloan 1992, Ekdahl, Andersson & 
Friedrichsen 2010). Early studies examining the preference of patient 
involvement in treatment decision-making, not specifically breast cancer, 
generally concluded that older patients prefer a passive role (Bilodeau & 
Degner 1996; Silliman, Dukes, Sullivan & Kaplan 1998; Jenkins; Fallowfield 
& Saul 2001; Cox, Jenkins, Catt, Langridge & Fallowfield. 2006; O'Leary, 
Estabrooks, Olson & Cumming 2007; Hawkins, Kreuter, Resnicow, Fishbein 
& Dijkstra 2008).  However, this view is not universal with some older breast 
cancer patients preferring a collaborative or active role in treatment decision-
making (Caldon, Walters & Reed 2008; Biganzoli et al. 2012). It is difficult to 
be confident about the relevance of much of this research as the studies 
have only a small number of patients age 75 years and older and frequently 
the sample includes a small proportion with breast cancer.  
Hack and colleagues (2006) undertook a study to examine the relationship 
between the preferred and the assumed decisional role and the impact on 
quality of life, three years post treatment. Whilst those in their study who 
played an active role in decision-making had improved quality of life and 
improved physical and social functioning they acknowledged work by 
Gattellari and colleagues (2001) who found role congruence i.e. the role 
desired and the role assumed, to be important in reducing anxiety in 
oncology patients. Although evidence suggests patients' benefit from an 
active role in treatment decision-making there is also evidence that some 
patients do not wish to participate in decision-making and find the offer of a 
choice stressful (Fallowfield, Hall, Maguire, Baum, A'Hern 1994). Fallowfield 
(1997) suggests that patients should have the right to decline the offer of 
participation in treatment decision-making and that the desire for clear and 
accurate information may be more important than autonomy. 
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Summary 
None of the studies identified in this overview were empirical studies that 
focused on decision-making in women over the age of 75.  In these studies 
the mean age of the women, where reported, is late 50s - early 60s with one 
describing ‘older’ as those over age 50.  Extrapolating the findings from 
these studies may not be appropriate and therefore the influence of patient 
age, culture, race and education remains unclear and justifies the 
programme of research undertaken for this PhD. 
1.12. Treatment decision-making in older women with breast 
cancer 
Previous studies that have focused on the choice women make between 
different breast cancer treatments, predominantly between mastectomy or 
breast conserving surgery (Degner  et al. 1997; Mastaglia & Kristjanson, 
2001; Collins et al. 2009; Sivell et al. 2011; Caldon et al. 2011).  
Women ≥75 years with primary operable breast cancer may face an 
additional choice; being required to decide between surgery and endocrine 
therapy or PET alone without surgery. Seventy-five is considered by HCPs 
to be the age at which it becomes clinically acceptable to introduce 
PET as an alternative treatment option (Mustacchi, Latteier, Bates & 
Houghton 1998). This is a complex issue as it requires the patient to 
consider available clinical information and balance this with their own 
preferences and values.  
For patients who wish to avoid surgery and the consequent, distress and 
disruption to their lives, and with evidence of efficacy in up to 80% of 
oestrogen receptor cancers, PET has much to recommend it.  In addition, the 
very frail elderly may have a pragmatic sense of their own impending 
mortality and not want any complex treatments but just be allowed to retain 
their dignity and independence for as long as possible. 
Being given a choice of treatment may be unfamiliar to older patients. The 
notion of considering preferences and values in treatment decision-making 
may be a difficult concept to grasp for a generation who have grown up with 
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a paternalistic view of the health care system. Traditionally, older women 
with breast cancer may have relied on HCPs to decide the most appropriate 
breast cancer treatment option (Husain et al. 2008).  
1.13. Information - a prerequisite for decision-making 
Making treatment decisions against a backdrop of limited and uncertain 
evidence and information presents a significant challenge for both the patient 
and the HCP. Breast surgery provides more certainty of local cancer control, 
but is associated with potential adverse effects: pain, temporary 
hospitalisation, anaesthetic risks and variable degrees of disfigurement to 
name but a few. In addition surgery may result in a temporary loss of 
independence and the need for social support, which may or may not be 
readily available. Evidence from a Cochrane review indicates that PET is 
associated with inferior rates of local disease control, although overall 
survival rates may be equivalent in the short term (Morgan et al. 2014a) 
although in the longer term there is evidence that they maybe inferior 
(Morgan et al. 2014a). In terms of local control PET has a limited median 
period of efficacy, estimated to be between 2-3 years (Horobin et al. 1991, 
Wyld et al 2004, Morgan et al. 2014a) with a more recent study suggesting 
the survival curve begins to diverge after three years (Fennessy et al. 2004).  
Should PET cease to be effective second line treatment may be necessary. 
This could be an alternative endocrine therapy or surgery at a point when the 
patient may be less likely to withstand it (Kenny 1998). Research is 
underway to develop means of predicting life expectancy using a mix of co-
morbidity, functional and cognitive status and anaesthetic assessment (Wyld 
& Reed 2007; Stotter, Reed, Gray, Moore & Robinson 2015).   
Patients' treatment preferences vary with many factors such as prior 
experience and knowledge of breast cancer, fear of cancer recurrence, 
personal responsibilities, practical issues surrounding treatment e.g. the 
need for radiotherapy and pre-existing values all influencing treatment 
decision-making (Fallowfield, Baum & Maguire 1986; Hughes 1993; 
Beisecker, Helmig, Graham & Moore 1994; Smitt & Heltzel 1997; Liang et al. 
2002; Collins et al. 2009). 
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1.14. The Gap in Knowledge 
Since much of the research into early breast cancer focuses on younger 
women, little is currently known about the information needs of older women 
with operable breast cancer or their preferences for involvement in the 
treatment decision-making process.  
Providing 'comprehensive, trustworthy and easy to understand information 
from a range of sources on …treatments' (Department of Health 2010) is a 
complex task. Producing the desired information in a style that is meaningful, 
taking account of the possibility of failing, age-related cognitive ability is an 
area which has yet to be examined in older women faced with a choice 
between PET and surgery in the treatment of primary operable breast cancer. 
This article based PhD study will provide a clinical, methodological and 
theoretical contribution to the current evidence base.  
1.15. Research aims, objectives and research questions 
This PhD study aimed: 
To establish the information needs and decision-making preferences of older 
women with primary, operable, oestrogen receptor positive breast cancer 
(here after referred to as primary, operable breast cancer) when faced with a 
choice of surgery or primary endocrine therapy (PET). 
Objectives 
To establish the evidence relating to information and decision-making 
preferences in older women (≥75 years) with primary operable breast cancer 
with a specific focus on the use surgery or PET. 
To elicit the views of older women towards preference for information and its 
source and presentation when facing a choice between surgery and PET. 
To elicit the views of older women towards decision-making styles when 
faced with a choice of surgery or PET. 
To determine the influence of the health care professional in treatment 
decision-making in older women with operable breast cancer. 
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It addressed the following research questions:  
1. “What are the preferences for information, its sources, format and 
presentation for older women faced with a treatment choice for 
operable breast cancer?” 
2. "What are the preferred decision-making styles in older women faced 
with a treatment choice for operable breast cancer?" 
The Researcher 
The researcher who undertook this PhD worked as a physiotherapist for 17 
years before taking up an academic career as a lecturer and researcher. The 
research path has been one largely of work involving older people and away 
from physiotherapy. Following on from a series of full time research projects 
involving older people the researcher was given the opportunity to work on 
an NIHR programme "Bridging the Age Gap in Breast Cancer (BTAG)". The 
researcher role within the BTAG programme was primarily focused on the 
development of a patient decision support intervention.  This involved the 
introduction and development of the mixed method study design and 
subsequently responsibility for gaining ethical approvals and research and 
development governance for all the study sites involved in this phase of the 
BTAG study. The researcher was responsible for undertaking the literature 
review, participant recruitment, development of the interview topic guide, 
data collection and analysis. 
The following chapter is the first article, published in Current Breast Cancer 
Reports that forms part of this Article-based PhD. It reports a critical review 
of the literature undertaken to establish current knowledge surrounding 
information needs and decision-making preferences of older women with 
breast cancer.  
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2. Chapter 2: Article 1 
"Information Needs of Older Women Faced with a Choice of Primary 
Endocrine Therapy or Surgery for Early-Stage Breast Cancer: A Literature 
Review" 
The aims of this article: 
• To establish the evidence relating to information and decision-making 
preferences in older women (≥75 years) with primary operable breast 
cancer with a specific focus on the use surgery or PET. • To establish older women towards preference for information and its 
source and presentation when facing a choice between surgery and 
PET. 
This article is an integral component of this article based PhD as it 
demonstrates the gap in current knowledge regarding the information needs 
and preferences of older women diagnosed with breast cancer and offered a 
choice between surgery or PET  
I am the first author on this paper as I conducted the literature search, 
performed the review and wrote the article. My co-authors supported by 
acting as second reviewers in the review process and provided input on the 
structure and writing of this paper. 
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2.1. Reflective Review of Article 1 
This article fulfilled objective one of this study which was:  
1. To establish the evidence relating to information and decision-making 
preferences in older women (≥75 years) with primary operable breast cancer 
with a specific focus on the use surgery or PET. 
In this section the rationale for the type of review undertaken will be given 
and, using the NICE qualitative appraisal checklist, (NICE 2012) a quality 
assessment of studies that focussed on women ≥65years identified in the 
published article will be reported. The ENTREQ statement (Tong, Flemming, 
McInnes, Oliver & Craig 2012) will be used to provide a framework for the 
critical commentary of the published review presented in this chapter. Finally 
the findings from a re-run of the search strategy undertaken in February 
2017) are presented to provide an update on the current evidence regarding 
the evidence in this area. 
Type of Review 
The growth of evidence-based practice has led to an increasing number of 
reviews being published and with them diversity in the terminology used to 
describe them. The best known type of review is the 'systematic review'. The 
aim of the systematic review is to report the details of the method used to 
enable others to reproduce the process (Grant & Booth 2009). The 
systematic review often adheres to the Cochrane Collaboration guidelines 
that are exacting and need significant resources to complete. Cochrane 
describes a systematic review as the summary of:  
 "….the results of available carefully designed healthcare studies 
 (controlled trials) and provides a high level of evidence on the 
 effectiveness of healthcare interventions. Judgments may be made 
 about the evidence and inform recommendations for healthcare."  
 (Cochrane http://consumers.cochrane.org/what-systematic-review) 
Given the resources required it was not feasible to undertake a Cochrane 
style systematic review within this PhD but it was important to undertake a 
comprehensive search to produce a more complete picture of the research 
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surrounding the topic. Therefore the systematic 'systematic search and 
review' type of review described by Grant & Booth (2009) was chosen.  
This type of review  
"…combines strengths of critical review with comprehensive search 
process. Typically addresses broad question to produce 'best 
evidence synthesis' (Grant & Booth 2009, pg 94) 
Using the Search, Appraisal, Synthesis and Analysis (SALSA) framework the 
characteristics of the 'systematic search and review' are: 
Search:  Aims for exhaustive comprehensive searching 
Appraisal:  May or may not include quality assessment 
Synthesis: Uses narrative and tabular summary of studies 
Analysis:   What is known. Recommendations for practice and identifies 
  limitations.   
  Reproduced from Grant & Booth (2009) 
Grant and Booth (2009) state that the review may or may not include a 
quality assessment. Their definition of quality assessment is wide ranging 
and does not explicitly mean the use of a formal tool. They refer to the use of 
inclusion and exclusion criteria and a clearly defined process of synthesis, 
which were undertaken in this study.  
2.2. Rationale for the type of review 
'Older' was variably defined within the literature. Since this PhD study aimed 
to contribute to the evidence surrounding preference for information and 
treatment decision-making in women who may be offered PET as an 
alternative to surgery, the age at which this became clinically appropriate, 
≥75 years, was chosen the age of interest. However, it was apparent that 
there were very few studies that focussed on this age group and therefore a 
pragmatic decision was taken to use the traditional, age of 65 years (NSPOP 
2001) became an eligibility criterion. See Figure 1.3 for review process. (See 
Appendix 2 for detailed search strategy & Appendix 3 for details of the 4 new 
articles identified).  
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Seventy-seven articles met the inclusion criteria but only six research papers 
focussed on women ≥65; Crooks 2006, Ciambrone 2006; Kreling, Figueiredo, 
Sheppard & Mandelblatt 2006; Husain, Collins, Reed & Wyld 2008; Wong et 
al. 2011; Schonberg, Silliman, McCarthy & Marcantonio 2012). (See 
published article for details of these studies).  The remaining 71 were from 
mixed cohort studies, mixed cancer studies or review papers. They were 
heterogeneous in the age range, research questions posed and 
methodologies and methods used making synthesis and analysis difficult. 
Despite being of variable quality it was necessary to include them in the final 
published review to gain an overview of the situation and identify 'what is 
known' with regards to information needs and the preference for involvement 
in decision-making.  
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Figure 2.1:  Flow diagram showing review process for original and updated search 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Text in red are for the updated search figures 
 
Articles identified through database 
searching (n = 3190) (1366*) 
Additional articles identified through 
other sources (n = 4)(1) 
Articles after duplicates removed 
(n = 2691)(1112) 
Articles  screened 
(n = 275)(111) 
Full-text articles 
assessed for eligibility 
(n =  122) (14) 
Full-text articles 
excluded,  
(n = 45)(97) 
Articles  included  
(n = 77)(4) 
Articles excluded,  
(n = 2416)(1001) 
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2.3. Quality Assessment 
Undertaking a 'systematic search and review' did not require papers to be 
quality assessed using a formal tool. However, the strength of evidence of 
the six focussed papers, identified above, five have been examined using the 
NICE qualitative appraisal checklist (NICE 2017). (See Appendix 4 for 
completed checklists). The overall conduct of a study can be graded as 
follows:  
• ++ All or most of the checklist criteria have been fulfilled; where they 
have not been fulfilled the conclusions are very unlikely to alter. 
• + Some of the checklist criteria have been fulfilled, where they have 
not been fulfilled, or not adequately described, the conclusions are 
unlikely to alter. 
• - Few or no checklist criteria have been fulfilled and the conclusions 
are likely or very likely to alter.  (NICE 2012) 
Of the six focussed studies Schonberg and colleagues (2012) employed a 
medical notes review whilst the remaining five used a qualitative 
methodology and therefore could be assessed using the NICE qualitative 
appraisal checklist. All of the five qualitative studies were graded as +. In 
each of these papers the criteria that were not addressed, were the lack of 
description about the role and relationship the researcher had to the 
participants and the need for more than one method of data collection and a 
justification for triangulation or for not triangulating. Ciambrone (2006) and 
Crooks (2001) failed to provide details of the procedure for data analysis or 
how the themes from the interviews were derived. This calls into question the 
trustworthiness of the findings and highlights the lack of transparency often 
levelled at qualitative research (Barbour & Barbour 2003; Farmer, Robinson, 
Elliott & Eyles et al. 2006; Ritchie, Spencer & O'Connor 2013).  
The items in the NICE checklist reflect the growing need for transparency in 
how qualitative analysis is undertaken. It is no longer acceptable to report 
that 'themes emerged' there must be an auditable process that describes to 
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the reader the thinking and the rationale for the themes derived. As Miles 
and Huberman (1994) comment,  
"They [qualitative reports] are most often heavy on the 'what'(i.e. the 
findings and description) and rather thin on the 'how' (how you got to 
the 'what')"      
     (Miles & Huberman 1994 pg 262) 
The paper by Schonberg and colleagues (2012) aimed "to identify factors 
that influence the breast cancer treatment decisions of women aged 80 and 
older". This was a medical notes review of 2,185 women 80 years and older 
of which 65 had a diagnosis of breast cancer with various grades or ductal 
carcinoma in situ. Data for these women were accessed from online medical 
records between1994 - 2004 and followed up in 2010. The data included 
patient demographics, tumour characteristics, the Charlson Comorbidities 
Index, survival data, and a scoring system, "provided by the physician", to 
assess the level of detail on decision-making recorded in the records. The 
authors state that the analyses will provide descriptive information and are 
careful not to claim any statistical associations or correlations between any 
factors. Although not described as such the analysis resembles thematic 
analysis but unfortunately no details are given of how the analysis was 
undertaken. This study was heavily dependent on the recording of the level 
of detail about the decision-making process and this was reported to be 
variable. Medical note reviews are considered the lowest level of evidence 
(Sackett, Straus, Richardson, Rosenburg & Haynes 2000) and therefore the 
findings from this study should be used with caution. What is striking about 
this paper is that despite the lack of scientific rigour it identifies many of the 
issues raised by the other five papers which may be judged to be 
methodologically superior. 
2.4. Critical Commentary of Article 1 
The ENTREQ statement (Tong et al. 2012) was used to guide a critical 
commentary of the published article presented in this chapter. The aim of the 
ENTREQ statement is clearly stated in its own name "Enhancing 
transparency in reporting the synthesis of qualitative research (ENTREQ)". It 
has no scoring system but provides a checklist of items which the authors 
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suggest should be addressed when reporting a literature review of qualitative 
studies.  
Assessing the quality of qualitative research is difficult and contentious (Pope 
& May 2000) as there is little evidence that the quality of reporting reflects 
the trustworthiness of the findings or the robustness of the study (Dixon-
Woods et al. 2007). The aim of the ENTREQ statement is to enhance the 
reporting of qualitative syntheses (reviews) which will allow the reader to 
better understand the conduct of the study and processes of the synthesis. 
The authors accept that it is unlikely that there will ever be standardised 
reporting guidelines so instead have produced a checklist for consideration 
when undertaking and reporting review.  
The literature review satisfactorily addressed many of the relevant areas 
identified in the checklist, some of which were reported in the article, and 
some that were undertaken during the process but not reported (See Table 
1.1 for the ENTREQ statement and completed assessment). Possibly the 
most significant omission was the lack of use of an appraisal tool (item 11 in 
the checklist) during the review. (This issue has since been addressed and 
reported earlier in this chapter.)  
Items 18 and 19 were not fully addressed (See Table 1.1).  Being explicit 
about the way in which the synthesis occurred would have enhanced the 
transparency of the review. The purpose of the review firmly directed the 
information being sought. Each article was read with the specific aim of 
identifying the current evidence regarding the information needs, its 
presentation and the decision-making preferences of older women faced with 
a treatment option for breast cancer. Findings were then categorised into 
themes. The findings from each article were then compared across others in 
the same theme.  
Item 21 was similarly not fully addressed however the purpose of the review 
was as described above and therefore it did not require this level of analysis.  
This review was undertaken with a strong emphasis on the findings being of 
practical application in healthcare and this was achieved
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Table 2.1: The ENTREQ statement  
Review of "Information Needs of Older Women Faced with a Choice of Primary Endocrine Therapy or Surgery for Early-Stage 
Breast Cancer: A Literature Review" 
No Item Guide and description Article Review 
1  Aim State the research question the synthesis 
addresses. 
Purpose of the review clearly stated 
 
2  Synthesis methodology Identify the synthesis methodology or theoretical 
framework which underpins the synthesis, and 
describe the rationale for choice of methodology  
The rationale for the choice of methodology 
i.e. the type of review undertaken, a 
systematic search and review' was not stated 
in the paper. 
 
3  Approach to searching Indicate whether the search was pre-planned 
(comprehensive search strategies to seek all 
available studies) or iterative (to seek all available 
concepts until they theoretical saturation is 
achieved). 
The search was pre-planned and aimed to 
identify all available studies. 
 
4  Inclusion criteria Specify the inclusion/exclusion criteria (e.g. in 
terms of population, language, year limits, type of 
Inclusion and exclusion criteria were 
reported. 
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No Item Guide and description Article Review 
publication, study type).   
5  Data sources Describe the information sources used (e.g. 
electronic databases, grey literature databases 
(digital thesis, policy reports), relevant 
organisational websites, experts, information 
specialists, generic web searches (Google 
Scholar) hand searching, reference lists) and 
when the searches conducted; provide the 
rationale for using the data sources. 
All electronic databases were reported and 
the use of hand searching. Other sources 
were not used but this was not reported. The 
rationale for the choice of  database was not 
reported 
6  Electronic Search 
strategy 
Describe the literature search (e.g. provide 
electronic search strategies with population 
terms, clinical or health topic terms, experiential 
or social phenomena related terms, filters for 
qualitative research, and search limits). 
A full search strategy was written and the 
main headings were included in the 
publication. A detailed strategy is appended 
to this thesis. 
7  Study screening 
methods 
Describe the process of study screening and 
sifting (e.g. title, abstract and full text review, 
number of independent reviewers who screened 
studies).  
Process reported 
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No Item Guide and description Article Review 
8  Study characteristics Present the characteristics of the included studies 
(e.g. year of publication, country, population, 
number of participants, data collection, 
methodology, analysis, research questions).  
The characteristics of the most relevant 
studies were included in the main body of the 
article. All other articles details included were 
made available on line via the publisher. 
9  Study selection results Identify the number of studies screened and 
provide reasons for study exclusion (e.g. for 
comprehensive searching, provide numbers of 
studies screened and reasons for exclusion 
indicated in a figure/flowchart; for iterative 
searching describe reasons for study exclusion ) 
A PRISMA chart was used to demonstrate 
numbers identified and excluded. Reasons 
for exclusion were reported. 
10  Rationale for appraisal Describe the rationale and approach used to 
appraise the included studies or selected findings 
(e.g. assessment of conduct (validity and 
robustness), assessment of reporting 
(transparency), assessment of content and utility 
of the findings).  
Although not reported in the review an 
appraisal was made of both the content and 
utility of the findings. 
11  Appraisal items State the tools, frameworks and criteria used to 
appraise the studies or selected findings  
No quality assessment tools were used 
during the review as there was such a limited 
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No Item Guide and description Article Review 
amount of information. Appraisal has since 
been undertaken and all but one of the 
studies highlighted in the article were of good 
quality 
12  Appraisal process Indicate whether the appraisal was conducted 
independently by more than one reviewer and if 
consensus was required. 
Two appraisers were involved and there were 
no major differences in the opinion of the 
selection or appraisal of the included articles.  
13  Appraisal results Present results of the quality assessment and 
indicate which articles if any, were 
weighted/excluded based on the assessment and 
give the rationale. 
NA 
14  Data extraction Indicate which sections of the primary studies 
were analysed and how were the data extracted 
from the primary studies?  
A data extraction template was used to 
assess all of the papers. This was included 
for the six studies reported in the article. For 
the remainder this was available on line via 
the publisher 
15  Software State the computer software used, if any. NA 
16  Number of reviewers Identify who was involved in coding and analysis. NA 
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No Item Guide and description Article Review 
17  Coding Describe the process for coding of data (e.g. line 
by line coding to search for concepts).  
NA 
18  Study comparison Describe how were comparisons made within and 
across studies (e.g. subsequent studies were 
coded into pre-existing concepts, and new 
concepts were created when deemed necessary).  
Comparisons were based on common 
findings from previous studies. 
19  Derivation of themes Explain whether the process of deriving the 
themes or constructs was inductive or deductive. 
Themes were predetermined on the basis of 
the aims of the search. 
20  Quotations Provide quotations from the primary studies to 
illustrate themes/constructs, and identify whether 
the quotations were participant quotations of the 
author’s interpretation. 
No 
21  Synthesis output Present rich, compelling and useful results that go 
beyond a summary of the primary studies (e.g. 
new interpretation, models of evidence, 
conceptual models, analytical framework, 
development of a new theory or construct).  
No 
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2.5. Literature Search Update 
The literature search strategy (see Appendix 2) was re-run in February 2017 
to identify any articles published since the original search was performed on 
4th January 2013.  
1367 titles were retrieved and after duplicates and ineligible abstracts 111 
remained. After reviewing twenty-five full articles, four were judged to provide 
new evidence. (See Figure 2.1).  
Two of the articles retrieved in the re-run have 2013 dates but they were not 
identified in the original search. The article by Livaudis and colleagues was 
not published until May 2013 and was therefore not available at the time of 
the original search. Although the article by O'Brien and colleagues was 
originally available electronically in 2011 this would not have been identified 
through the databases searched. The article was not indexed until December 
2013 and so would not have been retrieved in the original search.   
There were no studies that specifically addressed the information needs, of 
older women with operable breast cancer facing a treatment choice between 
surgery and PET or their preference for involvement in decision-making.  
Three studies addressed treatment decision-making in older women 
diagnosed with breast cancer and one examined sources of information used 
by women with breast cancer. See Appendix 3 for details of these four 
studies. 
Sowerbutt and colleagues (2015) report the findings of a qualitative study to 
explore in detail with women over > 70 years of age the factors influencing a 
decision not to have surgery. The mean age of the women was 86 years 
(range 76-99). This study explored the reasons why women did not have 
surgery and concluded that older women with breast cancer have differing 
priorities and reasons for their treatment decisions. It also suggests that they 
are not passive in their decision-making as previously been reported.  The 
findings of this study provide further supporting evidence of the diverse 
nature of treatment decision-making in older women with breast cancer.  
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O'Brien and colleagues (2013) aimed to describe the perceptions of women 
with early stage breast cancer regarding their involvement in treatment 
decision-making. Their findings suggest that patients interpret treatment 
decision-making in a much broader way than simply their final decisional role. 
They see it as including both formal (medical personnel) and informal 
networks (family, friends, & organisations) from which they gather 
information and discuss the options.  
Livaudis and colleagues (2013) examined the link between decision-making 
responsibility and knowledge of breast cancer treatment. Those with poorer 
knowledge more frequently reported they had too much responsibility for 
their treatment decision and higher rates of decisional regret at six months 
post treatment. Poor health literacy was identified as a contributory problem 
leading the authors to recommend health care professionals find alternative 
ways of providing information to support their preferred level of decision-
making. 
The final study by Schmidt and colleagues (2016) examined the role of 
different information sources in patient decision-making regarding breast 
cancer surgery. The two most common sources of information used by 
patients were written material from surgeons (75%), closely followed by the 
Internet (69%). Patients were seen to use the internet not only for treatment 
information but also to investigate their surgeon.  This was an American 
study and many sought additional information from a different surgeon via 
second, third or more opinions. Use of the internet previously reported in the 
literature review article in chapter 1 is much lower at approximately 20% for 
older people so it is surprising to see such a high rate of usage in this study. 
It is possibly a feature of the cohort, as although the age range, 28-87 is 
reported no further breakdown is given. It is possible this is essentially a 
much younger cohort.  
In summary re-running the original search strategy did not substantially alter 
the findings from the original search, but it did provide further detail and 
support. 
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Whilst there are studies that do not exclude older women, there remain few 
studies that provide findings relevant to this population. There also remains a 
quality issue surrounding the reporting of studies. Although it is reported that 
older women are included the actual proportion and/or age range is not 
documented. 
Although there was evidence, largely from research in much younger women 
(Schonberg et al. 2010; Schou, Ekeberg, Ruland, & Karesen 2002; Nold, 
Beamer, Helmer, & McBoyle 2000), that HCPs were influential in the 
treatment decision making process it was not until the interviews in this study 
had been completed that it became clear how significant the impact was for 
this group of older women. Having recognised this impact, the opportunity 
was taken to examine the views on treatment decision making of older 
women with breast cancer and compare them to those of the HCPs, 
predominantly breast surgeons and specialist nurses. The findings from this 
examination are presented in chapter 7.  
The following chapter will provide a detailed examination of the 
methodological approach adopted within this thesis, namely mixed methods. 
It outlines the philosophical stance of mixed methods and a justification for 
the design chosen. 
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Chapter 3: Methodology  
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3. Chapter 3: Methodology 
This chapter outlines the rationale for the study and for using a mixed 
methods design. A  review of the traditional research paradigms and an 
explanation of the development of mixed methods  will be undertaken  before  
examining how a  ‘pragmatic, sequential mixed methods’ research design 
was chosen. 
3.1. Rationale for the study 
Although there is much written about the needs of younger women, i.e. those 
under 70-75 years of age, there is currently little published research that 
provides evidence regarding the information and support needs of older 
women faced with a treatment choice for breast cancer (Husain et al. 2008). 
This study aims to address this issue. 
3.2. Overview of the study design 
This study used a pragmatic sequential mixed methods design (See Figure 
3.1) employing a critical review of the literature, qualitative, in-depth, semi-
structured interviews and a quantitative, self-completion postal questionnaire 
to meet the aims and objectives of the study.  
The overall aim of the study was to establish the information needs and 
decision-making preferences of older women with primary operable breast 
cancer when faced with a choice of surgery or primary endocrine therapy 
(PET).  
The objectives were 
1. To establish the evidence relating to information and decision-
making preferences in older women (≥75 years) with primary 
operable breast cancer with a specific focus on the use surgery or 
PET. 
2. To elicit the views of older women towards preference for 
information and its source and presentation when facing a choice 
between surgery and PET. 
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3. To elicit the views of older women towards decision-making styles 
when faced with a choice of surgery or PET. 
4. To determine the influence of the health care professional in 
treatment decision-making in older women with operable breast 
cancer. 
Figure 3.1: Overview of the exploratory, sequential mixed methods design 
 
 
 
 
 
 
 
 
3.3. Methodology 
Despite the notion that research is a systematic and clearly defined process 
the vast array of methodologies and methods from which to choose can be 
bewildering. Furthermore, the terminology used in the literature is used 
interchangeably and sometimes in contradictory ways (Crotty 1998). The 
words 'paradigm', 'epistemology', 'worldview' and more recently 
'communities' are all used interchangeably despite being defined clearly. 
Additionally 'theoretical perspective', 'theoretical stance'. ‘theoretical 
foundations',  'underpinning philosophy' and 'methodology' are similarly 
interchangeably used.  
Crotty (1998) suggests that there are two questions which need to be 
answered when developing a research proposal; what methodologies and 
methods will be used and how will their use be justified?  
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Underlying this justification is the interconnectedness of the basic elements; 
the epistemology, the ontology, the theoretical perspective, the methodology 
and the methods (See Figure 3.2).  
Epistemology is 'a way of understanding and explaining how we know what 
we know.' (Crotty 1998). Alternatively it is defined as 'a general orientation 
about the world and the nature of the research that a researcher holds' 
(Creswell 2012) and is 'a basic set of beliefs that guide action' (Guba1990). 
The action it guides in research is the collection and interpretation of data. 
Ontology is defined as 'the study of being' (Crotty 1998) and is concerned 
with the structure of reality and is inextricably linked to epistemology since it 
is not possible to discuss 'what it means to know' (epistemology) without 
discussing the 'what is' (ontology) (Crotty 1998:10). This link will become 
clear when the differing epistemologies are discussed later in this chapter. 
The methodological approach taken in a study arises from the worldview or 
paradigm or epistemology of the researcher (Guba 1990, Crotty 1998, 
Creswell 2012). Although these philosophical underpinnings may not be 
overtly expressed within research findings, these underpinnings are needed 
to inform the basis from which the research design is developed (Creswell 
2012). 
 Figure 3.2 Depiction of the relationship between the basic elements of research  
 
 
 
 
 
 
       
      (Adapted from Crotty 1998 pg 4) 
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Research methods are the techniques and procedures used to collect and 
analyse data. To ensure that the research process can be justified it is 
important to provide a detailed description of the methods to be used. For 
example, it is not sufficient to say 'interviews will be carried out'. The type of 
interview and method of analysis need to be described to provide the 
rationale and justification for their use (Crotty 1998). 
This section will focus on two traditional epistemologies: objectivism and 
constructionism and two respective theoretical perspectives as Crotty refers 
to them, positivism, and interprevitism before moving on to the theoretical 
perspectives of pragmatism and critical realism associated with the 
development of mixed methods research (Crotty 1998; Creswell 2007, 
Teddlie &Tashakkori 2009). 
3.4. Objectivism 
Objectivism is one of a range of epistemologies. Objectivists maintain that 
there is reality outside of our consciousness and that the aim of scientific 
investigation is uncover accurate and certain knowledge of this reality.   
Objectivism is the underlying theoretical perspective of positivism and post 
positivism (Crotty 1998).  
3.4.1.  Positivism 
Positivism is difficult to define precisely as it has it has evolved over time with 
12 distinct versions being identified (Halfpenny 2014).  However, a general 
belief held by positivists is that reality is stable and can be observed and 
described from an objective viewpoint (Levin & Clowes 1991). 
The fundamental feature of positivism is the need to engage with the 
scientific process, that is, using a highly systematic, well organised, 
approach to research, consistently using absolute principles (Crotty 1998).   
The use of experimental methodology, hypothesis testing and the collection 
and analysis of predominantly quantitative / numerical data are 
characteristics of positivism (Ibid). One of the key features that accompany 
objectivism is the need to separate the researched from the researcher to 
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reduce bias and minimise involvement which may influence the results or 
outcome of the study. Positivist research employs deductive logic or 
reasoning to argue from general observations to the particular. This 
hypothetico-deductive model involves the testing of a hypothesis, derived 
from a theory, using statistical methods and tests. This necessitates a need 
for measurement of the variables under investigation using systems that 
adhere to mathematical or unit of measurement conventions.  
This strict positivist view was first challenged by a number of scientists at the 
end of the 19th century but most influentially by Kuhn (2000) who questioned 
the logic of requiring objectivity and a context free, value-free stance for the 
discovery of knowledge. There was an emerging recognition that objectivity 
could not deliver one 'absolute truth' and this led to a branch of positivism 
called post-positivism. The key difference between positivism and post 
positivism is that positivists believe scientific method can result in truths that 
can be generalised to the world, post-positivists believe that the 
interpretation of results and scientific truths need to be set in context with 
conclusions being only cautiously generalized. Furthermore, Popper (1934) 
argues that observations alone are insufficient to make generalisations and 
that data only make sense in the context of a theory that can be tested. 
Popper rejects the idea that theory can be confirmed and instead proposes 
that all that can be achieved is that the theory can be shown not to be true, 
this becoming known as 'falsificationism'. It is far more cautious in its claims 
for the achievement of true facts through science and Popper developed it in 
direct opposition to the strict ‘logical positivism’ that dominated his era.  He 
believes that science will only progress if the theory or null hypothesis is 
tested. By being able to reject the null hypothesis, support can then be given 
to the hypothesis or theory under investigation.  Gradually there has been 
acknowledgment that positivism can only provide speculative truths and has 
limitations in accessing knowledge of the social world (Crotty 1998). 
3.5. Constructionism 
Constructionism is an epistemology predominantly related to the social world 
and not the natural world.  
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Crotty describes a purist view of constructionism as:  
‘…the view that all knowledge, and therefore all meaningful reality as 
such, is contingent upon human practices, being constructed in and 
out of interaction between human beings and their world, and 
developed and transmitted within an essentially social context’  
  (Crotty 1998 pg 42) 
In its purist sense constructionism is the antithesis of objectivism. As the 
term suggests, meaning or knowledge is considered to be constructed by 
human actors and not discovered as a reality outside human consciousness. 
Constructionists therefore argue there is no objective reality waiting to be 
discovered in the social world, and that all social meaning relies on human 
beings engaging with and interpreting the world (Crotty1998). 
The less purist view of constructionism holds true for both the social and 
natural world. For some the natural world is also constructed, in different and 
contradictory ways.  
3.5.1.  Interpretivism 
The epistemology of constructionism brings with it the theoretical perspective 
of interpretivism. In contrast to positivists, interpretivists believe that the 
researcher and the researched co-construct knowledge and that it is 
impossible to conduct objective, value free research (Crotty 1998) 
Constructionism and interpretivism are often associated with qualitative 
methodologies such as ethnography, phenomenology and grounded theory 
that dictate the use of narrative type methods of data generation such as 
interviews, focus groups or observation. Approaches such as thematic or 
framework analysis are used to organise and identify issues of importance 
and relevance.  The analysis and interpretation of these data rely on 
inductive logic, moving from the particular to the general (Crotty 1998).  
3.6. The Choice of Methodology 
The methodologies associated with each of these epistemologies and their 
respective theoretical perspectives can be broadly categorised into 
qualitative and quantitative research. The choice of methodology is 
dependent on the research question and the aims of the study. Quantitative 
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and qualitative research answer different questions, and produce different 
forms of knowledge with the essential focus of quantitative research being 
confirmatory, whilst qualitative research addresses predominantly 
exploratory questions (Teddlie & Tashakkori 2009).  
3.6.1. Quantitative Research 
Quantitative research is situated primarily within the objectivist epistemology 
(with a theoretical perspective of positivist / post positivist) and uses an array 
of techniques to collect, analyse and present numerical data (Teddlie & 
Tashakkori 2009).The purpose of quantitative research is commonly to 
confirm but may also be to explore the current knowledge base of the 
research phenomenon under investigation. This model requires a hypothesis 
or quantitative research question be posed and tested using statistical 
techniques. The use of statistical techniques and analyses is directly linked 
to the research design and the methods used to collect the data. Quantitative 
research uses experimental, correlational and survey designs. Underpinning 
these research designs is the use of probability sampling, which involves the 
random selection of participants from the target population (Teddlie & 
Tashakkori 2009). Both descriptive and inferential statistical techniques are 
used to analyse the data. The purpose of descriptive analysis is to provide 
an overview of and describe the relationship between the variables. 
Inferential statistics provide a way of "..making inferences from samples to 
populations." More specifically inferential statistics involves the testing of 
difference between group means or the relationship between variables and 
the trustworthiness of those differences. (Teddlie & Tashakkori 2009). 
3.6.2. Qualitative Research 
Qualitative research aligns within a constructionist epistemology and using 
narrative data employs inductive reasoning that is, a process of generating 
theory from data, rather than testing theory as in the case of deductive 
approaches. Qualitative research is predominantly, but not always 
exploratory using a variety of methodologies such as ethnography, grounded 
theory and case study. Unlike quantitative research, qualitative research 
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most commonly uses purposive sampling.   Purposive sampling is a type of 
sampling where: 
"…particular settings, persons, or events are deliberately selected for 
the important information that they can provide that cannot be gotten 
from as well from any other choices."  
      (Maxwell, 1998 pg 235) 
There are a number of characteristics that might differentiate participants 
including, age, gender, race, illness type and so on with their inclusion being 
dependent upon the aims of a particular study (Clark & Creswell 2011).  
Commonly the analysis of qualitative data involves the identification of 
themes, categories and/or patterns which are then examined to reach an 
understanding of the research questions. 
3.6.3. The 'Paradigm Wars' 
The 'paradigm war' (Creswell & Plano Clark 2011) was initiated by the rise of 
qualitative research and the criticism of quantitative research and its 
positivist stance as being limited in producing beneficial research (Guba & 
Lincoln 1994). Paradigms are belief systems or epistemologies that guide 
research (Teddlie &Tashakkori 2009). It was argued that since research 
paradigms are linked to particular research methods and the paradigms rise 
from differing theoretical perspectives they could not be combined or mixed 
and were incomensible  (Kuhn 1962). However arguments that  highlighted 
the differences also served to illuminate the strengths and weaknesses in 
both quantitative and qualitative research and it began to be argued (Denzin 
1978) that in combination they could address both exploratory and 
confirmatory questions simultaneously, provide 'better (stronger) inferences'.  
It is from this position that allowed the emergence of divergent views (Teddlie 
&Tashakkori 2009) that mixed methods research arose. 
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3.6.4. Mixed Methods Research 
The term 'mixed methods' was first coined by Teddlie &Tashakkori  in 'The 
Handbook of Mixed Methods in Social and Behavioural Research' (2010) and 
has been widely used ever since across many disciplines.  
Mixed methods are increasingly used in health research with the proportion 
of commissioned MM studies rising from 17 per cent in the 1990's to 30 
percent in the early 2000s. (O’Cathain, Murphy, & Nicholl, 2007) as it claims 
to address the complexity of this setting.   
"Within health services research, a mixed methods approach is 
justified on pragmatic rather than ideological grounds, to help 
researchers to engage with the complexity of health, health care, and 
the environment in which studies take place"   
       (O’Cathain et al. 2007). 
Despite this popularity a clear definition of the approach remains to be 
agreed, Johnson, Onwuegbuzie & Turner (2007) analysed many different 
definitions of MM research and suggested the following; 
"Mixed methods is the type of research in which the researcher or 
team of researchers combines elements of qualitative and quantitative 
research approaches, (e.g. use of qualitative and quantitative 
viewpoints, data collection, analysis, inference techniques) for the 
purpose of breadth of understanding or corroboration."  
      (Johnson et al. 2007pg 123) . 
Mixed methods has also been variously referred to as 'an important 
methodological approach' (O'Cathain, Murphy, Nicholl (2007), 'a research 
paradigm or research approach' Johnson et al. (2007) whilst Teddlie and 
Tashakkori state it is not a methodology and refer to MM research as the ' 
third methodological community' (Teddlie &Tashakkori 2009).  
Mixed methodologists argue that the research question drives the research 
process and that whatever methodological approaches are required to 
answer that question should be used (Teddlie &Tashakkori 2009). Johnson 
et al. (2007) describe it as lying in the centre of a continuum as illustrated in 
Figure 3.3 overleaf. 
 
73 
 
Figure 3.3: The QUAL-MM-QUAN Research Continuum 
 
 
 
 
 
 
 
 
Adapted from Teddlie & Tashakkori 2009 
Mixed methods research involves the collection, analysis and, pivotally an 
integration of findings with inferences drawn from both qualitative and 
quantitative data from a single study or programme of enquiry with a 
common research question (Tashakkori & Creswell 2007). .  
3.7. Mixed Methods Research - the philosophical stance 
The two prominent theoretical perspectives underpinning MM research are 
pragmatism and critical realism.  
3.7.1. Pragmatism 
There are many forms of pragmatism which derive from the work of Dewey, 
James and Mead (Cherryholmes 1992). Pragmatism is defined as;  
". a deconstructive paradigm that debunks concepts such as ‘truth’ 
and ‘reality’ and focuses instead on ‘what works’ as the truth regarding 
the research questions under investigation. Pragmatism rejects the 
either /or choice associated with the paradigm wars, advocates for the 
use of mixed methods in research, and acknowledges that the values 
of the researcher plays a large role in the interpretation of the results"’ 
  (Teddlie & Tashakkori 2003a p 713 cited in 2009)  
Pragmatists view the research question to be of utmost importance over and 
above the methods used or the underlying paradigm of those methods. 
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C 
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A = Totally Qualitative research 
B = Primarily Qualitative research with some Quantitative 
C = Totally integrated MM research  
D = Primarily Quantitative research with some Qualitative 
E = Totally Quantitative research 
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(Morgan 2007; Teddlie &Tashakkori 2009). This lack of affinity to a single 
paradigm allows the researcher to benefit from the strengths of both 
quantitative and qualitative approaches. Pragmatism is concerned with 'what 
works' and the solutions to problems and emphasises the use of all available 
methods to understand the problem. Pragmatism is thus understood as a 
practical and applied research philosophy that supports mixed or multiple 
methods of social science inquiry (Maxcy, 2003).  Pragmatism takes a 
neutral view of ontology and epistemology.  Its originators were concerned 
with the practical consequences of beliefs – if a belief had no practical 
consequence then it was meaningless and of no use.  From this point of view 
it could be argued that the debate between objectivists and constructivists is 
meaningless – it does not matter whether a theory is objectively true or 
socially constructed – what matters are the consequences of believing it.   
Although pragmatism is commonly the theoretical perspective aligned to MM 
research (Teddlie &Tashakkori 2009) is it not the only one. Critical realism 
has also been associated with MM and this has quite distinct views of 
ontology and epistemology to pragmatism. 
3.7.2. Critical Realism 
Critical realism is a philosophical stance which attempts to describe a link 
between the natural and social worlds (Sayer 2000). Critical realism is 
viewed as being an integration of a realist ontology i.e. there is a world which 
exists outside of human consciousness, with a constructionist epistemology, 
i.e. our understanding of the world is a construction of our experiences and 
perspectives (Creswell & Clark 2011). Critical realists believe there is a 'real 
reality'  that is, they agree with the objectivist position that entities exist 
outside  human consciousness  (Denzin & Lincoln 2011) but this can only be 
partially understood as our understanding of that external entity is 
constructed (Teddlie &Tashakkori 2009).   
Critical realists acknowledge the strengths of both the positivist and 
constructionist stance and consider that external realities can only be known 
in the social world through how they are socially constructed by human 
agents. This is acknowledged by Sayer when he states: 
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"…critical realism seeks to avoid both scientism and 'science envy' on 
the one hand and radical rejection of science on the other"  
 (Sayer 2000 pg 3) 
The foundation of critical realism is realism and based on developments of 
the original work by Bhaskar (1975 cited by Sayer) critical realists are 
interested in the context and mechanism of findings. (Sayer 2000). 
Pragmatists suggest that the practical consequences of a mixed method 
researcher adopting either pragmatist or critical realist views are moot; as 
such they might dispute the meaningfulness of the debate at all.  Realists 
would dispute this, particularly in relation to the understanding of complex, 
open systems.  However, in research on fairly straightforward social 
phenomena, the pragmatists have a point.  It is for this reason, a pragmatic 
view was taken in this study; there was no need for the researcher to take 
sides in this dispute and so she did not.  Critical realism was rejected in this 
study because the research questions are exploratory and do not require the 
complex social phenomena i.e. the context or mechanisms underlying the 
questions to be understood in depth as this was not the aim of this study. 
(Sayer 2000). 
3.8. Justification for the use of pragmatic sequential mixed 
methods design 
Creswell & Plano Clark (2011) have identified six major mixed methods 
research designs, the convergent parallel design, the explanatory sequential 
design, the exploratory sequential design, the embedded design, the 
transformative and the multiphase design.  
The choice of a ‘pragmatic, sequential mixed methods’ research design for 
this study is based on the need to both identify unknown factors or important 
issues, which lends itself to qualitative research methods, and the need to 
generalise or transfer the findings to a wider population necessitating the use 
of a more quantitative method. The data are generated and collected 
sequentially where the findings from the qualitative dataset are used to 
develop a quantitative tool that is then used to test or examine the extent to 
which the qualitative findings can be generalised / transferred.  
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The purpose of this study is to explore and confirm the information and 
support needs of older women when faced with a treatment choice for breast 
cancer. This requires a two-phase, pragmatic, sequential approach as 
neither a positivist nor constructionist philosophy alone is capable of 
achieving this.  
3.9. Benefits and Challenges of Mixed Method Research 
The benefits of MM research have been much discussed in the literature 
(Green & Caracelli 1997; Creswell & Clark 2011) and these have been 
synthesised in two now prominent frameworks based on the work of Greene 
and colleagues (1989) and Bryman (2008). Greene, Caracelli and Graham 
(1989) identified five broad reasons for the use of MM research, these are 
triangulation, complementarity, development, initiation and expansion. 
Bryman (2008) produced a second more detailed framework based on an 
analysis of researcher practices. (See Table 3.1 for the items within this 
framework that justify the use of MM for this study).  
Mixed methods research does not come without challenges. It requires the 
researcher is familiar with both qualitative and quantitative research including 
the methodologies employed and the methods of data collection and analysis 
(Creswell & Plano Clark 2011). Where a team is undertaking the research 
this may not be an issue. Consideration needs to be given to available 
resources since MM research requires significant time to complete all phases 
of the study.  
The greatest challenges identified are, data management, processing and 
analysis and the potential for data overload (Lieber 2009). Once the data are 
analysed this is likely to create significant amounts of information which 
needs to be synthesised and presented in an integrated or combined way 
demonstrating how the methods complement each other rather than expose 
their inherent weaknesses (Molina-Azorin 2010). 
The following chapter will outline the research procedure; describe the data 
collection tools, the rationale for their use and the analysis methods before 
detailing the ethical review process. 
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Table 3.1: Justification  for the use of Mixed Methods Research for this study.  
(Adapted from Bryman (2008)) 
 
Triangulation or greater validity: the combination of quantitative and 
qualitative research to triangulate findings in order that they may be mutually 
corroborated or provide a fuller picture 
 
Offset: recognition that quantitative and qualitative methods have strengths 
and weaknesses and combining the two will allow the weaknesses to be 
offset and the strengths to be drawn upon. 
 
Completeness: the notion that a more comprehensive understanding can be 
achieved using both quantitative and qualitative methods. 
 
Different Research Questions: quantitative and qualitative research answer 
different types of research questions. 
 
Explanation: one method is used to explain the findings from the other. 
 
Unexpected results: combining quantitative and qualitative research can help 
understand unexpected findings arising from one method. 
 
Instrument development: when qualitative research is used to develop a 
questionnaire and scale items 
 
Credibility: the notion that employing both approaches enhances integrity. 
 
Context:  qualitative research is used to provide contextual understanding to 
either generalizable or broad relationships among variables uncovered 
through a survey. 
 
Illustration: the use of qualitative data to illustrate quantitative findings.  
 
Utility or improving the usefulness of findings: the notion that combining the 
two approaches will be more useful to practitioners. 
 
Enhancement: the ability to enhance or augment the findings from qualitative 
or quantitative approach by the use of the alternative approach. 
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Chapter 4: Methods 
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4. Chapter 4: Methods 
This chapter details the methods employed in the study. The data collection 
tools and analysis methods of semi-structured interviews and postal self-
completion questionnaires will be described and examined against the 
objectives of the research. The process of ethics review will be presented 
first. 
4.1. Ethical Approval 
Multi-site ethical approval was gained via a proportionate review from NRES 
London -Surrey Borders Research Ethics Committee (12/LO/1722) as was 
local research governance at each of the sites (See Appendix 6 & 6A).  
Proportionate reviews are for questionnaire and or interview research that 
does not include highly sensitive areas or where accidental disclosure would 
not have serious consequence (NHS Health Research Authority)  
4.2. Ethical Implications 
In keeping with good practice, a number of ethical issues were carefully 
considered during the development, administration and analysis of the 
interview and questionnaire elements of the study.  
Research involving older people raises potential issues of age-related 
reduction in physical and cognitive ability, which may affect the ability to 
consent to participation and to give and receive information (Tinker 2003). 
Using advice from the Health Research Authority careful consideration was 
given to how the initial approach was made to invite the women to take part 
in the study and to the construction of the written information. Women were 
approached by their treating clinician or a breast care nurse as they were 
familiar with them and had developed a relationship with them. These HCPs 
were well placed to identify eligible patients and assess their cognitive ability.  
Written material, including invitation letters, participant information sheets 
and consent forms were developed in line with Health Research Authority 
guidance (HRA guidance). To address the possible reduction in visual 
capacity an increased font size and a generous space layout were used to 
create all research documents. Importantly non-medical, everyday language 
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was used in participant information and consent sheets and the 
questionnaire.  
Older people are often described as being 'vulnerable'. Vulnerable people 
are those who are unable to protect themselves from harm or exploitation 
possibly for reasons of physical or mental illness or age (Lange, Rogers & 
Dodds 2013).  To guard against any unintended pressure or coercion 
potential participants were given information packs and asked to reply to the 
researcher direct. In this way there was less chance they would feel any 
pressure to participate.   
Discussing the topic of cancer, whether this be the participant’s own cancer 
or that of a family member or friend, may be distressing. The researcher 
needs to be mindful of this during the interview. Some participants will be 
willing to disclose great detail whilst others may be more reluctant and the 
issue of using probe questions needs to be delicately handled before and 
during the interview.  At the start of the interviews all interviewees were 
reminded that they did not have to answer questions they were 
uncomfortable with and that they had the right to withdraw from the study at 
any time without giving a reason.  
Confidentiality of all documentation  was also assured by secure storage and 
handling according to the Data Protection Act 1998 (UK Government 1998). 
Confidentiality in research means that the participant will not be identified 
and any data, e.g. quotes from interviews, used in publications will be done 
anonymously. Protecting confidentiality can raise ethical issues. When a 
researcher obtains knowledge of malpractice, mistreatment or criminal 
activity this can present a dilemma of what action to take (Kvale & Brinkman 
2009). This situation needs to be considered prior to any interviews being 
conducted to inform the interviewee as to the action that would or wouldn't be 
taken.  
The women were given a choice of the most convenient and comfortable 
venue for the interviews to take place, their own home being one option. 
Entering a participant's home shifts the balance of power and means the 
researcher  has less control over the environment, for example other people 
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being present or the noise level not being conducive  to interviewing. It also 
requires the researcher to consider a number of health and safety issues. To 
maintain the safety of the researcher the' lone working policy' of the 
researcher's university was followed (Sheffield Hallam University lone 
working policy).  
4.3. Phase one - Qualitative Interviews 
The sequential mixed methods design introduced previously, includes an 
exploratory phase (phase one) which was achieved by the use of interviews 
to generate data to explore the topic. These data were then used to develop 
a questionnaire that was used in phase two to test or confirm the findings 
within a wider population. 
The study objectives met by the interviews were:   
• To elicit the views of older women towards preference for 
information and its source and presentation when facing a choice 
between surgery and PET. 
• To elicit the views of older women towards decision-making styles 
when faced with a choice of surgery or PET. 
 4.3.1  The Sample 
Purposive sampling was used for this phase of the study.  
 Purposive sampling is a type of sampling where: 
"… the sample is chosen because they have particular features or 
characteristics which will enable detailed exploration and 
understanding of the central themes and questions which the 
researcher wished to study"      
  (Ritchie,et al. 2014 pg 113).  
Within this study, the interview participants were purposively sampled from 
the target population of women, over 75 years of age, who had received a 
choice of surgery or PET for the treatment of primary operable, oestrogen 
receptor positive, breast cancer, and therefore able to provide the 
information sought in the study. The sampling frame for the purposive 
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sample for the qualitative interview phase comprised five NHS breast cancer 
units within UK hospitals in England and Wales. Where purposive, non-
probability sampling is undertaken it is not necessary to calculate a sample 
size with all women in the sites being eligible. Thirty-eight women 
participated in an interview, forming the purposive sample for the study.  
The aim of qualitative research is to explore issues and in the case of this 
study the information needs and decision-making style preferences of older 
women faced with a treatment choice for breast cancer. Adler & Adler (Baker, 
Edwards & Doidge 2012) recommend that data be gathered until empirical 
data saturation is reached. They acknowledge that the number will depend 
on the size of the sample pool, the ease with which the participants can be 
accessed and the time and resources available to the researcher. In this 
study an estimate of 35-40 was made.   
4.4. Eligibility Criteria 
Women were eligible if:  
• they were ≥ 75 years, (the lower age at which PET is predominantly 
used),  • had been diagnosed with invasive breast cancer in the preceding 60 
months  • offered an initial treatment choice between PET and surgery 
(documented in the medical records). 
Women were not eligible if 
• in the view of their Health Care Practitioner (HPC) they showed signs 
of significant cognitive impairment,  • they were unable to give informed consent  • they had locally advanced or metastatic breast cancer as they would 
have a different set of experiences and characteristics.  
Women were not excluded on the basis of language. Where an interpreter 
was required this would be supported with funding from the parent study. 
However, this strategy was not required. 
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4.4.1.  Recruitment  
The recruitment strategy employed is detailed in the article two in chapter 5. 
Below is an overview of the sites involved and process of engagement. 
During the development of the parent study an invitation to take part in the 
identification and recruitment of participants had been accepted by many 
sites. Five of these sites were invited to participate in this PhD study. The 
sites were approached as it was known they had sufficient numbers of 
potentially eligible patients, they had expressed interest in the project and the 
geographical location meant they were accessible to the interviewers.  
Prior to the start of this study a certificate of good clinical practice, a research 
passport and letters of access or honorary research contracts (See Appendix 
7 & 8) were obtained in compliance with the Research Governance 
Framework for Health and Social Care 2005. In line with NHS research 
guidelines (NIHR 2012) 'set up' meetings were undertaken at each of the five 
sites participating in the interviews. Set up meetings enhance common 
understanding of the study protocol, including participant eligibility, data 
reporting mechanisms, data storage and the roles and responsibilities of 
each member of the research team.  
In accordance with the specific governance approval at each site, patients 
were approached to participate by either the consultant surgeon or a 
research nurse during a routine check-up visit to the breast clinics. Each 
eligible patient received a study pack that contained: a letter of invitation, a 
participant information sheet, a study reply slip (See Appendix 9, 10 & 11) 
and a freepost return envelope. The surgeon and/or research nurse 
answered any immediate questions but the patients were not asked to make 
a decision immediately but to take the pack home and discuss their 
involvement with their family and friends if they wished to do so. Using the 
freepost return envelope the reply slips were sent directly to the researcher 
who was then able to contact the patient to make arrangements for the 
interview. No reply was requested should the patient decide not to take part. 
Informed written consent was taken at the beginning of the interview (See 
Appendix 12).  
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Once a positive response was received by the researcher, women were 
contacted to arrange a convenient date, time and venue to conduct the 
interview. Women were encouraged to choose a venue in which they felt 
most comfortable and they were invited to have a friend or relative in 
attendance during the interview if they so wished. The researcher arranged 
to call the participant earlier in the day of the interview to check they were 
well and that it was still convenient for them to take part. 
In line with the university 'lone working' policy the researcher left details, with 
the administrative staff, of the address they were visiting and contact was 
made with the administrative staff prior to meeting with the participant and 
immediately following the interview. 
At the beginning of the interview the researcher took the opportunity to 
refresh the participant's understanding of the study, address any questions 
they may have and ask permission to digitally record the interview. Once it 
was apparent that the participant was happy to proceed they were asked to 
give written consent (Appendix 12). 
At the end of the interview the participants were thanked for their time and 
support for the project. They were also offered the opportunity to receive a 
copy of the research findings on completion of the study.  
4.5. Research Interviews 
Research interviews are commonly categorised by the degree of structure or 
standardisation, ranging from the very structured at one end of the 
continuum to the unstructured at the other (Robson 2002). Structured 
interviews commonly have a combination of closed questions often with a 
pre-coded response choice which create quantitative data and open 
questions which allow for some elaboration on responses producing 
qualitative data. (Bowling 2009; Kvale & Brinkmann 2009). These are used to 
survey populations or when the participant does not have the capacity to 
complete a self-administered questionnaire. (Tod 2006)   Unstructured 
interviews have only a rudimentary interview guide of the topics to cover and 
are most often conducted where little is known of the phenomenon and are 
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led more by the participant than the researcher (Tod 2006). At the centre of 
this continuum lies the semi-structured interview.  
The semi structured interview is commonly used to explore something that is 
already known about a particular phenomenon but requires further 
exploration. This format allows a narrative and/or discursive style of interview 
where the familiar act of talking and conversation are used. Kvale & 
Brinkmann (2009) state; 
"Conversation is a basic mode of human interaction….Through 
conversation we get to know other people, learn about their 
experiences, feelings, attitudes, and the world they live in."   
 (Kvale & Brinkmann 2009 pg xvii)  
Semi-structured interviews are conducted using a guide that enables topics 
to be explored within a conversational style of interview.  This format also 
has the flexibility to probe answers and draw on cues to gain more detailed 
information and discuss issues that previously have not been identified 
(Kvale & Brinkman 2009; Gray 2013).  
A semi-structured interview format was used in this study. The topic guide 
(see Appendix 13) was developed from the literature findings, with input from 
members of the North Trent Cancer Network Consumer Research Panel and 
by identifying key areas to be explored in order to meet the study objectives.  
The semi-structured research interview uses conversation that has a 
structure and aims to produce knowledge (Kvale & Brinkmann 2009). 
Obtaining data to create knowledge requires that the researcher listens 
carefully and probes the answers given without influencing the perspective of 
the participant. Unlike everyday conversation the parties involved are not 
equal partners because the researcher determines the topic and through 
follow on questions, directs the flow and focus of the interview by picking up 
on areas which are of most interest to the researcher. Directing the flow and 
topic areas is not always easy, particularly with older people (Robertson & 
Hale 2011).  
Semi-structured interviews may have the benefit of being pleasurable to take 
part in, particularly when the topic is non-contentious (Gray 2013). Reflecting 
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on events with a stranger (the researcher) may arguably be cathartic 
(Robertson & Hale 2011).  Asking people to commit, in writing, their thoughts 
and feelings is a much more onerous task so the opportunity to talk about 
events in a relaxed situation may also be more appealing (Gray 2013) and 
possibly have the benefit of increasing recruitment.  
4.6. Interviewing the older person 
Sensory Impairments 
Research interviews with older people are in many ways no different to 
interviews undertaken with other groups of people, however there are some 
specific issues which require consideration (Gubrium & Holstein  2002; 
Robertson & Hale 2011). Potential age related physical impairments such as 
visual disturbance and hearing loss need to be considered. Where poor sight 
is an issue providing a suitable lighting level and appropriate close 
positioning of the researcher will enable the older person to make out the 
features and facial expressions more clearly and make them feel more 
comfortable. Hearing loss requires the researcher speaks clearly and slowly 
and position themselves to allow the respondent to gain additional 
information from the facial expressions and lip reading. (Whitbourne et al., 
2010). 
4.6.1.  Cognitive Function and the Research Interview 
Although many cognitive abilities remain in older age, there is an acceptance 
that there is general slowing of information processing (Salthouse 1996). 
This slowing process increases with advancing age.   Salthouses'  'general 
slowing hypothesis' (Salthouses 1996) is also used to explain the decline in 
working memory (short term memory), the part of the memory that makes 
information temporarily available. The loss of processing speed creates a 
backlog of cognitive processes that impairs memory (Hasher, Zacks & May 
1999). Coupled with this slowing process is the theory that older people have 
difficulty filtering out information that is not relevant to the task (Whitbourne 
et al. 2010). To overcome the possibility of overloading and overwhelming 
the participant consideration needs to be given to the style and pace of the 
interview. 
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A conversation style of interview was utilised in order to help the older 
women interviewed in this study feel more relaxed. Conversation being 
viewed as a familiar activity is likely to reduce the burden of the interview 
(Kvale & Brinkmann 2009). During a conversation there is an expectation 
that information will be exchanged and the researcher needs to consider 
their stance on this element of the interview. It seems unavoidable to 
disclose nothing of one's own life but equally full disclosure may not be 
appropriate (Wegner 2001). Reciprocity may build trust in a relationship and 
may encourage the respondent to be more expansive in the information they 
reveal (ibid). Wegner (2001) states that reciprocity is particularly expected by 
older people during interviews. 
4.6.2.  Story-telling during the Research Interview 
Older participants tend to require more frequent re-focusing back to the topic 
than their younger counterparts (Robertson & Hale 2011). Additionally, 
allowing the older person to tell their stories in their own way may also 
facilitate richer description and foster mutual respect between the researcher 
and the researched (Robertson & Hale 2011).  Context is important when 
recollecting events (Errante, 2000) and storytelling can be one way of 
providing the context. Storytelling may trigger the recall of related issues or 
events and provide a richer description. Re-telling a story also provides an 
opportunity for reflection and deeper understanding of a situation or event 
(Davidson 2004). Interweaving the 'set questions' whilst listening to the story 
may further stimulate other recollections which may be pertinent to the topic 
under review.  
Answering questions in an indirect fashion, such as story-telling, may result 
in lengthy interviews which may in turn fatigue an older people (Wegner 
2001). However, conversely, older people may benefit from story-telling  and 
reminiscing which might  serve a positive function,  for example evaluating 
events or re-living pleasing events giving a sense of self-esteem (Webster, 
Bohlmeijer, Westerhof 2010).  
For all of these reasons a conversational style was adopted during the 
interviews in this study.  
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4.6.3. The Research Interview Relationship 
Regardless of age, the need to establish and develop an interviewer-
interviewee relationship is essential to conducting a productive interview 
(Tod 2006). The participant needs to feel at ease with the research topic, 
which comes from a clear understanding of the research and the part they 
will play during the interview and beyond.  
Giving a degree of control as to the location, timing and providing any 
additional support required during the interview may further engender a 
sense of ease. Participants in this study were given the freedom to choose 
when and where the interview was conducted and given the opportunity to 
have a member of the family or friend present.  
4.7. Interviews - Data Analysis 
The interview transcripts were analysed using the Framework approach to 
identify recurrent themes (Ritchie & Lewis 2013). The aim of the study was to 
explore the information and decision support needs of older women faced 
with a choice of surgery or PET for the treatment of primary operable breast 
cancer it was necessary therefore to identify common themes amongst the 
narratives of this group of women.  The Framework approach enables the 
systematic analysis of large volumes of textual data and permits within and 
across case and theme comparison and so was ideally suited to analyse the 
interview data in this study.  The advantage of the Framework approach is 
that it provides a comprehensive, robust and transparent approach to data 
management and analysis. However, it is extremely time consuming and 
labour intensive. It requires the researcher to be skilled in the approach and 
informed, reflexive and critical when developing the themes and analysing 
and interpreting the data.  
Other methods of analysis were considered and could have been used, for 
example thematic analysis as described by Braun and Clarke (2006) which 
has similar stages.  However, the researcher was familiar with Framework 
analysis and it was therefore convenient to use, and its flexibility for use 
across epistemological viewpoints made it congruent with MM research and 
in this study supported the inductive approach to the data (Gale et al. 2013).   
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Framework Analysis 
There are five steps to Framework analysis: familiarisation; theme 
development; indexing; charting and finally mapping and interpretation 
(Ritchie & Lewis 2008)   
Familiarisation 
Familiarisation is the first step to identifying the themes and involves listening 
to audio and/or reading the transcripts, any field notes and being aware of 
the topic guide. Through this process the researcher will become aware of 
the recurring issues and topics and this leads onto the next step: theme 
development.  
Theme development 
Important and recurring themes are highlighted and sub-themes are 
developed. This stage relies on making judgments about meaning and 
relevance and the connection between the issues. 
Indexing 
Based on this framework the researcher returns to the data and begins 
'indexing'. Indexing is the process of identifying which sections of the data 
corresponds to which themes or sub-themes. Ritchie & Lewis (2013) 
recommend the use of a numerical system of labelling or coding the 
transcripts. It is important that the thematic framework remains flexible and 
that data are not forced into a theme. Further themes or sub-themes can be 
introduced if necessary.  
Charting 
The fourth stage is charting. Charts are developed based on a theme 
identified at the theme development stage or by transcript that is based on 
each transcript in the study.  In this study the researcher was interested in 
common issues surrounding information and support needs for decision-
making in breast cancer therefore the charts were theme based. Data related 
to each of the themes and the associated sub-themes are separated from 
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the original framework, but crucially the context is not lost. One of the key 
features of the Framework approach is that all findings should have a 
transparent trail, therefore the context and any quotes must be identifiable 
and traceable.  
Mapping and interpretation 
The final stage is mapping and interpretation and it is here that the links are 
made within the data and between themes to allow findings to be described 
and explained. In the descriptive accounts the researcher uses the organised 
data to identify key dimensions and maps the range of phenomena.  
Explanatory accounts seek to explain patterns in the data and why those 
patterns occur. It is important that the construction of the findings based on 
the patterns and their explanation are clearly reported to allow to assess their 
validity and credibility (Ritchie & Lewis 2013)   
The thirty-three interviews undertaken in this study created a large amount of 
data; Framework analysis was well placed to handle such large amounts of 
data. It also allowed a second researcher to easily examine and scrutinise 
the theme development providing credibility to the themes and the findings. 
Agreement about the themes was reached and this gave confidence to the 
development of the questionnaire for use in phase two of the study.    
4.8. Phase 2 - Questionnaire Survey 
The purpose of the questionnaire was to quantify and present the level of 
agreement with the information and support needs identified in the interviews 
and to assess the level of and satisfaction with involvement in the treatment 
decision-making process.  
The objectives of the questionnaire survey were:  
• To quantify the themes and concepts arising from the interviews • To facilitate transferability of information to the wider population of 
women over 75 years of age with breast cancer. 
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In this mixed methods study the questionnaire (See Appendix 14 for full 
questionnaire) was designed to quantify issues raised in the interviews and 
thus further illuminate the findings.  
4.8.1. Questionnaire Sample 
The sampling frame for the quantitative questionnaire survey phase 
comprised ten NHS breast cancer units in England and Wales. 
All women in this study were ≥75 years and all had primary operable breast 
cancer the major difference was the type of treatment they received. In the 
UK population of women, 75 years and older with breast cancer 60% are 
treated with surgery and 40% with PET (Morgan et al. 2014a). This can be 
further broken down by age with those over 85 years of age 60% being likely 
to receive PET (Morgan et al. 2014a). Based on these figures it was possible 
to draw up a sampling strategy that would achieve an acceptable measure of 
representativeness.  
4.8.2. Sample Size Calculation 
Probability sampling requires the application of statistical procedures to 
ensure sufficient numbers, with the correct characteristics, to achieve 
representativeness in the sample.  To increase the chance of trustworthy 
information a number of decisions need to be made before a sample size 
calculation can be made. The confidence interval, that is the range between 
which the total population parameter is expected to lie and the confidence 
level, the level of confidence that can be placed in the population mean of 
that parameter need to be decided. A confidence level of 95 percent is 
deemed acceptable for most studies however a higher level of confidence, 
usually set at 99 percent, is often required for medical research (Gray 2013)  
A sample size calculation for this study was based on a population of 13000 
(the number of women over 70 who are diagnosed with breast cancer) and a 
confidence interval width of ±5% with a confidence level of 95%, 373 
completed questionnaires would be required to give accurate information. 
With an ambitious return rate of approximately 65% (Ausch 1997) 573 
questionnaires would need to be distributed. It was known that this target 
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would be unrealistic as previous studies in this area had closed prematurely 
due to poor recruitment (Reed, Wyld, Ellis, Bliss & Leonard 2009). Therefore 
a more pragmatic approach was taken and recruitment was set at 100. 
Whilst it is acknowledged that the evidence from an underpowered study 
provides weaker evidence in this mixed methods study the questionnaire is 
only a part of the evidence.  The strength of the evidence based on this 
approach can only be determined once the analysis is complete (Gray 2013). 
Should the data show clear agreement on items within the questionnaire and 
with items in the interviews then this will provide a level of confidence in the 
findings. However, should there be gross disagreement then the findings will 
have little value (Gray 2013). 
4.8.3. Eligibility Criteria 
The eligibility criteria were the same as for the interviews.  
Women were eligible if;  
• they were ≥ 75 years, (the lower age at which PET is predominantly 
used), • had been diagnosed with invasive breast cancer in the preceding 60 
months and  • offered an initial treatment choice between PET and surgery 
(documented in the medical records). 
Women were ineligible if;  
• in the view of their Health Care Professional (HPC) they showed signs 
of significant cognitive impairment,  • they were unable to give informed consent or they had locally 
advanced or metastatic breast cancer as they would have a different 
set of experiences and characteristics.  
Women were not excluded on the basis of language. Where an interpreter 
was required this would be supported with funding from the parent study. 
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4.9. Questionnaire Procedure 
4.9.1. Recruitment 
All of the five sites involved in the interviews were invited to participate in this 
part of the study. Five other sites also agreed to recruit patients subject to 
the necessary ethics and governance regulations being approved.  
For those women who had taken part in the interviews and had given 
consent to be approached for the questionnaire, were sent a slightly different 
set of paperwork. This simply acknowledged their previous involvement, 
reminded them of their agreement to take part but also that they were free to 
withdraw should they wish to. 
For those previously not involved the initial invitation, recruitment for the 
questionnaire was undertaken in a three ways, all of which had been given 
ethical approval via a non-substantial amendment (See Appendix 15). The 
patients were either approached in person by the HCPs at a routine check-
up appointment, a telephone call made to their home or a direct postal 
invitation.  
4.9.2. Administration of Questionnaire 
Study packs including the questionnaire, a combined letter of invitation and 
participant information sheet (See Appendix 16) and a freepost return 
envelope were sent to all sites.  
Study site contacts were requested to record the age and treatment type of 
each patient they invited to complete the questionnaire. This was to allow the 
researcher to more fully understand the response and the non-response 
rates. This strategy was not completely successful and is discussed further in 
article 3 in chapter 6. 
4.10. Questionnaire Development 
Questionnaires are a commonly used method of collecting information about 
participants' attitudes, knowledge, beliefs and behaviour (Boynton & 
Greenhalgh 2004).  
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Initial consideration needs to be given to the information required to answer 
the research question. What questions need to be included? Every question 
included should have a purpose and provide information relevant to the study 
(Oppenheim 1992). Whilst it is tempting to add additional questions because 
'they might be useful' this should be avoided. What type of response is 
required? Should open and/or closed questions be used? Deciding on the 
questions and the way in which they are asked are crucial to the success of 
the data collection and are heavily influenced by the topic of the study and 
the sample population (Tod 2006).  
In the same way that interviews are categorised as structured or semi 
structured, so are questionnaires. Structured questionnaires contain 
standard questions with a pre-coded response choice frequently used. 
Unstructured questionnaires are used in exploratory studies and create 
qualitative data (Bowling 2009). Both categories of questionnaire can be 
administered via a face to face meeting with a researcher, via telephone or 
by postal self-administration and each has strengths and weaknesses.  
The strength of structured questionnaires is the potential to collect large 
amounts of unambiguous quantitative data that is easy to analyse (Boynton 
& Greenhalgh 2004). Including a pre-coded response choice allows the use 
of a 'tick box', reducing participant burden and allows those with reduced 
hand dexterity to participate more easily. These are potentially important 
issues in this study with older women,   
However, structured questionnaires can place significant cognitive demands 
on participants. Participants require comprehension skills to understand the 
instructions surrounding the questionnaire and the questions, recall and 
memory skills and the ability to link the question with the retrieved 
information (Bowling 2009). The wording and type of questions i.e. open or 
closed questions, and the flow of the questions, need careful consideration. 
Using familiar language and words to ask the questions will reduce the 
cognitive burden and facilitate participant response (Oppenheim 1992).  
Words used in questionnaires can be a source of ambiguity. Oppenheim 
cites the example of the term 'tea' as one that has different meanings 
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depending on the culture and geographical location. For some, tea is a drink 
taken any time of the day, for others it is the meal taken at the end of the day. 
Still further discrepancy arises as for some the meal taken at the end of the 
day is referred to as dinner. It is important therefore to make sure the words 
are within the participants' frame of reference, which can be assessed during 
the piloting of the questionnaire. Forming questions that are preferably less 
than 20 words, grammatically correct and free of spelling errors will 
encourage participation. It is important that all questions asked are done so 
politely demonstrating respect and an understanding that the participants are 
giving their time to the study (ibid) 
Dividing the questionnaire into sections with questions about a particular 
aspect of the study grouped together will allow the participant to concentrate 
more fully and provide a more considered response. Sections of the 
questionnaire should be introduced by providing an explanation as to why 
the questions have been included and reassurance that there are no right or 
wrong answers (ibid) 
Providing clear, consistent instructions about how to indicate their answer to 
the questions, and what to do when they have completed the questionnaire 
will reduce participant burden and enhance completion and return rates. 
Seemingly minor details such as neatly placing tick boxes in the same 
position on the page make the process of completing the questionnaire an 
easier task (ibid). Providing a freepost envelope in which to return the 
questionnaire will also enhance the return rate (Dillman, Smyth & Christian 
2014).  
The final presentation of a self-completion questionnaire is important and 
possibly more so for postal distribution. A well laid out questionnaire, using 
colours and high resolution pictures or other graphic, printed on good quality 
paper gives a sense of importance and value to the study. Without initial 
visual attraction, a well-designed questionnaire may be disregarded without 
the participant ever taking the first step to complete it (Bowling 2009). 
All postal questionnaires require an accompanying letter from the researcher 
giving the outline to the study and politely inviting them to take part. The 
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letter should explain why they have been invited, what will happen to the 
data and confirm the confidentiality of the information provided and that there 
will be no detrimental consequences should they choose not to take part.  
4.11. Development of the Study Questionnaire 
Each of the items in the above section was considered in the development of 
the questionnaire for this study. Given the age range of the study population 
particular attention was paid to the use of language and to the layout and 
presentation of the questionnaire. Over time the meaning of words change 
and this may lead to confusion. It is now common for doctors, nurses, 
physiotherapists etc. to be referred to as 'clinicians' or 'health care 
professionals' but in this questionnaire  'doctor' and 'nurse' were chosen as 
these would be more familiar and meaningful to this older population.  
It was important to convey to this group of older women that the 
questionnaire was about them and their views, and so the questions were 
phrased to emphasise the personal often using statements prefaced with the 
word 'I'. For example 'I wanted to know….' or 'I was helped….'. 
A photograph of a, smiling older woman was placed on the front page to 
signify relevance and portray a user friendly questionnaire. Since some of 
the questionnaires would be delivered without warning it was important that 
the women were clear of from where and whom this was sent. All 
questionnaires and letters had the study logo and more importantly the 
header of the recruiting hospital; the hospital where they received their 
treatment and therefore a place with which they were familiar and trusted.   
Although Oppenheim (1992) and Bowling (2009) recommend that the 
demographic data is collected at the end of the questionnaire, in this study 
this was collected on the first page. These questions could be considered as 
'warm up' questions. They were simple questions which required very little 
recall or any decision-making as they were factual questions about age, type 
of treatment, level of education and the ethnic group they belonged to.  
Adjusting font size and colours to accommodate any visual impairment and 
giving consideration to the manual dexterity required for writing will further 
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enhance response. To reduce writing burden pre-coded responses can be 
used; however this creates the problem of 'forced' responses. Pre-coded 
responses may not provide an option that the participant would choose and 
they are therefore forced into an inappropriate answer that does not truly 
represent their view. This has implications for the quality of the data.  
All of these issues were carefully considered in the development of this 
study's questionnaire as the participants were older women who had to 
contend with some or all of these issues.   
To obtain the data required, the questionnaire needed to be completed by 
women 75 years and older with primary operable oestrogen receptor positive 
breast cancer across the country.  Therefore a postal, self-administered 
questionnaire was the most efficient and cost effective method. Despite 
some of the potential problems of postal surveys in terms of lower response 
rates (compared to face to face completion), the inability of the participant to 
clarify questions and the lack of control over who completes the 
questionnaire, there are a number of advantages for both the participant and 
the researcher. In this study, participants were not known to the researcher 
and the questionnaires were anonymous, reducing the pressure of social 
desirability i.e. giving answers that present a positive image when this is not 
the participant's view (Bowling 2009). When completed at home, participants 
have the luxury of time and flexibility as they are able to complete it in stages 
and in any order they wish (Bowling 2009). 
A concise, clearly written letter of invitation along with the questionnaire and 
a pre-paid reply envelope were included as these are all known to enhance 
response rate. (Bowling 2009)  
4.12. Attitudinal Measurement Scales 
Assessing the different elements required the use of differing pre-coded 
response scales. The response options were kept simple with dichotomous 
'yes/no' being used to ascertain the usefulness of some of the items listed. It 
was important to also give the option of 'unsure' to avoid forcing the women 
to make inappropriate choices. Other sections of the questionnaire required 
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confirmation of information and so statements were offered and the 
participant selected the most appropriate.  
Embedded within the questionnaire were two validated scales, the modified 
Control Preference Scale, (CPS) (Sutherland, Llewellyn-Thomas, Lockwood, 
Tritchler & Till 1989; Degner et al  1997) and the Decision Regret Scale 
(DRS), (Brehaut et al. 2003). The CPS assesses the 'degree of control an 
individual wants to assume when decisions are being made about medical 
treatment' and asks the patient to indicate which of the statements most 
accurately described the role they preferred to play in the decision-making 
process and role they actually achieved. The DRS (Brehaut et al 2003) was 
designed to measure regret after healthcare decisions and uses a Likert 
scale. Two other questions within the questionnaire were open to a graded 
response and so the Likert scale was also used for these. (See Appendix 14 
Section 5 Questions 3&5).  
In attitudinal measurement, i.e. the measurement of people's beliefs, feelings, 
etc. on a scale of positivity to negativity, the Likert scale is the most 
commonly used. The scale contains a series of opinion statements in which 
the participant is asked to state their level of agreement or disagreement with 
each of those statements. There are generally five points along the scale 
from favourable / positive responses through to unfavourable or negative 
responses. For example the response options for the  statement 'I regret the 
choice I made' are 'strongly disagree' 'disagree' 'neither agree nor disagree' 
'agree' 'strongly agree'. The Likert scale is easy to use and analyse and 
provides ordinal level data. A score can be calculated from Likert scales with 
each response being allocated a value with higher values generally being 
assigned to favourable evaluation. The major disadvantage of this type of 
scoring system is that a total score can be derived from different 
configurations of the responses. This is not an issue for this questionnaire as 
scores are not required. (Bowling 2009) 
4.13. Questionnaire pre-piloting & piloting  
A draft questionnaire was developed based on the findings from the literature 
review, interviews and the expert opinion of members of the BTAG team. 
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Members of the BTAG trial management group, including members of the 
North Trent Cancer Network Consumer Research Panel (NTCNRP) were 
then invited to comment.  
The questionnaire was then piloted with members of the North Trent Cancer 
Network Consumer Research Panel. Members were asked to comment on 
the content, length, flow, ease of administration, clarity, comprehensibility 
and overall acceptability of the questionnaire. Table 4.1 shows the 
amendments made based on the feedback from the pre-piloting and the 
piloting.  
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Table 4.1: Feedback from the pre-piloting and piloting 
 
Issue raised 
 
Actions taken 
Questionnaire is too long. 
 
Some repetition in questions. 
The same questions being asked 
in different ways. 
 
14 questions from section 3 which were 
felt to be repetitive were removed. 
 
GP missing as a source of 
information giving. 
 
Added GP to section 2. 
Need to include a statement 
regarding the use of general or 
local anaesthetic for the 
operation. 
 
Item added - "if I could be asleep (general 
anaesthetic) or wake (local anaesthetic 
injection) for the operation"   
Section 3 - it would be useful to 
understand why women were 
unsure if they were offered a 
choice. 
 
Free text box added to section 3. 
Text box after the control 
preference scale in section 3 is 
not required. 
 
Free text box removed. 
Would be useful to allow women 
to say more about their answer 
in final question in section 3. 
 
Free text box added. 
Section 5 - need to split question 
which include doctor and nurse 
together. 
 
Additional response item, "Face to face 
chat with a nurse" was added.  
Videos to show what would 
happen when they go into 
hospital are available and might 
be useful. 
 
Response added to include "I would like 
to see a video of what happens when you 
come into hospital for an operation" 
Six questions required additional 
words to clarify the meaning. 
 
Words added 
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4.14. Psychometrics of the questionnaire 
Content validity 
The content was derived following a review of the literature, findings from the 
interviews, with input from experts within the BTAG research team and 
members of the (NTCHRP). 
Face validity 
Face validity was confirmed during the piloting of the questionnaire when 
members of the BTAG research team and members of the (NTCHRP) were 
asked to identify any missing or irrelevant items. 
Criterion or concurrent validity  
It was not possible to assess the criterion validity as this was a bespoke 
questionnaire and there were no other validated questionnaire against which 
to examine.  
Construct validity 
Construct validity assesses abstract constructs such as pain. This 
questionnaire did not measure any abstract concepts therefore it was not 
assessed.  
Reliability 
Test-retest reliability was not assessed due to the small numbers involved in 
the pilot study. There were also concerns about the extra burden placed on 
the members of the NTCNRP.  
The final questionnaire can be found in Appendix13 
4.15. Questionnaire Analysis 
Demographic and limited number of clinical characteristics of the responders 
to the questionnaire were summarised using appropriate descriptive statistics. 
Five of the six sections of the questionnaire were analysed using descriptive 
statistics and sixth section in the free text boxes were subjected to 
framework analysis and included in the convergence coding matrix.  
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Questionnaire responses were compared according to treatment, modality 
(i.e. surgery or PET) using chi-squared tests for categorical responses or 
where not valid Fisher's exact test, and the two-independent samples t-test 
for continuous responses. The association between age and the preferred 
media for information support, format, level and type of risk information was 
also examined, using Fisher's exact test. 
4.16. Mixed Methods Analysis 
Integration of data is an essential component of mixed methods research 
(Creswell, Fetters & Ivankova 2004). To ensure integration of the findings 
from all components of the study a triangulation protocol was used in this 
study. The word triangulation can be confusing as it has two meanings. It is 
used to describe the corroboration between two sets of data i.e. one data set 
supporting the other. However, the alternative meaning of gaining a more 
complete picture of the issues under investigation was used in this study 
(O'Cathain, Murphy & Nicholl 2010). Triangulation also contributes to the 
validity of the research findings where there are multiple sources of data 
(Famer et al. 2006). Triangulation takes place at the interpretation stage of 
the study with the data sets first being analysed separately. Once the 
findings are known, the researcher then examines them to see where they 
converge or agree, i.e. complement each other, or where they contradict, 
also referred to as dissonance or discrepancy.  
Integrating the large quantities of data that a mixed methods study produces 
can be problematic (O'Cathain, Murphy & Nicholl 2010). Making the process 
of analysis clear to the reader requires a systematic approach to the handling 
of the data. Farmer and colleagues (2006) describe the use of a 
'convergence coding matrix' that clearly demonstrates the integration of the 
findings from each source of data. This technique requires the researcher to 
assess where there is 'agreement', 'partial agreement' or 'dissonance' across 
the findings. Dissonance refers to disagreement in the findings and indicates 
the need for further exploration but not that there are flaws in the study 
(O'Cathain, Murphy and Nicholl 2010). This technique also includes a 
'silence' code to describe where findings exist about a topic in one set of data 
but are absent in another.  
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Convergence coding matrices were developed for each of the research 
questions and the study objectives.  
The following chapter is the second article that forms part of this Article-
based PhD and was published in Psycho-Oncology. It reports the findings 
from the interview phase of the study. 
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Chapter 5: Article 2 
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5. Chapter 5: Article 2 
'The information and decision support needs of older women (≥75 yrs) facing 
treatment choices for breast cancer: a qualitative study' 
The aim of this article was to present findings regarding the preference for 
information when faced with a treatment choice and the preferred decision-
making styles of these older women. This article reports the qualitative 
component of this study to meet study objective 2 'to elicit the information 
needs and preferences of older women (≥75years) with operable breast 
cancer to treatment options; surgery (plus adjuvant endocrine therapy) and 
PET'. 
This article builds on the literature review and offers an original contribution 
to the current knowledge base.   
I am the first author on this paper as I led on the development of the 
participant information packs and topic guide, liaised with the breast clinic 
staff to facilitate recruitment; I conducted the interviews, developed the 
analysis framework and wrote the article. My co-authors contributed in 
advising on the participant information packs, the topic guide, acting as 
second reviewers in the analysis process (KL) and provided input on the 
structure and writing of this paper. 
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5.1. Reflective review of Article 2 
This section presents a reflective review of article 2 post-publication and 
provides additional detail that it was not possible to include in the publication 
due to the scope of the author's guidelines of the journal. 
Critical commentary 
The article was reviewed using the NICE Quality appraisal checklist - 
qualitative studies (2012) (See Appendix 5 for the details of the review).  
The article was shown to be of good quality. Less strong areas included the 
limited level of detail of the recruitment procedure, the lack of justification for 
the research methods chosen and no examination of the relationship 
between the participant and the researcher. These omissions are addressed 
below but were largely due to the limited word count and the focus of the 
journal.  
Recruitment  
Women were approached by clinical / research staff in the breast clinics. 
These staff reported that they had discussed the study with a number of 
women and given them a study pack including a reply form, but the number 
of and which women were not recorded. Therefore, it was not possible to 
know how many were women approached or to send reminders about the 
study. Therefore only details about the participants who actually volunteered 
were available.  
It is unfortunate the number of women approached and their demographics 
were not available as this would have provided information about the sample 
and the women who decided not to volunteer. Tetley, Grant & Davies (2009) 
highlights how older people are often excluded from research activities.  It is 
only in recent times that older people have been invited to participate in 
studies, and there appears to be a nervousness and suspicion surrounding 
the word 'research'. This was evidenced in some of the interviews where 
women confessed to being worried about what was expected of them or that 
they what they had to say was not helpful. There is still work to do to make 
research more transparent and appealing to older women.  
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Rationale for the choice of data collection method 
The rationale for the choice of interviews stems from the qualitative 
methodology used in this study. Qualitative research aims to provide a 
detailed description of the topic under exploration from the perspective of the 
participants.  This method of data collection ensures the concepts and/or 
theories are grounded in data.  
Semi-structured interviews are ideally suited to fulfil these aims. The 
conversational style interviews used in this study allows the participant to tell 
their story using the familiar act of talking, and the researcher attempts to 
make the interview a comfortable and non-pressurised event. Story telling 
during interviews also triggers memories and provides a richer description of 
the topic (Davidson 2004). A more detailed examination of interviewing as a 
method of data collection was given in chapter four of this thesis.  
Acknowledging the position of the researcher 
Detailing the role of the researcher within a qualitative study is difficult to 
achieve within the permissible word count of the journal Psycho-Oncology. 
An important aspect of rigor in qualitative interviews is that the researcher 
acknowledges and makes public his or her perspectives or 'biases' so that 
their influence on the interpretations of the data can be judged (Frank 1997). 
This process is termed reflexivity that has been described as 
"…….. an integral process in qualitative research whereby 
researchers reflect continuously on how their own actions, values and 
perceptions impact upon the research setting and can affect data 
collection and analysis"    
     (Gerrish & Lacey, 2006 pg 346). 
 
The making public of the researcher's reflexive position is done through 
providing an account that reflects on the process of the data generation and 
analysis. Throughout the interviews I was very conscious of how my 
demeanour and attitude could affect the interviews. It is key that researchers 
are organised and prepared for the interview (Legard et al. 2013) and I feel 
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that this was the case. Each interview added to the next in terms of how to 
raise questions and probe issues raised without 'grilling' the participant.  
The qualitative approach to uncover the multi-layered realities of the social 
world made it important for me not to be rigid in my approach to interviewing. 
This meant there was sometimes a tension between being flexible with the 
questioning and straying away from the point. I am aware this did happen on 
occasions, but I also found that this often triggered memories and allowed 
the participant to provide greater insight. Allowing the women to speak 'off 
track' provided space to talk to someone who was interested in their illness 
and let them enjoy it as a social occasion. As the interviews progressed I 
learned to say less, control my natural instinct to convey agreement or overly 
encourage a statement. I did however use information, anonymously, from 
other interviews or create imaginary scenarios to encourage thinking about a 
topic, particularly when the interview was stalling. Despite some, from a more 
positivist perspective, considering such practice inappropriate, it is seen as a 
legitimate way to conduct qualitative semi-structured interviews (Kvale 2007). 
As a HCP it is a natural reaction to try to help or provide guidance about a 
problem a woman might raise (Tod 2006). Women in the interview would 
sometimes raise a problem with the prosthesis or with the side effects of the 
drugs or the lack of movement they have in the shoulder, and I naturally 
wanted to offer support or direct them to appropriate services.  It is 
recommended that roles are strictly separated and I continued throughout 
trying to remain within the researcher role (Tod 2006).  However, it is 
important to show genuine interest and a degree of reciprocity of information 
to develop a good interview relationship, and I felt my open, flexible 
approach assisted in achieving these things.  
I acknowledge that my gender, maturity and extensive experience as a HCP 
and as a researcher were a factor in interviewing the women in this study, 
and feel that they were advantageous (Stevens, Abrams, Brazier, Fitzpatrick 
& Lilford 2001) I have a great deal of experience of talking to patients in the 
hospital setting and from previous research with older people. I feel my age 
conveyed a sense of credibility and of someone with experience of the world, 
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and this, including being a woman, allowed an easy rapport to develop with 
these older women who arguably could feel more comfortable talking on this 
topic with someone of the same sex. Gaining an understanding of breast 
cancer services and attending clinics where women were given a diagnosis 
and the treatment options discussed gave me very valuable insight into the 
experience of the women and gave me confidence to conduct the interviews. 
The interview findings reported in this chapter informed the development of 
the questionnaire and the also contributed to two further papers, 'The 
balance of clinician and patient input into treatment decision-making in older 
women with operable breast cancer' and 'Understanding older women’s 
decision-making and coping in the context of breast cancer treatment'.  
The following chapter is the third article that forms part of this Article-based 
PhD and was published in Psycho-Oncology. It reports the findings from the 
questionnaire phase of the study. 
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6. Chapter 6: Article 3 
Burton, M., Kilner, K., Wyld, L., Lifford, K. J., Gordon, F., Allison, A., ... & 
Collins, K. A. (2017). Information needs and decision‐making preferences of 
older women offered a choice between surgery and primary endocrine 
therapy for early breast cancer. Psycho‐Oncology. 
The aim of this article was to present results from the quantitative component 
of this study that further established older women's preferences regarding 
receiving information about breast cancer treatment options (surgery or PET) 
and quantified issues raised in the interview study. Other results reported a 
quantification of women's preferences regarding the presentation of 
information; and established their preferred DM styles. 
This article builds on the literature review and qualitative study offering an 
original contribution to the current knowledge base.   
I am the first author on this paper as I was a major contributor to the 
development of the questionnaire, to the participant information packs and I 
liaised with the breast clinic staff to facilitate recruitment. With support from 
statisticians I cleaned and analysed the questionnaires and wrote the paper. 
My co-authors contributed in advising on the questionnaire development and 
analysis, by acting as second reviewers in the analysis process (KK) and 
provided input on the structure and writing of this paper. 
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6.1. Reflective review of Article 3 
This section presents a reflective review of article 3 post-publication and 
provides additional detail that it was not possible to include in the publication 
due to the scope of the author's guidelines of the journal. 
6.2. Critical commentary 
Despite careful consideration at all stages of the questionnaire development 
and administration the non-completion i.e. where the participant fails to 
answer all items of the questionnaire, was disappointingly high with all 
questions missing at least one response. Section 2, the list entitled 'I wanted 
to know…' was most affected with 35% of responses missing. This figure is 
in line with that of Brazier and colleagues (1996) who reported 31.9% of 
missing data in one section of the SF-36. Non-completion is a feature 
commonly recorded in health surveys that target older people (Hayes, Morris, 
Wolfe & Morgan 1995; Brazier, Jones & Kind 1993).  
However, others have reported high response and completion rates when 
surveying older people (English Longitudinal Survey of Ageing, ELSA). ELSA 
is a nationally representative panel survey of community-dwelling people 
aged 50 years and older in England. Running since 2002 this survey has 
amassed objective and subjective data relating to health and disability, 
biological markers of disease, economic circumstance, social participation, 
networks and well-being (ELSA).The core participants across the waves of 
ELSA are those who responded to the Health Survey for England in 1998 
through to 2011. The survey uses both self-completed questionnaires and 
face to face computer assisted personal interviews (CAPI). Over the seven 
waves of data collection they have achieved response rates, ranging across 
ages, from 63 - 85% and completion rates (item non-response rates) of 
between < 0.1 - 2.6%. (Technical report ELSA Wave 6).  
There are a number of features that are likely to have contributed to these 
impressive response and completion rates. Response rates are known to be 
high when people have responded to an initial survey, in this instance the 
HSE, because they are more likely to respond to subsequent requests 
(Dillman 2014). Establishing trust in a survey and the researchers further 
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enhances the likelihood of response and this is particularly so for 
government or university backed research (Dillman 2014). Similarly the offer 
of an incentive further impacts the response rate (Dillman 2014). The ELSA 
study was able to offer a £20 gift voucher, something that was not possible in 
this PhD.  
The ELSA high completion rates are impressive. It is reasonable to assume 
that the use of assistance in the form of a computer assisted personal 
interview has significantly impacted the completion rates. This method 
ensures the participant is able to seek clarification from the researcher about 
questions they don't understand and that questions are not inadvertently 
missed. There are obvious costs associated with this method of data 
collection, however they are not excessive and would be something to be 
taken into consideration for future projects.  
It was recognised early in the study that the random sample of 344 women 
required to enable estimates of proportion to within a maximum of ±5% 
would not be possible due to the timescale of the study. It was therefore 
decided that 100 questionnaires would be the target response. The recruiting 
breast cancer units received a total of 247questionnaires based on their 
estimation of the number they would be able to recruit. Subsequently 101 
were returned which, if we presume that all of the 247 questionnaires were 
distributed to patients, equates to a 41% response rate. It is suggested that a 
response rate of 70% is necessary for a questionnaire to be representative 
(Stevens et al. 2001) others suggest a higher rate of 80 - 90% (Kerlinger & 
Lee 2000) but it is also known that response to health surveys are often 
much lower (Asch, Jedrziewski & Christakis 1997).  
The ELSA study also used a self-completion questionnaire (unassisted) in 
wave 7 to examine the sexual activity of older people and again the rate of 
return of 67% was good with an item non-response of between <0.1 - 2.6%. 
The mean age of these participants is 66.7 years, which is significantly 
younger than the participants in this PhD study (mean age 82). They report 
the responders to be slightly older, less likely to be married or cohabiting, 
and in poorer health (Hinchliff, Tetley, Lee & Nazroo 2017). This is contrary 
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to the findings of others who found that in both general and health care 
populations, non-responders tend to be older, less well educated, with poor 
levels of literacy, of lower socioeconomic status and in poorer health (Czaja 
& Blair 2005; Müller-Nordhorn, Roll & Willich 2004; Smeeth et al. 2001; Lim 
& Fisher 1999; Hayes et al. 1995; Brazier, Jones & Kind 1993 Cartwright 
1986).  
The low response rate is now considered in the light of the relevant key 
themes relating to patients' views on completing questionnaires identified by 
Moore, Jones & Radley, (2012) 
During their development of the QQ10, an instrument designed to assess the 
face validity, feasibility and utility of questionnaires, the authors identified ten 
key themes relating to patients' views on completing questionnaires (Moore, 
Jones & Radley, 2012). These were split into six value items and four burden 
items. (See Figure 6.1) 
Figure 6.1: Key themes from the development of the QQ10 
Value items Burden items 
 
 Helped communication  
 Relevant  
 Easy to use  
 Comprehensive  
 Willing to repeat  
 Enjoyable  
 
 Overlong  
 Embarrassing  
 Overcomplicated  
 Upsetting  
 
 
Although the QQ10 development (See Appendix 17 for the full QQ10) was 
undertaken in a group of women with a mean age of 53, it is possible the 
themes identified are also important to older women.  The patients' perceived 
value, relevance, ease of use and level of burden of the questionnaire are 
likely to impact on the completion and return rates, (Lohr & Zebrack. 2009; 
Moore, Jones & Radley 2012), which may have affected the completion rates 
in this survey. 
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Perceived value 
People often agree to participate in surveys knowing that they will not 
personally benefit but feel their input may benefit others (Dillman, et al 2014 ; 
Blau 1964). At the point at which the women agreed to participate in this 
study they had no real notion of what was expected of them. Once they 
received the questionnaire the scale of the task may have been too great 
and so they 'did their best' to complete. It may be that the mental challenge 
outweighed the desire to contribute to the study.  
Relevance 
From the interviews it was clear that women were only interested in 
information and discussion about their own condition and treatment. It is 
feasible that the women invited to take part felt that some of the questions 
were irrelevant as there were many questions unrelated to their own situation. 
Women who chose PET were asked to consider questions about surgery 
and vice versa. For some women although they were given a choice of 
treatment, they may never have considered the alternative option seriously 
and therefore the questions were irrelevant. In essence, they were being 
asked questions about a subject with which they were unfamiliar. 
Cognitive function 
A number of the returned questionnaires were incomplete, i.e. women had 
missed questions or deliberately chosen the ones they wished to answer.   
There is a common perception, backed by some evidence (McArdle, Fisher 
& Kadlec (2007) that age related cognitive decline is a linear process. Using 
data from the well designed and executed longitudinal ELSA study, 
Tampubolon (2015) demonstrated this is not the case. Since cognitive 
functioning is a multivariate concept and there is no accepted single measure, 
episodic memory was chosen as the dependent variable in the ELSA and 
McArdle, Fisher & Kadlec (2007) study. Episodic memory (the sum of 
delayed and immediate recall) a key feature in the day-to-day activities of 
older people and in decision making and is therefore an appropriate 
representation.  
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The ELSA data from British adults, 50-89 years of age, demonstrated that 
cognitive function was curvilinear in nature with the peak appearing in the 
early 60s (Tampubolon 2015). This contradicts most studies that put the 
peak variously in the 20s, 30s and 40s (Singh-Manoux et al 2012; Salthouse 
2009; Schaie, Willis & Caskie 2004). When the ELSA study findings were 
examined across cohorts, pre and post-world war II (WWII), those in the pre 
WWII cohort did show a linear decline. It was also noted that there were 
significant individual variations within the cohorts i.e. some with linear decline 
whilst others maintaining their function.  
Physical function, occupational class, wealth, marital status and education 
social networks and interactions of various kinds were also seen to affect 
cognitive function in the ELSA study. Those who were more physically able, 
in the managerial / professional classes, had received higher education, 
were in the top wealth bracket, married and had regular social contacts had 
higher cognitive function. Ill health, i.e. chronic disease such as arthritis, 
cardiovascular disease, diabetes and depression impacted negatively on 
cognitive function.  
Since the median age of the respondents to the questionnaire in this PhD 
was 82 (range 75 to 99) it is reasonable to assume that at least some were 
experiencing some decline in cognitive function and that this had a bearing 
on  the response and completion rates. Presenting the questionnaire, that 
may be considered lengthy, and asking women to remember detailed 
information about an event that happened up to five years previously may 
have been too ambitious. The impact of length of a questionnaire was found 
to be unclear (Iglesias & Togerson 2000; Rolstad, Adler & Ryden 2011). 
Although the content was broken down into clear sections, the wording 
carefully chosen and the provision of instructions for completion very detailed, 
it is possible that the women found it too complicated. Women were asked to 
remember the information they received and its usefulness and also what 
information they would have preferred. This level of cognitive processing 
may have been too great for some women and these women then filtered out 
the information they felt was irrelevant or difficult to answer and answered 
only the questions they perceived to be pertinent.  
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Sensitive questions 
Surveys containing embarrassing questions are known to reduce uptake and 
completion (Moores, Jones & Radley 2012). The women asked to take part 
in this survey were asked to relive a potentially upsetting time in their life and 
this may have impacted the completion rate.  
Surveys are complex. They rely on a large number of elements positively 
interacting to ensure a valuable level of uptake, completion and return. 
Should one or more of this elements be missing it is likely to influence the 
quality of the data collected (Stevens et al. 2001). 
6.3. Summary 
The development and administration of the questionnaire was rigorously 
undertaken but despite this the completion rate was disappointing. Although 
telephone support to complete the questionnaire was offered none of the 
women chose to contact the researcher. It is clear that many of the women 
struggled to complete this questionnaire and on reflection it may be that 
much closer support in the form of a structured telephone interview would 
have enhanced the completion rate (Musselwhite, Cuff, McGregor & King 
(2007).  
Further examination of the self-completion questionnaire method of data 
collection will be addressed in the discussion.  
The following chapter is the fourth and final article that forms part of this 
Article-based PhD.  
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7. Chapter 7: Article 4 
Morgan, J. L., Burton, M., Collins, K., Lifford, K. J., Robinson, T. G., Cheung, 
K. L., Audisio, R., Reed, M.W & Wyld, L. and on behalf of the Bridging the 
Age Gap Trial Management Team (2015). The balance of clinician and 
patient input into treatment decision‐making in older women with operable 
breast cancer. Psycho‐Oncology, 24(12), 1761-1766. 
Aim of the article 
The aim of this article was to present results and findings regarding the 
preferred decision-making styles including the influence of the HCP on the 
process. This article reports the qualitative component of this study to meet 
study objective 4 'to determine the influence of the health care professional in 
treatment decision-making in older women with operable breast cancer'. 
The influence of the HCP, particularly the doctor, in treatment decision-
making was made very clear during the interview and the questionnaire 
phases of this PhD. Some women reported being given the choice of 
treatment and supported by HCPs to make a decision, whilst others 
reported either not being offered a choice or simply informed it was up 
to them to decide despite asking for a recommendation. It seemed that 
there were very different perspectives on the issue of treatment 
decision-making.  Another researcher within the wider Age Gap study 
was investigating the regional variation in treatment patterns of older 
women with breast cancer. This element included an exploration of the 
factors that HCPs take into account when assessing the treatment 
options and their views on patient choice. The opportunity was 
therefore taken to explore the interaction and concordance between 
HCPs and older women in the decision-making process and their views 
regarding the process and this is reported elsewhere (Morgan et al., 
2017). 
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This article builds on the qualitative component of the study and draws on 
results and findings derived from a complementary study within the main 
BTAG study and offers an original contribution to the current knowledge base.   
This article presents both a combined analysis of two components of the 
parent BTAG study; a questionnaire to older women undergoing consultation 
about breast cancer treatment options that established their DM preferences; 
and qualitative interviews with HCPs (both of which focused on DM 
preferences in this setting) and secondly the qualitative patient interviews 
undertaken as part of this PhD study.  
The issue of HCP influence on DM has been explored in younger women 
with breast cancer but little is known about the experience of older women.  
Integrating these three components allowed a fuller picture of the process 
and drivers of DM to be developed.  
I am the joint first author on this paper as I was the major contributor to the 
development of the qualitative interviews of older women and in the mixing of 
the findings from all three components of data collection. I was a contributor 
to the structure and writing of the article.  
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Reflective Review of Article 4 
This section presents a reflective review of article 4 post-publication and 
provides additional detail that it was not possible to include in the publication 
due to the scope of the author's guidelines of the journal. 
The reporting of MM research is frequently criticised for not providing 
sufficient detail of the process and method of integration of data (Farmer et al. 
2006; O'Cathain, Murphy & Nicholl 2008). This reflective review will therefore 
give further details of the theme development and outline the method of 
integration used.  
7.1. Summary of the decision preference questionnaire 
findings 
The decision preference questionnaire findings were able to provide 
evidence of the strong links between the decision-making style and the final 
treatment and of the involvement of the HCP in the decision-making process.  
The questionnaire showed that patients who preferred a patient-centred style 
were more likely to choose PET and those who preferred a doctor-centred 
style were more likely to choose surgery. Moderate agreement was found 
between the patients' actual and preferred decision-making style with 73.5% 
achieving their preferred decision-making style. Whilst this can be seen as a 
good level of agreement it means that 26.5% do not achieve their preferred 
style. The findings from both the HCP and patient interviews allowed these 
findings to be further explored and understood.  
7.2. Analysis and integration of the interviews 
A triangulation protocol was used and the data demonstrated using the 
convergence coding matrix as suggested by Farmer and colleagues (2006).  
Separate analysis of each set of interviews (i.e. the HCP and patient 
interviews) were undertaken by the authors (JM the HCP interviews and MB 
the patient interviews). Each then familiarised themselves with the findings 
from the other set of interviews. Based on the topic guides, the data and the 
focus of the study, three themes and eight sub-themes were developed and 
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the data categorised accordingly.  Quotes from both sets of interviews were 
identified which represented the sub-themes. Although not displayed in the 
paper there was an assessment of the agreement, partial agreement or 
dissonance of views. A fuller description of the integration is given in chapter 
4 & 8. Table 7.1 shows the findings displayed using the convergence coding 
matrix. 
Generally there were high levels of agreement which supports the findings of 
the questionnaire but there were also areas of partial agreement and 
disagreement. Areas of partial agreement and dissonance help to better 
understand of the discordance between the patient's preferred and actual 
decision-making styles seen in this PhD study.  
The following chapter will integrate the findings from each component of this 
PhD study. The findings will be discussed in the light of current literature and 
it will conclude with practice recommendations and further research
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Table 7.1:  Representative quotes from interviews comparing HCP and patients views 
 
Theme 1: Patient 
involvement in DM 
 
HCP views  
 
Patient views Convergence 
Coding Matrix 
Subtheme 1a: patients’ 
preconceived ideas 
 
"Some ladies will say at 70 ‘I’m too old 
to have an operation' ". 
(Female Nurse; High PET unit) 
 
 
"Well I am too old, 91 to go to a big 
operation like that." 
(91 yrs; PET) 
 
 
Agreement(A) 
 
"The older woman who lives 
independently, they’d rather die than 
lose their independence… their priorities 
are very different…It’s not about 
survival… thorough treatment of their 
breast cancer may be something that 
they’re not actually interested." 
in.’ (Female Surgeon; High PET unit) 
 
"I was feeling okay and I thought if my 
quality of life is like this at the moment, 
if I can keep it like this for a couple 
more years, well, that’s okay with me, 
so that was my decision."  (81 yrs; 
PET) 
 
A 
 
"Usually when people hold such strong, 
seemingly irrational, views it’s usually 
because of an experience that they 
have had or an experience that a 
member of family or close friend has 
had." 
(Male Geriatrician; High PET unit) 
 
 
 
“Do what you’ve got to do,’ we lost a 
daughter-in-law with breast cancer, 
she was only 26, and that’s 30 years 
ago…Cancer is the most frightening 
word" (82 yrs; Surgery) 
 
 
 
 
 
A 
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Subtheme 1b: DM 
styles 
"A lot of women in that age group have 
their own opinions and they can’t be 
changed" (Male Surgeon; Low PET unit) 
 
"I’d already made my mind up because 
I knew it was cancer—you know in my 
own mind and made my mind up that I 
was having the breast taken off " (81 
yrs; Surgery) 
 
A 
 
"Some women really don’t want to make 
that decision, they think it’s the sort of 
thing that a doctor should do" (Female 
Surgeon; High PET unit) 
 
"..[Dr] deals with that all day and every 
day so I just said ‘Well what do you 
advise? And I mean because he knew 
about it, I just took his advice." (81 yrs; 
Surgery) 
 
A 
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Theme 2: Influence of 
HCP on DM 
 
   
Subtheme 2a: Impact of 
HCP view on DM 
 
"…it’s the way you… sell something and 
personal opinion comes 
into it… a surgeon might think they 
know best and patients obviously listen 
to their doctor" (Female Nurse; Low PET 
unit) 
 
"I think she [Dr] played a big part, 
because she put it so clearly that it was 
easy to make a decision" (89 yrs; PET) 
 
"I said ‘well I’m not taking tablets, I’m 
going to have my breast off’… he [Dr] 
said ‘but I’m very reluctant' he said 
‘you’re 94 year old." (94 yrs; Surgery). 
 
 
 
 
Partial 
Agreement 
(PA) 
Subtheme 2b: Offering 
a choice 
 
"The literature suggests… they should 
be offered an operation and so that’s 
what I offer them. So I don’t give them a 
choice between surgery and PET" (Male 
Surgeon; Low PET unit) 
 
 
‘P: "I wasn’t given a choice, no. 
I: No, would you have liked a choice? 
P: I think I would really. I don’t know 
what I would of chosen though thinking 
about it." (80 yrs; PET) 
 
 
 
Dissonance(D) 
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Subtheme 2c: Making 
recommendations 
"If they ask me well what do I think, I will 
tell them… ‘You choose what is right for 
you, not what is right for me… I don’t 
know how I will choose if I was sitting 
where you’re sitting so it really is your 
choice." (Female Surgeon; High PET 
unit) 
 
"I certainly tell them which is the 
preferable option" (Male Surgeon; High 
PET unit) 
 
"My son said to him… ‘if it was your 
wife what would you recommend her to 
do’ and he said ‘I can’t answer 
that…it’s your mother’s decision. She 
has to decide for herself’." (75 yrs; 
Surgery) 
 
"What would happen if I don’t have 
treatment? And… the doctor actually 
did say to me, ‘your other option is to 
have nothing done…but I wouldn’t 
recommend that…" (81 yrs; PET) 
 
 
A 
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Theme 3: Processes of 
DM 
 
   
Subtheme 3a: Timing of 
DM 
"Giving them time to think through it, the 
pros and cons, is very important" 
(Female Surgeon; Low PET unit) 
 
"Get rid of it. And see you don’t have 
time, because you want it done there 
and then. So you don’t have a lot of 
time to think about it." (81 yrs; PET) 
 
D 
Subtheme 3b: HCP 
involved in DM process 
‘ 
"She [nurse] does all the decision-
making with them. They go into a 
room with her, I just tell them what it is 
and what the options are and over to the 
Breast Care Nurse." (Male Surgeon; 
Low PET unit) 
 
"It was when the nurse took us into a 
separate room away from Dr [name] 
we thrashed this out" (85 yrs; PET) 
 
A 
Subtheme 3c: 
Information 
requirements 
"A lot of the older population, I feel, don’t 
want information" 
(Female Nurse; High PET unit) 
 
"They weren’t very forthcoming with 
information" (75 yrs; PET) 
 
"…why would you need all the other 
information? It’s only extra 
worrying" (81 yrs; PET) 
 
D 
 
Key:  
A = agreement   PA = partial agreement   D = dissonance 
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8. Chapter 8: Summary of Mixed Methods Findings 
The integration of findings derived from multiple data sources is considered a 
hallmark of mixed method research studies (Creswell, Fetters & Ivankova, 
2004. This chapter reports the integration of the findings from the literature 
review, the semi-structured interviews and the questionnaire utilised in this 
study. A triangulation protocol was used and the data displayed in a 
convergence coding matrix (Farmer et al, 2006) with the aim of gaining a 
more complete picture through addressing the research questions.   
Research Questions 
1. “What are the preferences for information, its sources, format and 
presentation for older women faced with a treatment choice for 
operable breast cancer?” 
2. “What are the preferred decision-making styles in older women faced 
with a treatment choice for operable breast cancer?” 
8.1. Study aim and objectives 
Aim: 
To establish the information preferences and decision-making styles of older 
women faced with a choice of surgery and adjuvant endocrine therapy or 
PET. 
Objectives: 
1. To establish the evidence relating to information and decision-making 
preferences in older women (≥75 years) with primary operable breast 
cancer with a specific focus on the use of surgery or PET. 
2. To elicit the views of older women towards preference for information 
and its source and presentation when facing a choice between surgery 
and PET. 
3. To elicit the views of older women towards decision-making styles when 
faced with a choice of surgery or PET. 
4. To determine the influence of the health care professional in treatment 
decision-making in older women with operable breast cancer. 
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Using a convergence coding matrix, as described by Farmer and colleagues 
(2006), the findings from each of the study components were triangulated 
and presented under three meta-themes. The meta-themes were developed 
from the findings of the interviews and used as a framework to consider the 
results and findings of all data sets. The Meta-themes are: 
1. Receiving a choice  
2. Shaping the decision 
3. Making the decision  
 
Each meta-theme was sub-divided into themes to address key findings. (See 
Tables 8.1, 8.2, 8.3 for each meta-theme matrix.) 
For each theme there was an assessment of where, across the findings from 
each component, there was 'agreement' A; 'partial agreement' PA; 
'dissonance' (disagreement) D; or 'silence' S (where findings exist about a 
topic in one set of data but are absent in another).  
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Table 8.1: Integration of findings to address research question 2 
Meta-theme: Receiving a Choice 
 Literature Review 
* based on literature in the 
review article. 
Qualitative 
(Interviews)  
Quantitative 
(Questionnaires) 
Convergence 
code 
PhD 
Objective 
addressed 
Themes      
 
The offer of 
treatment choice. 
 
Previous studies only 
examine the choice 
between WLE & 
mastectomy in - not 
focussed on older women. 
 
Most women reported being 
offered a choice of treatment. 
Some remember the choice as 
being between mastectomy 
and wide local excision. 
 
Only 37/93 women 
remember being offered 
a choice between 
Surgery & ET and PET 
 
Dissonance 
(D) 
 
3 
 
Older age and the 
offer of treatment 
choice. 
 
Fewer choices were given 
with increasing age. All 
women >80 said they were 
not given a choice.   
 
Some of the older women said 
they were offered a choice and 
others said they were offered a 
choice with direction as to the 
best option. Others interpreted 
the doctor/nurses comments to 
decide which treatment they 
felt they were being 
 
12/15 women aged 90+ 
and 12/22 women 85-89 
were offered a choice of 
surgery or PET. 
Compared to those 75-
79 and 80-84yrs who 
were offered choice 6/25 
and 7/27 respectively. 
 
Partial 
Agreement 
(PA)  
 
3 
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Meta-theme: Receiving a Choice 
 Literature Review 
* based on literature in the 
review article. 
Qualitative 
(Interviews)  
Quantitative 
(Questionnaires) 
Convergence 
code 
PhD 
Objective 
addressed 
recommended. Others said 
they were offered a choice of 
mastectomy or WLE. There 
was little difference in the 
median age of those offered a 
choice and those offered no 
choice - 81(range 73-95) and 
82 yrs (range 73 98) 
respectively. Two women age 
76 &98 were unsure whether 
they had been offered a 
choice. 
The latter two groups 
were more often offered 
surgery. 
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Meta-theme: Receiving a Choice 
 Literature Review 
* based on literature in the 
review article. 
Qualitative 
(Interviews)  
Quantitative 
(Questionnaires) 
Convergence 
code 
PhD 
Objective 
addressed 
 
Reactions to being 
offered a choice of 
treatment. 
A study of younger (median 
age 44.5yrs, range 23-88) 
Chinese women with breast 
cancer highlights the 
difficulty and worry that the 
women suffered when 
asked to make a treatment  
decision without the Drs 
guidance, albeit they had 
received information from 
the Dr. Older women 
worried about having to 
make a decision. Women 
said they needed time to 
make a decision and some 
felt they were rushed into a 
decision. In studies of 
Most women appreciated 
being given a choice of 
treatment. For some women 
being given a choice caused 
anxiety as they worried they 
would make the wrong choice. 
A small number were surprised 
to be given a choice as they 
expected the doctor to know 
the best treatment for them.  
This was not directly 
addressed in the 
questionnaire. A couple 
of women use the free 
text section to express 
their belief that women 
should 'listen to the 
doctor' whilst another 
four expressed the need 
for reassurance during 
the decision-making 
process. 
Agreement 
(A) 
3 
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Meta-theme: Receiving a Choice 
 Literature Review 
* based on literature in the 
review article. 
Qualitative 
(Interviews)  
Quantitative 
(Questionnaires) 
Convergence 
code 
PhD 
Objective 
addressed 
younger women some 
appreciated it whilst others 
found it traumatic and 
anxiety provoking.  
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Table 8.2: Integration of findings to address research question 1 
Meta-theme: Shaping the decision 
 Literature Review 
* based on literature in the 
review article. 
Qualitative  
(Interviews) 
Quantitative 
(Questionnaires) 
Convergence 
Code 
PhD 
Objective 
addressed 
Themes      
Preferred source 
and method of 
receiving 
treatment 
information. 
Older patients prefer 
information to be given to 
them verbally by their 
treating clinician. 
Information given verbally by 
the doctor in the breast clinic 
was the most preferred and 
trusted method of information.  
Only two women sought further 
information.  
A face to face chat with 
the doctor in the breast 
unit was the most 
preferred way to receive 
information. Followed by 
a chat with a nurse. 
Booklets were the third 
most preferred  
A 1,2 
Information needs 
to facilitate 
decision-making 
At diagnosis information 
about the chance of a cure 
and the spread of the 
disease were the most 
commonly requested, 
regardless of age. Medical 
information about the 
Women wanted information 
that was personal to them. 
They wanted Information about 
the need for further treatment 
e.g. radiotherapy, 
chemotherapy; the risk of 
recurrence or spread and the 
Ranked 1st for 
information needs: 
whether there was a 
need for further 
treatment and how long 
tablets would need to be 
taken for. Other items 
A 1,2 
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Meta-theme: Shaping the decision 
 Literature Review 
* based on literature in the 
review article. 
Qualitative  
(Interviews) 
Quantitative 
(Questionnaires) 
Convergence 
Code 
PhD 
Objective 
addressed 
disease, the nature of 
breast cancer, symptoms, 
diagnostic tests, treatment 
options and prognosis were 
also important for older 
women (>70 yrs).  Older 
women wanted information 
on the impact of treatment 
on their functional 
independence, self-care, 
quality of life, social life and 
on the practical aspects of 
treatment e.g.travel. 
implications for daughters. 
Practical consideration e.g. 
impact of treatment on 
independence, transport for 
further treatment, dates and 
times of appointments, length 
of stay post surgery, and  
prescription collection. 
were; how long they 
would be in hospital; 
whether it was necessary 
to have a mastectomy or 
was a WLE possible; the 
side effects of the tablets 
and the operation; how 
safe the operation was at 
'my age'; the side effects 
or complications of the 
operation; whether it was 
possible for family & 
friends to care for the 
women after the 
operation; the likelihood 
of the cancer recurring; 
the likelihood of cure 
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Meta-theme: Shaping the decision 
 Literature Review 
* based on literature in the 
review article. 
Qualitative  
(Interviews) 
Quantitative 
(Questionnaires) 
Convergence 
Code 
PhD 
Objective 
addressed 
after surgery and how 
the tablets would be 
obtained.  
Views on 
information 
materials e.g. 
booklets, leaflets, 
DVDs, CDs, in 
shaping the 
treatment decision. 
Simple booklets with short 
explanations of risks and 
benefits of treatment, free of 
medical language and with 
clear diagrams were 
requested by older women 
undergoing adjuvant 
therapy. Personal cancer 
stories within the 
information were viewed as 
being in helping to 
understand and cope with 
the disease and its 
treatment. 
Clear, uncomplicated, jargon 
free booklets containing 
relevant information were the 
preferred option. Very little 
interest in acquiring 
information from DVDs, CDs or 
the internet.  
Booklets were the 
preferred source. 
DVD/videos, internet 
based material and CD 
were helpful to 6 or fewer 
women. 5 women did not 
want any information. 
A 1,2 
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Meta-theme: Shaping the decision 
 Literature Review 
* based on literature in the 
review article. 
Qualitative  
(Interviews) 
Quantitative 
(Questionnaires) 
Convergence 
Code 
PhD 
Objective 
addressed 
 
Preferred 
presentation to 
ease 
understanding of 
information.  
Older women with breast 
cancer preferred words to 
quantify or describe risk. 
Younger and more 
educated people had a 
greater preference for 
numerical expression.  
With two exceptions all the 
women said they did not find 
graphs, charts or percentages 
helpful. They preferred 
information in words. 
51/101 women preferred 
a statement in words e.g. 
'Breast cancer is a 
common cancer in 
women'. Followed by a 
number e.g. '1 in 8 
women in the UK will get 
breast cancer'. Very few 
women (11 or fewer) 
preferred a pictogram, 
graph, a chart, 
percentages or fractions. 
A 1,2 
Amount of 
information 
preferred to make 
a decision about 
treatment.  
Cancer patients regardless 
of age have high 
information needs. The 
amount required by older 
people is variable. Some 
There were a range of 
opinions on the amount of 
information preferred. Some 
felt they had enough others felt 
overwhelmed and a very small 
The majority of women 
felt they had all the 
information they needed 
to decide on treatment. 
A 1,2 
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Meta-theme: Shaping the decision 
 Literature Review 
* based on literature in the 
review article. 
Qualitative  
(Interviews) 
Quantitative 
(Questionnaires) 
Convergence 
Code 
PhD 
Objective 
addressed 
want as much information 
as possible whilst others 
have fewer information 
needs. 
number would have liked more 
information. All said they had 
enough information.  
 
The role of 
previous 
experience of 
serious illness and 
own perceptions of 
cancer in shaping 
the decision.  
Personal experience of 
others' cancer is a factor 
which impacts on 
knowledge of cancer 
treatments. Prior 
experience or perception of 
cancer was a barrier to 
treatment. 
Almost all the women 
interviewed cited previous 
experience of cancer in a 
family of friend which 
influenced their decision-
making. This was sometimes 
cited as a reason for not 
wanting surgery, but for others 
it was a reason to choose 
surgery.  
This topic was not 
addressed in the 
questionnaire 
Silence(S) 3 
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Meta-theme: Shaping the decision 
 Literature Review 
* based on literature in the 
review article. 
Qualitative  
(Interviews) 
Quantitative 
(Questionnaires) 
Convergence 
Code 
PhD 
Objective 
addressed 
The role of family 
and friends, and 
others play in 
shaping the 
decision.  
The role of family varied. 
Some families have little or 
no influence on DM whilst 
others are heavily involved 
with some making decisions 
on behalf of the women due 
to dementia, cognitive 
impairment or cultural 
reasons.  Family and 
friends were also a source 
of information for some 
women.  
Approximately half of the 
women interviewed said they 
talked to family & friends and 
three talked to their GP. 
Daughters were heavily 
involved in DM. There were a 
small number of women who 
only told their family after they 
had made their decision. 
Others didn't speak to anyone 
other than breast cancer staff. 
15 or fewer women 
spoke to their family & 
friends or to their GP. 2 
spoke to no one.  
A 3 
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Table 8.3: Integration of findings to address research question 2 
Meta-theme: Making the Decision     
 
Literature Review*  
* based on literature in the 
review article.  
Qualitative  
(Intdecision-makinger views) 
Quantitative 
(Questionnaires) 
Convergence 
code 
PhD 
Objective 
addressed 
Themes 
     
 
Making the final 
treatment decision. 
 
Across all age groups women 
with breast cancer want to be 
involved in the treatment 
decision. One systematic 
review reported a wide range 
of DM styles. Between 15.5-
64.63%.experienced active 
DM, 21-63.5% experienced 
SDM, & 8.1-60.7% 
experienced passive DM.   
With increasing age women 
are reported to want less 
involvement than younger 
women but this is variable. 
 
Most women stated they 
made their own decision. 
Some made a 'snap' decision 
before diagnosis or 
immediately on diagnosis. 
Some women decided 
against surgery without 
knowing that PET was an 
alternative treatment. A small 
number of women chose a 
treatment against what the 
Dr/nurse was encouraging 
them to choose. Some were 
happy for the Dr to make the 
 
21/98 stated they made 
the final treatment 
decision. A further 23/98 
said they made the 
decision after 
considering the Dr or 
nurses' opinion. 15/98 
shared the decision, 
15/98 allowed the doctor 
to make the decision 
after to listening to her 
opinion and 24/98 stated 
the Dr or nurse made the 
final treatment decision.  
 
A 
 
4 
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Meta-theme: Making the Decision     
 
Literature Review*  
* based on literature in the 
review article.  
Qualitative  
(Intdecision-makinger views) 
Quantitative 
(Questionnaires) 
Convergence 
code 
PhD 
Objective 
addressed 
One study of older women 
with breast cancer reported 
women more likely to take an 
active / sole role in the final 
treatment decision.  
decision. 
 
The role of the Dr 
or nurse in the 
discussing the 
treatment decision. 
 
Decision-making was 
influenced by the doctor and 
most women trusted the Dr to 
make the decision. 
 
The doctor or nurse had a 
major role in discussing the 
treatment decision. Women 
were frequently of the opinion 
that they should be guided by 
the doctor or nurse as they 
had the experience to make 
the decision. 
 
53/101 had input from 
the Dr or nurse in 
making the treatment 
decision.             
 
A 
 
3&4 
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Meta-theme: Making the Decision     
 
Literature Review*  
* based on literature in the 
review article.  
Qualitative  
(Intdecision-makinger views) 
Quantitative 
(Questionnaires) 
Convergence 
code 
PhD 
Objective 
addressed 
 
Preferred decision-
making style. 
This varies considerably 
across all ages of women 
with breast cancer. Between 
13-40.4% preferred an active 
style of decision-making, 21-
63.5% a shared role, 12.2-
66% preferred a passive role. 
This item was not specifically 
addressed but comments 
about 'knowing their own 
mind' and I made the decision 
immediately, and for some 
this was without consideration 
of possible alternatives, were 
made by some of the women 
interviewed. Women 
frequently stated they wanted 
to discuss the option 
intimating a shared decision-
making preference. The 
oldest women were very 
active decision makers with 
some choosing without input 
from the Dr/nurse.  
16/96 would prefer to 
make their own decision. 
20/96 would prefer to 
make the decision after 
considering the doctor or 
nurses' opinion. 23/98 
prefer to share the 
responsibility; 16/96           
preferred the doctor 
made the final decision 
after considering her 
opinion; 21/96 said they 
would prefer the doctor 
or nurse to make the 
final decision. Women 
who had an operation 
were more likely to want 
 
A 
 
3&4 
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Meta-theme: Making the Decision     
 
Literature Review*  
* based on literature in the 
review article.  
Qualitative  
(Intdecision-makinger views) 
Quantitative 
(Questionnaires) 
Convergence 
code 
PhD 
Objective 
addressed 
(ideally) to experience 
SDM whereas women 
who chose PET 
preferred an ADM role. 
Fisher Exact p=.015. 
Women who had an 
operation were more 
likely to experience SDM 
whereas women who 
chose PET experienced 
an ADM role. Fisher 
Exact p=.008   
 
Satisfaction with 
treatment decision. 
 
Regardless of age there is a 
high level of satisfaction with 
the decision-making process 
and the treatment decision. 
 
Only one woman said she 
would have chosen a different 
treatment. 
 
83/89 women said they 
agreed or strongly 
agreed they had made 
the right decision. 5 
 
A 
 
3 
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Meta-theme: Making the Decision     
 
Literature Review*  
* based on literature in the 
review article.  
Qualitative  
(Intdecision-makinger views) 
Quantitative 
(Questionnaires) 
Convergence 
code 
PhD 
Objective 
addressed 
women either 'strongly 
disagreed' or 'disagreed' 
they would choose the 
same treatment again. 
Influencing factors 
in the treatment 
decision. 
Few studies have examined 
the factors influencing 
treatment decision-making in 
women ≥70 yrs but there are 
a number of studies that have 
examined post-menopausal 
women. Age, education level, 
independence, treatment 
preference, family 
involvement and doctor 
communication are all known 
to influence the decision. 
Some women saw 
themselves as too old for 
surgery, whilst others felt the 
doctors were implying they 
were too old. Fear of surgery 
and the impact on 
independence it would have 
post-operatively were also 
cited as a reason not to 
choose surgery. Others 
wanted to rid themselves of 
cancer so chose surgery. One 
No association was 
found between level of 
education and type of 
treatment received, or 
between the person they 
preferred to help them 
decide and the treatment 
received. There was a 
strong association 
between age and the 
treatment received. 
(Fisher's Exact p =.000) 
A 3 
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Meta-theme: Making the Decision     
 
Literature Review*  
* based on literature in the 
review article.  
Qualitative  
(Intdecision-makinger views) 
Quantitative 
(Questionnaires) 
Convergence 
code 
PhD 
Objective 
addressed 
Women saw older age as a 
reason to rule out some 
adjuvant therapy.  
woman was unconvinced of 
the efficacy of PET and 
therefore chose surgery. 
Personal experience of illness 
and lay information about 
cancer treatments also 
influenced their decision.  
Women under the 
median age of 82 were 
more likely to receive 
surgery and those above 
more likely to receive 
PET. 
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8.2. Mixed methods findings 
The following sections provide a summary discussion that draws together the 
integrated findings presented in the convergence coding matrix. 
Interpretation of the qualitative findings had resulted in the generation of 
three major themes.  
These meta themes were then expanded on ‘mixing’ the data to include sub-
themes, as presented in the convergence coding matrix above, to draw 
together findings meeting the study objectives and questions as a whole. The 
three meta themes represent a trajectory that represents older women’s 
preferences for information to aid decision-making and their decision-making 
styles when faced with a choice of surgery and adjuvant endocrine therapy 
or PET. The findings illustrate older women’s reactions to being offered a 
decision, how the decision they make is shaped and the processes involved 
in making the decision.  
8.2.1.  Receiving a choice 
There was little evidence in the literature review concerning specifically older 
women being offered a choice of treatment. The survey results show less 
than half the women remembering being offered a choice between surgery 
and ET with PET. However, the interview data suggest that whilst most 
women interviewed remember being offered a choice, they do not all recall 
the choice being between surgery and ET with PT. There was agreement 
between the literature and the quantitative (questionnaire) findings for this 
theme but there was dissonance with these datasets and the qualitative 
(interviews) findings. Examining the relationship between age and treatment 
offered across the datasets showed agreement between the literature and 
the quantitative data but not with the qualitative data. The literature and the 
quantitative data show a tendency towards fewer older women being offered 
a choice, however women in the interviews felt they had been offered a 
choice. Further interrogation of the qualitative data highlighted a possible 
difference in interpretation between the women and HCP of the meaning of 
‘choice’.  
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There was full agreement across the datasets for the theme concerning 
reactions to the offer of a choice, with most women appreciating the offer. 
However, it was clear that across the data sets that some women found the 
offer of choice a cause of anxiety and it seems that these older women, 
whilst pleased to be having a choice, wished to have time and support to 
consider the options available, but many did not want to delay a decision 
being made. The data sets all suggest that older women being offered a 
choice may prefer, or expect, to be guided by the HCP. Some women in the 
interviews felt they had 'no choice' as either their co-morbidities dictated PET 
or that they must have surgery to rid themselves of cancer. It is possible that 
the choice made by the women was a reflection of the doctor's preference 
(Hamaker et al. 2013). Some of the oldest women in the interviews had 
already made up their mind what treatment they did not want and for some 
the offer of PET was a bonus as they had simply decided against surgery 
prior to any discussions with their HCP. 
8.2.2.  Shaping the decision 
The findings indicate that older women’s treatment decisions are shaped by 
how they receive information and from whom; the amount and type of 
information they need; the format of that information and how it assists 
understanding. Also important is the women’s own illness experience and 
perceptions of the meaning of cancer and the role of significant others 
including HCPs as well as family. 
There was agreement across the themes 'Preferred source and method of 
receiving treatment information', 'Views on information materials in shaping 
the treatment decision', 'Preferred presentation to aid  easy to understand 
information', 'Amount of information preferred to make a decision about 
treatment' and 'The role of family and friends, and others play in shaping the 
decision'. 
There was strong agreement across the data sets that older women prefer to 
receive verbal information from a trusted HPC. Much of the information 
women needed to shape their decision-making was similar to that which 
younger women might also require, and included issues around prognosis; 
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the nature of the disease; investigations and treatment and its duration; 
possible side effects. More specifically associated with older women were 
functional sequelae of treatment including impacts on independence and 
thus burden on family; age-related safety of treatments and the convenience 
and practical management of engaging in the different treatments offered.   
Although verbal information was most strongly preferred, when considering 
other information sources, there was agreement across the data sets that 
booklets were preferred and these materials should be simply and clearly 
stated and be free from medical jargon. Personal cancer stories were 
considered helpful. Whilst simple diagrams were considered to be of 
assistance, graphs, charts, fractions or percentage statements were found to 
be unhelpful with the use of more narrative approaches strongly preferred.  
There was little interest found across the data sets in electronic forms of 
information presentation such as DVDs CDs or the internet. It was found 
across all data sets that women wanted information, but the amount 
appeared very variable, possibly reflecting an individualised, personal need. 
There was agreement between the literature and the findings from the 
interviews for 'The role of previous experience of serious illness and own 
perceptions of cancer' in shaping the decision. However, there was 'silence' 
between these two and the questionnaire findings. This could be explained 
by it not being specifically addressed in the questionnaire but it was not 
raised in the free text section. The literature review identified that personal 
experience or knowledge of others having had cancer impacted negatively 
on older women’s treatment decisions. The interview data agreed that this 
factor impacted on shaping decisions but revealed a more personalised 
picture dependant on the personal situation being drawn upon.  
The role of family and significant others was agreed as variable across all 
data sets. While some women rely on other people to inform and support the 
decision-making process, others do not. This is possibly a reflection on 
individual and family differences in approaches to information sharing and 
decision-making. 
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8.2.3.  Making the decision 
There was agreement across all datasets for the themes, ''Making the final 
decision'; 'The role of the doctor or nurse in discussing the final decision' 
‘Preferred decision-making style' 'Satisfaction with treatment decision', and 
'Influencing factors in the treatment decision'. 
There was agreement across the data sets that older women wish to be 
involved in deciding the treatment they will have. There was also agreement 
that the level of involvement for individual women is variable. The interview 
data indicates some women were happy for their doctor to make the decision, 
some of these after explaining their perspective to the doctor; others shared 
the decision with health staff; some made the final decision after considering 
the doctor’s opinion. The interview data revealed a few women making a 
decision but not being aware of options and others making a decision against 
the advice of their HCP. Some women described making an immediate 
treatment decision without consideration of the alternatives.  All data sets 
agree that the HPC has a major role in influencing the final decision and as 
discussed previously older women expect and prefer input from their HPC. 
The data sets agree that the majority of women are satisfied with the 
treatment decision they took. The factors that influence the decision are not 
entirely clear in the literature review data, but factors such as age (reflecting 
the discussion in the shaping the decision theme); fear of surgery or the wish 
to rid themselves of cancer through surgery. The survey data indicates that 
women over the median age of 82 were less likely to opt for surgery.  
8.3. Conclusions 
The findings from this mixed methods study provide further evidence of the 
broad areas of agreement of factors involved in treatment decision-making in 
older women with primary operable breast cancer. It also demonstrates the 
highly variable nature of this preference sensitive choice that includes the 
need to consider and trade-off values and benefits of many personal and 
clinical factors. The wide range of information requirements and variable 
preferences for decision-making styles suggest the need for a more tailored 
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approach to treatment decision-making in older women with operable breast 
cancer. 
The following chapter provides a concluding discussion of the implications of 
these findings. 
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9. Chapter 9: Discussion 
The wider Age Gap project, in which this study is nested, concerns the 
problem of women over 70 years of age having seen less than half of the 
reduction in cancer mortality compared to younger women (ONS 2010).  This 
is, in part, due to sub-optimal treatment as a result of concerns about poor 
treatment tolerance (Wylie & Ravichandran 2013).  Older women have not 
benefitted from the advances in treatment and many do not undergo surgery, 
being offered instead anti-oestrogen tablets (Bouchardy et al. 2003; 
Moneypenny 2004; Wyld, et al. 2004; Lavelle et al. 2007; Bastiaannet, et al. 
2010; Lavelle et al. 2012; Morgan, Wyld, Collins & Reed 2014a). 
Both ageism, the stereotypes and prejudices held about older people on the 
grounds of their age (Butler 1969) and sexism, the belief in traditional gender 
role stereotypes and in the inherent inequality between men and women, are 
generally accepted in to exist within society (Minichiello 2000, Chrisler, 
Barney & Palatino 2016). North and Fiske (2012) further categorise sexism 
as 'hostile' (belief that women should conform to traditional less powerful 
roles) and 'benevolent'' (wishing to protect). Chrisler, Barney & Palatino 
(2016) suggest that women often experience benevolent sexism combined 
with ageism in healthcare. This can lead to women receiving less aggressive 
medical treatment than men with a similar condition (Travis, Howerton, & 
Szymanski, 2012). A review by Lievesley, Hayes, Jones, Clark & Crosby 
(2009) also asserts there is evidence to suggest that ageism and age 
discrimination (behaviour where older people are treated unequally (directly 
or indirectly) on grounds of their age) (Ray, Sharp and Abrams, 2006) are 
frequently found in healthcare settings.  
It could be argued that a combination of ageism and sexism is a feature in 
the assessment and treatment of breast cancer in older women. The most 
obvious of these is the cut off for routine breast screening. Despite a third of 
all breast cancers occurring in women over the age of 70 routine screening 
stops at 73, and women are subsequently expected to request further 
mammograms. In a series of studies undertaken by Lavelle and colleagues 
(Lavelle et al. 2007a; Lavelle et al. 2007b; Lavelle et al. 2012; Lavelle et al. 
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2014) there is clear evidence of sub-optimal treatment with increasing age. It 
is acknowledged that comorbidities increase with age; however even after 
adjusting for this; age is still a predictor of surgery, the recommended 
treatment, not occurring. The predominant reasons cited by surgeons for not 
performing surgery are the patients are unfit for surgery, the presence of 
comorbidities, patient preference and old age (Morgan et al. 2017, 
Sowerbutts et al. 2015). It is patient preference that this PhD aims to 
investigate further since it not clear why patients are choosing not to opt for 
surgery.  Information is a pre-requisite to decision-making and little is known 
about the information needs and treatment decision making preferences of 
older women.  
This PhD study aimed to establish the information needs and decision-
making preferences of older women with primary operable breast cancer 
when faced with a choice of surgery or primary endocrine therapy (PET). 
The justification for this study was the lack of evidence of the information and 
decision support needs of increasing numbers of older women (≥75years) 
who are diagnosed with a primary operable breast cancer and receive a 
choice of treatment options. Seventy-five is considered by HCPs to be the 
age at which it becomes clinically acceptable to introduce PET as an 
alternative treatment option (Mustacchi, Latteier, Milani, Bates & Houghton 
1998). (There are exceptions to this particularly where a younger patient has 
significant comorbidities in which case PET may be a suitable option.) 
Using a sequential mixed methods design, comprising a literature review, 
semi-structured interviews and a questionnaire each phase of the research 
built on the previous with the findings from each integrated to answer the 
research questions. 
“What are the preferences for information, its sources, format and 
presentation for older women faced with a treatment choice for operable 
breast cancer?” 
“What are the preferred decision-making styles in older women faced with a 
treatment choice for operable breast cancer?” 
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9.1. Summary of Findings 
The key findings from this study were:  
1. Older women with breast cancer are less likely to be given the option of 
making a decision about their treatment options. However, older women 
wish to be given a choice in the treatment options available to them, 
however they do not want to be simply given information and left to make 
the decision themselves. Although they wish to be given time to think 
about the decision to make, and consider it important that they are 
supported and guided in making a choice by their HCP, many do not want 
to delay a decision being made and some make an immediate decision 
without wishing to discuss alternatives.  
2. Treatment decisions are shaped by information available to the women. 
Some of this information is drawn from previous personal illness or 
cancer experience or that of others known to them, and the impact on the 
decision is dependent on how that information is perceived. Older women 
prefer to receive information, which is pertinent to their situation, from 
their HCP in a face to face setting.  Information in the form of booklets is 
preferred to electronic formats including DVDs; CDs or the internet. 
Booklets, the preferred option after consultation with an HPC, should be 
simply stated without jargon or statistical presentations. Case scenarios 
are seen as acceptable in booklets; this is interesting considering the role 
of previous experience impacting on treatment decisions and may provide 
the opportunity to provide realistic positive information acceptable to older 
women. 
3. Older women wish to be involved in their treatment decisions. However, 
there is agreement across all data sets that decision-making style in 
terms of whether they prefer to make their treatment decision actively and 
independently; sharing the decision with their HPC or taking a passive 
role is variable.  The majority of women are satisfied with the treatment 
decision they took. Their considerations of their own age is a factor in 
making their decision, and women over the median age of 82 were less 
likely to opt for surgery. 
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9.2. Limitations of the study 
The studies included in the literature review were heterogeneous in terms of 
the design, focus, and country of study and therefore limit the comparability 
of the findings.  The lack of studies dedicated to older women also weakens 
the evidence directly applicable to this group of women.  However, the mixed 
method approach allowed wider perspectives to strengthen this evidence.  
The data from the questionnaire was sub-optimal in terms of the completion 
rates and missing items. However, it was possible to generate useful results 
from some areas of the questionnaire.  Although the questionnaire was 
developed in line with best practice this guidance may not be directly 
applicable to the needs of older women with a serious health issue.  
The women who were interviewed were a self-selecting group and as a 
result it could be that they represent a particular subset of women. Details of 
all of the women approached were not available and it is impossible to know 
whether women from other backgrounds and experiences were approached 
or whether they simply declined the invitation to participate.   
The time from diagnosis to interview may have impacted on the memory 
recall of the details of the women's treatment options offered. The passage of 
time will have allowed time for reflection and evaluation which may also have 
altered the views and feelings about the circumstances surrounding the 
breast cancer diagnosis and treatment offer. However, the commonality of 
the items raised in the interviews gives confidence in the findings. 
It was recognised early in the study that it was not possible to achieve a 
large enough sample to enable generalisablility of questionnaire findings. 
The lack of generalisability would have been detrimental had the 
questionnaire been the only means of data collection. As this was a mixed 
methods study the sub-optimal data did not jeopardise the whole study as it 
was possible to integrate the data collected from the other two elements. 
In an effort to make the questionnaire and the participant information sheet 
attractive and give the study an identity, a photograph of an older woman 
was inserted into the documents. Since this was a study with more than one 
177 
 
element it was felt that a photograph of someone with whom the women may 
identify would encourage continued involvement. However, this proved to not 
always being the case. When invited to take part in the study some women 
expressed strong feelings that they did not identify with the image and 
therefore chose to decline the invitation, impacting on recruitment. These 
women felt that the photograph of the woman did not reflect them as she 
looked older than their own self-image.  On reflection the photograph used, a 
smiling, harmless looking woman with ageing skin, conformed to all the 
stereotypes of an older women when trying to portray a positive ageing 
image. Trying to find an image that would represent how all women over 75 
saw themselves was naïve as it is clear 'one size doesn’t fit all'. This was a 
valuable lesson and something that will be seriously considered in future 
studies.      
9.3. Discussion of the findings 
This study was aligned to a pragmatic philosophical position and therefore is 
concerned with ‘what works’ (Johnson & Onwuegbuzie 2004). The following 
discussion of the findings centres on how they may inform future practice in 
enhancing the care and treatment of older women diagnosed with primary 
operable breast cancer. 
9.3.1. Improving Information Support 
The tendency to prefer brief / simple and/or limited amounts of tailored 
information was a recurrent theme in the interviews of this study. During the 
interviews women talked about being 'overwhelmed' by the amount and 
complexity of information received and would frequently produce numerous 
documents that they revealed were either skimmed or unread. This finding 
was echoed by Schonberg et al (2014) 
Many studies report cancer patients generally have high information needs 
(Cassileth et al. 1980; Hack et al. 1994; Davison et al. 1995; Bilodeau & 
Degner 1996; Blanchard, Labrecque, Ruckdeschel & Blanchard 1996; 
Galloway et al 1997; Vogel, Bengel & Helmes 2008b). Degner et al (1997) 
support the findings of this PhD reporting that older women have variable 
178 
 
information needs with a small number preferring a large amount whilst most 
prefer limited amounts. 
A preference for limited information should not be construed as a lack of 
interest or an inferior approach to decision-making. Restricting the amount of 
information both verbal and written is a coping strategy some older people 
use to conserve cognitive resources (Aldwin 2011). There are a number of 
subtle ways in which women in this study sought to control the level and 
amount of information they preferred.  Both in the literature and in the 
interviews women expressed a preference for information that was directly 
relevant to them. Personalising or tailoring information will remove 
extraneous general material and automatically reduce the amount of 
information. It will focus only on the information relevant to the women's 
options which will allow them to use their cognitive resources in the most 
efficient manner (Aldwin 2011).  
Reading is known to be a more exacting activity with increasing age 
(Salthouse 1996) so decreasing the amount of information will also reduce 
the resources needed. Declining short term memory was an issue some 
women said impacted on the usefulness of longer documents with some 
reporting that by the time they had read a couple of pages they had forgotten 
the earlier information!   
Visual displays of data are introduced into documents to reduce the reading 
load and provide a short-cut to information but the findings in this study 
contradict this. Although there is research to support the use of visual 
displays to explain risk and benefit (Feldman-Stewart 2007) the majority of 
women in this study reported little or no understanding or were confused by 
graphs, pictograms and charts.  
Findings from this study show older women wish to be given a choice of the 
treatment options available to them, however they do not want to be simply 
given information and left to make the decision themselves. The findings 
from this study indicate that older women prefer to be involved in the 
treatment decision but they also have a desire for very focused, limited in 
amount information on which to make that decision.   
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In all three elements of this study women preferred to 'discuss' the 
information before making a treatment decision suggesting they wanted to 
ask questions and retrieve information relevant to themselves and their 
situation. Conversation is an activity constant throughout life and therefore a 
well-rehearsed skill that is generally not lost with age. Preferring verbal 
information is another way of reducing the amount and depth of information 
and therefore the cognitive load.  A conversation with a doctor or nurse 
specialising in breast cancer is seen to be an optimum route to high quality 
information (Bilodeau, & Degner 1996) in comparison to the potential barriers 
surrounding written documents. Given the trust and respect most women 
have for the doctors and nurses, accessing information via a conversation 
seems to be an effective coping strategy.  
9.3.2. Supporting decision-making 
It is reported in this study that involvement in treatment decision-making was 
preferred by older women with breast cancer. This finding is supported by 
Harder, Ballinger, Langridge, Ring & Fallowfield (2013). Previously older 
women have been reported to prefer a more passive role in treatment 
decision-making (Brom et al. 2014). This was not supported by this study as 
the findings from the Control Preference Scale (CPS) (Degner, Sloan & 
Ventakesh 1997) that was integrated into the questionnaire in this study 
showed an equal distribution for preference  of an 'active' (patient-centred) or 
'passive' (doctor-centred) decision-making style with fewer women preferring 
a 'shared' decision-making style. Brom et al (2014) reported a disparate  
range of results among younger women. This pattern of preference suggests 
women ≥75 years with primary operable breast cancer are not predominantly 
'passive' decision makers compared to other cohorts.  However, making any 
meaningful comparison with previous studies should be treated with caution 
as this is also the first study to examine the preferred role in DM in women 
≥75 years faced with a choice of treatment for primary operable breast 
cancer.  
It is claimed that a preference for high levels of information does not always 
indicate a desire for greater involvement in decision-making (Cassileth et al. 
1980; Strull, Lo & Charles 1984; Sutherland et al. 1989; Hack et al. 1994; 
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Cox et al. 2005; Fallowfield 2008). However, the findings from this study 
suggest that women make immediate decisions often based on limited 
and/or lay information. It emerged in the interview data that whilst the 
older  women described making seemingly quick decisions, based on their 
holding lay information about cancer treatments and outcomes that could be 
inaccurate or outdated. It could also be based on the women being experts 
of their own experience; their decision being based on knowing their own 
bodies, their levels of resilience and deep understanding of what they 
themselves valued and believed to be the best option for them. 
The theory of 'unbounded rationality' proposes that to make a rational 
decision all information must be known, that time is unlimited and 
computation is unlimited (Simon 1955). These conditions are unrealistic in 
situations of uncertainty such as health but this does not mean that all 
human decision-making is 'irrational' (Marewki, Gaissmaier, Gigerezer 2010). 
Based on the concept of 'bounded rationality' Gigerenzer and Goldstein 
(1996) propose the 'fast and frugal heuristic' model, also referred to as the 
'rule of thumb', in which they argue, based on the later work of Simon (1978), 
that information processing systems need to 'satisfice' and not 'optimise' in 
order to make decisions with limited time, knowledge or computational 
capacity (cognitive capacity). Simon (1978) rejects the idea of 'unbounded 
rationality' that decisions made under uncertain conditions are made by 
examining all possible items of information and calculating their possible 
outcome and choosing the alternative that scores highest. Results of 
research comparing the use of the fast and frugal model versus more 
classical norms of rational decision-making show the number of correct 
decisions made to be either the same, or in some cases more, using the fast 
and frugal model (Gigerenzer and Goldstein 1996). During their research a 
'less is more' effect was detected. There was a point at which more 
information eventually caused a decrease in correct decisions being made.  
The fast and frugal model supports the notion that providing a preferred 
amount and level of information can lead to decisions that are no less valid 
than using a greater volume of information (Gigerenzer and Goldstein 1996; 
Reyna 2008; Marewki, Gaissmaier, Gigerezer 2010). In fact, it is argued that 
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the ability to make valid decisions on key pieces of information which, give 
the gist of the situation, is an innate feature of human beings (Gigerenzer 
and Goldstein 1996).  
Computation that can be interpreted as cognitive capacity, plays a part in the 
decision-making process. With increasing age cognitive abilities change 
often making it difficult to understand more complex information such as the 
options of treatment for breast cancer. Providing large quantities of 
information is likely to be counterproductive in informing women of the 
options as they become overwhelmed and cease to engage in the process 
and ultimately make less rational decisions (Marewski, Gaissmaier, 
Gigerezer 2010).  
The third element proposed to be essential in decision-making is time. Time 
is relative to the situation. Faced with an immediate threat which requires a 
decision then the timespan is extremely short. In this study women were 
concerned about the amount of time they should take in making a decision 
about the treatment for what they perceive as a life threatening illness. Many 
wanted to make, or made, an instant decision despite being reassured that 
they could take time to consider their options. In line with other studies 
(Schonberg et al. 2014; Ekdal, Andersson & Friedrichsen 2010; Husain 
2008) some women made their decision on pre-conceived ideas about the 
treatment and quickly rejected or accepted treatments offered to them. 
Others immediately deferred the decision to the HCPs they trusted and 
believed had greater knowledge and experience to make this decision. 
Deferring to HCPs to make treatment decisions is supported by Husain 
(2008)  who also found women to be guided either by looking for cues as to 
what the HCP was recommending or by a direct request to make a final 
decision. Making decisions quickly is no less valid than using a protracted 
deliberative and resource intensive approach (Marewski, Gaissmaier, 
Gigerezer 2010) and is a way of using limited personal resources (Aldwin 
2011). 
Although it could be inferred that women are choosing an effective coping 
strategy in deferring to others, it may also be that they are faced with barriers 
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that preclude participation in treatment decision-making. Not recognising that 
they were being offered a choice, poor understanding of the information 
given or feeling they were unable to ask questions about the options 
presented to them have been recognised as barriers to patient involvement 
in decision-making (Joseph-Williams, Elwyn and Edwards 2014).  
9.4. Conclusions 
This mixed methods study has explored the information needs and decision-
making preferences of older women faced with a treatment option of surgery 
or PET for primary operable breast cancer. New understandings have been 
generated around the processes of decision-making undertaken by older 
women and how they can be supported.  This study indicates that this group 
of women are not passive decision makers and make quick based on, at 
times, limited information. They appreciate being offered a choice of 
treatment and wish to discuss their options face to face with a HCP from 
whom they take cues and hold in high regard. This group of women are not 
inclined to access digital information and prefer clearly stated simply framed 
information formats. 
The findings from this study show there is diversity across the information 
and decision support preferred by older women with breast cancer and faced 
with a treatment choice of surgery or PET. The majority wish to be involved 
in the decision-making process whilst a few prefer to defer total responsibility 
of the final decision to HCPs, most commonly the doctor. With very few 
exceptions the women trusted the information and the views of the doctor but 
still preferred to discuss the treatment options. There were women who did 
not understand why they were given a choice or feel they had the knowledge 
and experience to make such a decision.  
It may be appropriate that when considering treatment options HCPs are 
mindful that those deferring responsibility are in the minority and they may 
need encouragement to understand that they can make a valid contribution 
to the discussion and the decision if they prefer. For those who find the 
possibility of decision-making too exacting the HCP should perhaps view this 
as an efficient coping mechanism and provide support.  
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Giving time and space to women who have little knowledge and a reluctance 
to participate in decision-making may seem resource intensive. However, the 
benefits of appropriate decisions being made outweigh the disadvantages 
and have been clearly demonstrated in the literature.  
Recommendations 
It has been reported that younger women prefer to receive extensive 
information about their breast cancer diagnosis and treatment. Evidence 
from this study suggests the information needs of older women are different 
and the information offered should be limited in terms of amount and 
complexity. This study identified information and decision support 
preferences that could be used in the development of dedicated decision 
support tools. Such support for decision-making has been shown to be of 
benefit (Bennett et al 2011). This work has already provided the foundational 
basis for the development of the decision-making tools in the form of a 
booklet and brief decision aid dedicated to the information needs of older 
women with a choice between PET and surgery. 
This study identified the need to tailor decision support tools and provide 
treatment decision support information to meet individual needs and this has 
been undertaken in the online decision support tool of the wider Age Gap 
study. 
Digital sources are currently unpopular with this group of women and should 
not be considered a main source for information. Brief jargon-free booklets 
should be provided avoiding charts and/or graphs. Statistics should be stated 
simply using words, for example 'Breast cancer is common in women in the 
UK'.  
Women should be given opportunities for face to face discussions with a 
HCP about their individual situation. They should be part of decision-making 
that aligns with their preferred decision-making style, this could include being 
sensitive to requests for help in coming to a decision. 
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Some women arrive at a decision very quickly and seemingly without due 
consideration of the options. Practitioners should invest time in exploring 
women's rationale for making their decisions.  
Training in the use of decision support tools should be planned and 
implemented for HCPs. 
The development of a more comprehensive booklet to address the issues 
surrounding the treatment option of surgery or PET paying close attention to 
the language and the presentation would satisfy the needs of those who 
want more detailed information following consultation.  
Recommendations for further work 
Older women are frequently excluded from research particularly large scale 
survey approaches. This study demonstrated some of the difficulties in the 
administration of self-completion questionnaires. Further work is required in 
the development of data collection tools appropriate for an older, frail 
population.   
The interviews in this study established information needs and decision-
making preferences, but it was not within the scope of the work to explore 
the underlying reasons that the women held for the decisions they came to, 
and the speed with which they were made. This important issue requires 
further research.  
 
Word count: 54,846 
 
185 
 
 
 References
 
  
186 
 
References 
Aldwin, C. (2011). Stress and coping across the lifespan. The Oxford 
Handbook of Stress, Health, and Coping, , 15-34.  
All party parliamentary group on breast cancer (2013). A mixed picture: an 
inquiry into geographical inequalities and breast cancer. Retrieved from 
https://www.publications.parliament.uk/pa/cm/cmallparty/register/breast-
cancer.htm [Accessed 16/6/17] 
Andersen, M. R., Bowen, D. J., Morea, J., Stein, K. D., & Baker, F. (2009). 
Involvement in decision-making and breast cancer survivor quality of life. 
Health Psychology, 28(1), 29.  
Asch, D. A., Jedrziewski, M. K., & Christakis, N. A. (1997). Response rates to 
mail surveys published in medical journals. . Journal of Clinical Epidemiology, 
50(10), 1129.  
Atkins, H., Hayward, J. L., Klugman, D. J., & Wayte, A. B. (1972). Treatment 
of early breast cancer: A report after ten years of a clinical trial. British 
Medical Journal, 2(5811), 423-429.  
Audisio, R., Bozzetti, F., Gennari, R., Jaklitsch, M., Koperna, T., Longo, W., 
et al. (2004). The surgical management of elderly cancer patients: 
Recommendations of the SIOG surgical task force. European Journal of 
Cancer, 40(7), 926-938.  
Baker, S. E., Edwards, R., & Doidge, M. (2012). How many qualitative 
interviews is enough?:  Expert voices and early career reflections on 
sampling and cases in qualitative research. National Centre for Research 
Methods Review Paper 
Balducci, L., Extermann, M., & Carreca, I. (2001). Management of breast 
cancer in the older woman. Cancer Control, 8(5), 431.  
Ballard-Barbash, R., Potosky, A. L., Harlan, L. C., Nayfield, S. G., & Kessler, 
L. G. (1996). Factors associated with surgical and radiation therapy for early 
187 
 
stage breast cancer in older women., 88(11), 716-726. Journal of the 
National Cancer Institute, 88(11), 716.  
Barbour, R. S., & Barbour, M. (2003). Evaluating and synthesizing qualitative 
research: The need to develop a distinctive approach. Journal of Evaluation 
in Clinical Practice, 9(2), 179-186.  
Bastiaannet, E., Liefers, G., De Craen, A., Kuppen, P., Van De Water, W., 
Portielje, J., et al. (2010). Breast cancer in elderly compared to younger 
patients in the Netherlands: Stage at diagnosis, treatment and survival in 
127,805 unselected patients. Breast Cancer Research and Treatment, 
124(3), 801-807.  
Beisecker, A. E., Helmig, L., Graham, D., & Moore, W. P. (1994).  Attitudes 
of oncologists, oncology nurses, and patients from a women's clinic 
regarding medical decision-making for older and younger breast cancer 
patients. The Gerontologist, 34(4), 505.  
Stacey, D., Bennett, C. L., Barry, M. J., Col, N. F., Eden, K. B., Holmes-
Rovner, M., ... & Thomson, R. (2011). Decision aids for people facing health 
treatment or screening decisions. Cochrane Database Syst Rev, 10(10). 
Biganzoli, L., Wildiers, H., Oakman, C., Marotti, L., Loibl, S., Kunkler, I., ... & 
Cutuli, B. (2012). Management of elderly patients with breast cancer: 
updated recommendations of the International Society of Geriatric Oncology 
(SIOG) and European Society of Breast Cancer Specialists (EUSOMA). The 
Lancet oncology, 13(4), e148-e160. 
Bilodeau, B. A., & Degner, L. F. (1996). Information needs, sources of 
information, and decisional roles in women with breast cancer. Oncology 
Nursing Forum, 23(4), 691-696.  
Blanchard, C. G., Labrecque, M. S., Ruckdeschel, J. C., & Blanchard, E. B. 
(1988). Information and decision-making preferences of hospitalized adult 
cancer patients. Social Science & Medicine, 27(11), 1139-1145.  
Blau, P. M. (1964). Social exchange theory. Retrieved September, 3, 2007.  
188 
 
Bleicher, R. J., Abrahamse, P., Hawley, S. T., Katz, S. J., & Morrow, M. 
(2008). The influence of age on the breast surgery decision-making process. 
Annals of Surgical Oncology, 15(3), 854-862.  
Borger, J. H., Kemperman, H., Smitt, H. S., Hart, A., van Dongen, J., 
Lebesque, J., et al. (1994). Dose and volume effects on fibrosis after breast 
conservation therapy. , 30(5), pp.1073-1081. International Journal of 
Radiation Oncology* Biology* Physics, 30(5), 1073-1081.  
Bottomley, A., & Jones, L. (1997).  Breast cancer care: Women’s 
experience. . 1997;6:124–32. Eur J Cancer Care (Engl), 6, 124-132.  
Bouchardy, C., Rapiti, E., Fioretta, G., Laissue, P., Neyroud-Caspar, I., 
Schäfer, P., et al. (2003). Undertreatment strongly decreases prognosis of 
breast cancer in elderly women. Journal of Clinical Oncology, 21(19), 3580-
3587.  
Bowling, A. (2009). Research methods in health: Investigating health and 
health services. McGraw-Hill International. 
Boynton, P. M., & Greenhalgh, T. (2004).  Selecting, designing, and 
developing your questionnaire. ), . BMJ (Clinical Research Ed)., 328(7451), 
1312-1315.  
Bradbeer, J. W., & Kyngdon, J. (1983).  Primary treatment of breast cancer 
in elderly women with tamoxifen. ). Clinical Oncology, 9, 31.  
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. 
Qualitative Research in Psychology, 3(2), 77. 
doi:DOI:10.1191/1478088706qp063oa  
Brazier, J., Jones, N., & Kind, P. (1993). Testing the validity of the euroqol 
and comparing it with the SF-36 health survey questionnaire. Quality of Life 
Research, 2(3), 169-180.  
Brehaut, J. C., O'Connor, A. M., Wood, T. J., Hack, T. F., Siminoff, L., 
Gordon, E., et al. (2003).   Validation of a decision regret scale. Medical 
Decision-making, 23(4), 581-292.  
189 
 
Bridging the Age Gap in Breast Cancer Study.  WYLD, Lynda, REED, 
Malcolm, et al. Bridging the Age Gap in Breast Cancer:  Improving outcomes 
for older women. Helping older women choose' Study commenced July 2012 
- end date June 2018 
Brom, L., Hopmans, W., Pasman, H. R. W., Timmermans, D. R., 
Widdershoven, G. A., & Onwuteaka-Philipsen, B. D. (2014). Congruence 
between patients’ preferred and perceived participation in medical decision-
making: A review of the literature. BMC Medical Informatics and Decision-
making, 14(1), 25.  
Bruera, E., Willey, J. S., Lynn Palmer, J., & Rosales, M. (2002). Treatment 
decisions for breast carcinoma. Cancer, 94(7), 2076-2080.  
Brunt, A. M., Wheatley, D., Yarnold, J., Somaiah, N., Kelly, S., Harnett, A., et 
al. (2016). Acute skin toxicity associated with a 1-week schedule of whole 
breast radiotherapy compared with a standard 3-week regimen delivered in 
the UK FAST-forward trial. Radiotherapy and Oncology, 120(1), 114-118.  
Bryman, A. (2008). Why do researchers integrate /combine /mesh /blend 
/mix /merge /fuse quantitative and qualitative research. Advances in mixed 
methods research, 87-100. 
Butler, R. N. (1969). Age-ism: Another form of bigotry 
Caldon, L. J., Collins, K. A., Reed, M. W., Sivell, S., Austoker, J., Clements, 
A. M., et al. (2011). Clinicians’ concerns about decision support interventions 
for patients facing breast cancer surgery options: Understanding the 
challenge of implementing shared decision‐making. Health Expectations, 
14(2), 133-146.  
Caldon, L., Walters, S., & Reed, M. (2008). Changing trends in the decision‐
making preferences of women with early breast cancer. British Journal of 
Surgery, 95(3), 312-318.  
Cancer Research UK (2012) http://www.cancerresearchuk.org/health-
professional/cancer-statistics/statistics-by-cancer-type/breast-
190 
 
cancer/mortality?_ga=2.188741864.1750638499.1497291942-
1752829980.1497291942#heading-One 
Canter, R. (2001). Patients and medical power. BMJ (Clinical Research Ed.), 
323(7310), 414.  
Carpenter, J. S., Johnson, D. H., & Wagner, L. J. (2002). Hot flushes and 
related outcomes in breast cancer survivors and matched comparison 
women. Oncology Nursing Forum, 29, 16-25.  
Cassileth, B. R., Zupkis, R. V., Sutton-smith, K., & March, V. (1980). 
Information and participation preferences among cancer patients. , 92(6), 
pp.832-836. Annals of Internal Medicine, 92(6), 832-836.  
Cherryholmes, C. H. (1992).  Notes on pragmatism and scientific realism. 
Educational Researcher, , 13-17.  
Chrisler, J. C., Barney, A., & Palatino, B. (2016). Ageism can be hazardous 
to women's health: Ageism, sexism, and stereotypes of older women in the 
healthcare system. Journal of Social Issues, 72(1), 86-104. 
Ciambrone, D. (2006). Treatment decision-making among older women with 
breast cancer. Journal of women & aging, 18(4), 31-47. 
Clarke, M., Collins, R., Darby, S., Davies, C., Elphinstone, P., Evans, E., et al. 
(2005). Early breast cancer trialists collaborative group (EBCTCG). effects of 
radiotherapy and of differences in the extent of surgery for early breast 
cancer on local recurrence and 15-year survival: An overview of the 
randomised trials. Lancet, 366(9503), 2087-2106.  
Clark, V L. Plano and Creswell, J W. (2011). Designing and conducting 
mixed methods research. Sage Thousand Oaks 
Coleman, M. P., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C., 
et al. (2011). Cancer survival in Australia, Canada, Denmark, Norway, 
Sweden, and the UK, 1995–2007 (the international cancer benchmarking 
partnership): An analysis of population-based cancer registry data. The 
Lancet, 377(9760), 127-138.  
191 
 
Collins, E. D., Moore, C. P., Clay, K. F., Kearing, S. A., O'Connor, A. M., 
Llewellyn-Thomas, H. A., et al. (2009).  Can women with early-stage breast 
cancer make an informed decision for mastectomy? Journal of Clinical 
Oncology, 27(4), 519-525.  
Cooper W.A The history of radical mastectomy. Ann Med Hist. 1942;36-54 
Cox, A., Jenkins, V., Catt, S., Langridge, C., & Fallowfield, L. (2006). 
Information needs and experiences: An audit of UK cancer patients. 
European Journal of Oncology Nursing, 10(4), 263-272.  
Creswell, J. W., & Tashakori, A. (2007).  Editorial: Differing perspectives on 
mixed methods research. . Journal of Mixed Methods Research, 1(4), 303-
308.  
Creswell, J. W., & Plano-Clark, V. L. (2007).  Designing and conducting 
mixed methods research. . Sage. Thousand Oaks. CA.:  
Creswell, J. W., & Clark, V. L. P. (2011). Designing and conducting mixed 
methods research.(2nd Ed.) Sage. Thousand Oaks. CA 
Creswell, J. W. (2012). Qualitative inquiry and research design: Choosing 
among five approaches.  Sage publications.  
Creswell, J. W., Fetters, M. D., & Ivankova, N. V. (2004). Designing a mixed 
methods study in primary care. Annals of Family Medicine, 2(1), 7-12.  
Creswell, J. W., & Tashakkori, A. (2007). Editorial: Differing perspectives on 
mixed methods research. Journal of Mixed Methods Research, 1(4), 303-308. 
Crile Jr, G. (1972).  Low incidence and morbidity of local recurrence after 
conservative operations for cancer of the breast. Annals of Surgery, 175(2), 
249.  
Crooks, D. L. (2001). Older women with breast cancer: New understandings 
through grounded theory research. Health Care for Women International, 
22(1-2), 99-114.  
192 
 
Crotty, M. (1998). The foundations of social research: Meaning and 
perspective in the research process. Sage Thousand Oaks. CA  
Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & 
Forbes, J. F. (2010). Effect of anastrozole and tamoxifen as adjuvant 
treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. 
The Lancet Oncology, 11(12), 1135-1141. 
Czaja, R., Blair, J., Czaja, R., & Blair, J. (2005). Selecting the method of data 
collection. Designing Surveys: A Guide to Decisions and Procedures, , 33-58.  
Davidson, M. R. (2004). A phenomenological evaluation: Using storytelling 
as a primary teaching method. Nurse Education in Practice, 4(3), 184-189.  
Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., Abraham, 
M., Alencar, V.H.M., Badran, A., Bonfill, X. and Bradbury, J., 2013. Long-
term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 
5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, 
a randomised trial. The Lancet, 381(9869), pp.805-816. 
Davison, B. J., Degner, L. F., & Morgan, T. R. (1995). Information and 
decision-making preferences of men with prostate cancer. Oncology Nursing 
Forum, 22(9), 1401-1408.  
Degner, L. F., Kristjanson, L. J., Bowman, D., Sloan, J. A., Carriere, K. C., 
O'Neil, J., et al. (1997). Information needs and decisional preferences in 
women with breast cancer. Jama, 277(18), 1485-1492.  
Degner, L. F., & Sloan, J. A. (1992). Decision-making during serious illness: 
What role do patients really want to play?. Journal of Clinical Epidemiology, 
45(9), 941-950.  
Degner, L. F., Sloan, J. A., & Venkatesh, P. (1997). The control preferences 
scale. Canadian Journal of Nursing Research, 29(3), 21-43.  
Denzin, N. K., & Lincoln, Y. S. (2011). The Sage handbook of qualitative 
research. Sage. 
193 
 
Denzin, N. K. (1978). The research act: A theoretical introduction to research 
methods. New Brunswick, NJ: Aldine Transaction,  
Department of Health (2007) Cancer Reform Strategy Retrieved from 
http://www.nhs.uk/NHSEngland/NSF/Documents/Cancer%20Reform%20Str
ategy.pdf [Last accessed 21/6/17] 
Department of Health (2001). National service framework for older people. 
Retrieved from https://www.gov.uk/government/publications/quality-
standards-for-care-services-for-older-people [Accessed [16/6/17] 
Department of Health (2005). Research Governance Framework for Health 
and Social Care 2005. Retrieved from 
http://www.hra.nhs.uk/resources/research-legislation-and-
governance/research-governance-frameworks [Accessed 21/12/16] 
Department of Health (2004). Choosing Health. Retrieved from 
http://www.nhshistory.net/choosing%20health%20summary.pdf 
Department of Health. (1991). The patient's charter: Past and future. 
http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsa
ndstatistics/Publications/AnnualReports/Browsable/DH_4931265  
Department of Health (2010). Liberating the NHS White Paper. Retrieved 
from https://www.gov.uk/government/publications/liberating-the-nhs-white- 
Dillman, D. A., Smyth, J. D., & Christian, L. M. (2014). Internet, phone, mail, 
and mixed-mode surveys: The tailored design method John Wiley & Sons.  
Dixon-Woods, M., Sutton, A., Shaw, R., Miller, T., Smith, J., Young, B., et al. 
(2007). Appraising qualitative research for inclusion in systematic reviews: A 
quantitative and qualitative comparison of three methods. Journal of Health 
Services Research & Policy, 12(1), 42-47.  
Donker, M., van Tienhoven, G., Straver, M. E., Meijnen, P., van de Velde, C. 
J., Mansel, R. E., ... & Bouma, W. H. (2014). Radiotherapy or surgery of the 
axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 
194 
 
AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority 
trial. The Lancet Oncology, 15(12), 1303-1310. 
Early Breast Cancer Trialists' Collaborative Group. (2006). Effects of 
radiotherapy and of differences in the extent of surgery for early breast 
cancer on local recurrence and 15-year survival: An overview of the 
randomised trials. The Lancet, 366(9503), 2087-2106.  
Eekhout, I., de Boer, R.M., Twisk, J.W., de Vet, H.C. and Heymans, M.W., 
2012. Missing data: a systematic review of how they are reported and 
handled. Epidemiology, 23(5), pp.729-732 
Ekdahl, A. W., Andersson, L., & Friedrichsen, M. (2010). “They do what they 
think is the best for me.” frail elderly patients’ preferences for participation in 
their care during hospitalization. Patient Education and Counseling, 80(2), 
233-240.  
Ekmektzoglou, K. A., Xanthos, T., German, V., & Zografos, G. C. (2009). 
Breast cancer: From the earliest times through to the end of the 20th century. 
European Journal of Obstetrics & Gynaecology and Reproductive Biology, 
145(1), 3-8.  
Elkin, E. B., Kim, S. H., Casper, E. S., Kissane, D. W., & Schrag, D. (2007). 
Desire for information and involvement in treatment decisions: Elderly cancer 
patients' preferences and their physicians' perceptions. Journal of Clinical 
Oncology, 25(33), 5275-5280.  
ELSA Study https://www.elsa-project.ac.uk/about-ELSA 
Technical report (ELSA Wave 6) The dynamics of ageing: Evidence from the 
English Longitudinal Study of Ageing 2002-12 
https://www.ifs.org.uk/publications/7778Errante, A. (2000). But sometimes 
you're not part of the story: Oral histories and ways of remembering and 
telling. Educational Researcher, 29(2), 16-27.  
Fallowfield, L., Hall, A., Maguire, P., Baum, M., & A'Hern, R. (1994). A 
question of choice: Results of a prospective 3-year follow-up study of women 
with breast cancer. The Breast, 3(4), 202-208.  
195 
 
Fallowfield, L. (1997). Offering choice of surgical treatment to women with 
breast cancer. Patient education and counseling, 30(3), 209-214. 
Fallowfield, L. J., Baum, M., & Maguire, G. P. (1986). Effects of breast 
conservation on psychological morbidity associated with diagnosis and 
treatment of early breast cancer. British Medical Journal (Clinical Research 
Ed.), 293(6558), 1331-1334.  
Fallowfield, L. J., Hall, A., Maguire, P., Baum, M., & A'Hern, R. P. (1994). 
Psychological effects of being offered choice of surgery for breast cancer. 
BMJ (Clinical Research Ed.), 309(6952), 448.  
Fallowfield, L. J. (2008). Treatment decision-making in breast cancer: the 
patient–doctor relationship. Breast cancer research and treatment, 112(1), 5-
13. 
Farmer, T., Robinson, K., Elliott, S. J., & Eyles, J. (2006). Developing and 
implementing a triangulation protocol for qualitative health research. 
Qualitative Health Research, 16(3), 377-394.  
Feldman‐Stewart, D., Brennenstuhl, S., McIssac, K., Austoker, J., Charvet, 
A., Hewitson, P., et al. (2007). A systematic review of information in decision 
aids. Health Expectations, 10(1), 46-61.  
Fennessy, M., Bates, T., MacRae, K., Riley, D., Houghton, J., & Baum, M. 
(2004). Late follow‐up of a randomized trial of surgery plus tamoxifen versus 
tamoxifen alone in women aged over 70 years with operable breast cancer. 
British Journal of Surgery, 91(6), 699-704.  
Fisher, B., Ravdin, R. G., Ausman, R. K., Slack, N. H., Moore, G. E., & Noer, 
R. J. (1968). Surgical adjuvant chemotherapy in cancer of the breast: Results 
of a decade of cooperative investigation.. Annals of Surgery, 168(3), 337.  
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, 
M., Cronin, W. M., et al. (1998). Tamoxifen for prevention of breast cancer: 
Report of the national surgical adjuvant breast and bowel project P-1 study. 
Journal of the National Cancer Institute, 90(18), 1371-1388.  
196 
 
Fisher, B. (2005). A vignette from breast cancer history: One hundred years 
after the Greenough report. Journal of the American College of Surgeons, 
200(4), 484-486.  
Frank, G. (1997). Is there life after categories? Reflexivity in qualitative 
research. The Occupational Therapy Journal of Research, 17, 84-98.  
Frisk, J., Källström, A., Wall, N., Fredrikson, M., & Hammar, M. (2012). 
Acupuncture improves health-related quality-of-life (HRQoL) and sleep in 
women with breast cancer and hot flushes. Supportive Care in Cancer, 20(4), 
715-724.  
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, 
A. M., et al. (2010). Radiation dose–volume effects in the heart. International 
Journal of Radiation Oncology* Biology* Physics, 76(3), S77-S85.  
Gibson, L., Lawrence, D., Dawson, C., & Bliss, J. (2009). Aromatase 
inhibitors for treatment of advanced breast cancer in postmenopausal 
women. The Cochrane Library,  
Gigerenzer, G., & Goldstein, D. G. (1996). Reasoning the fast and frugal 
way: Models of bounded rationality. Psychological Review, 103(4), 650.  
Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, & Bondy, M. L. (2005). 
Breast cancer treatment guidelines in older women. Journal of Clinical 
Oncology: Official Journal of the American Society of Clinical Oncology, 
23(4), 783-791.  
Gnant, M., Thomssen, C., & Harbeck, N. (2015). St. Gallen/Vienna 2015: A 
brief summary of the consensus discussion. Breast Care, 10(2), 124-130.  
Gort, M., Broekhuis, M., Otter, R., & Klazinga, N. S. (2007). Improvement of 
best practice in early breast cancer: Actionable surgeon and hospital factors. 
Breast Cancer Research and Treatment, 102(2), 219-226.  
Grant, M. J., & Booth, A. (2009). A typology of reviews: An analysis of 14 
review types and associated methodologies. Health Information & Libraries 
Journal, 26(2), 91-108.  
197 
 
Gray, R.G., Rea, D., Handley, K., Bowden, S.J., Perry, P., Earl, H.M., Poole, 
C.J., Bates, T., Chetiyawardana, S., Dewar, J.A. and Fernando, I.N., 2013. 
aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years 
versus stopping at 5 years in 6,953 women with early breast cancer. DOI: 
10.1200/jco.2013.31.18_suppl.5 Journal of Clinical Oncology 31, 
no. 18_suppl (June 2013) 5-5. 
Gray, D. E. (2013). Doing research in the real world. Sage. Thousand Oaks 
Greene, J. C., Caracelli, V. J., & Graham, W. F. (1989). Toward a conceptual 
framework for mixed-method evaluation designs. Educational evaluation and 
policy analysis, 11(3), 255-274. 
Greene, J. C., & Caracelli, V. J. (1997). Advances in mixed-method 
evaluation: The challenges and benefits of integrating diverse paradigms. (pp. 
5-17) Jossey-Bass Publishers.  
Guba, E. G. (Ed.). (1990). The paradigm dialog. Sage Publications. 
Guba, E. G., & Lincoln, Y. S. (1994). Competing paradigms in qualitative 
research. Handbook of qualitative research, 2(163-194), 105. 
Gubrium, J. F., & Holstein, J. A. (2002). Handbook of interview research: 
Context and method Sage. Thousand Oaks 
Hack, T. F., Degner, L. F., & Dyck, D. G. (1994). Relationship between 
preferences for decisional control and illness information among women with 
breast cancer: A quantitative and qualitative analysis. Social Science & 
Medicine, 39(2), 279-289.  
Hack, T. F., Degner, L. F., Watson, P., & Sinha, L. (2006). Do patients 
benefit from participating in medical decision-making? longitudinal follow‐up 
of women with breast cancer. Psycho‐oncology, 15(1), 9-19.  
Halfpenny, P. (2014). Positivism and sociology (RLE social theory): 
Explaining social life Routledge.  
198 
 
Halsted, W. S. (1894). The results of operations for the cure of cancer of the 
breast performed at the John Hopkins Hospital from June, 1889, to January, 
1894. Annals of Surgery, 20(5), 497-555.  
Hamaker, M. E., Bastiaannet, E., Evers, D., van de Water, W., Smorenburg, 
C. H., Maartense, E., et al. (2013). Omission of surgery in elderly patients 
with early stage breast cancer. European Journal of Cancer, 49(3), 545-552.  
Harder, H., Ballinger, R., Langridge, C., Ring, A., & Fallowfield, L. J. (2013). 
Adjuvant chemotherapy in elderly women with breast cancer: Patients' 
perspectives on information giving and decision-making. Psycho‐oncology, 
22(12), 2729-2735.  
Hasher, L., Zacks, R. T., & May, C. P. (1999).  Inhibitory control, circadian 
arousal, and age. In D. Gopher, & A. Koriat (Eds.), Attention and 
performance XVII (pp. 653). Cambridge: MA MIT Press.  
Hawkins, R. P., Kreuter, M., Resnicow, K., Fishbein, M., & Dijkstra, A. (2008). 
Understanding tailoring in communicating about health. Health Education 
Research, 23(3), 454-466.  
Hawley, S. T., Zikmund-Fisher, B., Ubel, P., Jancovic, A., Lucas, T., & 
Fagerlin, A. (2008). The impact of the format of graphical presentation on 
health-related knowledge and treatment choices. Patient Education and 
Counseling, 73(3), 448-455.  
Hawley, S. T., Lantz, P. M., Janz, N. K., Salem, B., Morrow, M., Schwartz, 
K., ... & Katz, S. J. (2007). Factors associated with patient involvement in 
surgical treatment decision-making for breast cancer. Patient education and 
counseling, 65(3), 387-395.   
Hayes, V., Morris, J., Wolfe, C., & Morgan, M. (1995). The SF-36 health 
survey questionnaire: Is it suitable for use with older adults? Age and Ageing, 
24(2), 120-125.  
HRA guidance (http://www.hra-ecisiontools.org.uk/consent/principles-
general.html) 
199 
 
Hermaneck, P., Henson, D., Hutter, R., & Sobin, L. (Eds) (1993). Union 
Internationale Contre le Cancer. TNM Classification of Malignant Tumours,  
doi 10.1007/978-3-642-46792-9_1 
Hinchliff, S., Tetley, J., Lee, D., & Nazroo, J. (2017). Older adults’ 
experiences of sexual difficulties: Qualitative findings from the English 
Longitudinal Study on Ageing (ELSA). The Journal of Sex Research, 1-12. 
Hind, D., Wyld, L., Beverley, C., & Reed, M. W. (2006).  Surgery versus 
primary endocrine therapy for operable primary breast cancer in elderly 
women (70 years plus). . The Cochrane Library.,  
Hind, D., Wyld, L., & Reed, M. W. (2007). Surgery, with or without tamoxifen, 
vs tamoxifen alone for older women with operable breast cancer: Cochrane 
review. British journal of cancer, 96(7), 1025-1029. 
Horobin, J. M., Preece, P. E., Dewar, J. A., Wood, R. A., & Cushieri, A. 
(1991).  Long term follow-up of elderly patients with loco-regional breast 
cancer treated with tamoxifen only. Br J Surg, 78, 213-217.  
Hughes, K. K. (1993). Decision-making by patients with breast cancer: The 
role of information in treatment selection. . Oncology Nursing Forum, 20(4), 
623-628.  
Husain LS, Collins K, Reed M, & Wyld, L. (2008). Choices in cancer 
treatment: A qualitative study of the older women's (>70 years) perspective. 
Psycho-Oncology, 17(4), 410-416.  
Iglesias, C., & Torgerson, D. (2000.). Does length of questionnaire matter? A 
randomised trial of response rates to a mailed questionnaire., 5(4), pp.219-
221. Journal of Health Services Research & Policy, 5(4), 219-221.  
Janz, N. K., Mujahid, M. S., Hawley, S. T., Griggs, J. J., Hamilton, A. S., & 
Katz, S. J. (2008). Racial/ethnic differences in adequacy of information and 
support for women with breast cancer. Cancer, 113(5), 1058-1067.  
Janz, N. K., Wren, P. A., Copeland, L. A., Lowery, J. C., Goldfarb, S. L., & 
Wilkins, E. G. (2004). Patient-physician concordance: preferences, 
200 
 
perceptions, and factors influencing the breast cancer surgical decision. 
Journal of Clinical Oncology, 22(15), 3091-3098. 
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). 
Global cancer statistics. , 61(2), 69-90. CA: A Cancer Journal for Clinicians, 
61(2), 69-90.  
Jenkins, V., Fallowfield, L., & Saul, J. (2001). Information needs of patients 
with cancer: Results from a large study in UK cancer centres. British Journal 
of Cancer, 84(1), 48-51.  
Johnson, R.B. & Onwuegbuzie, A.J., 2004. Mixed methods research: A 
research paradigm whose time has come. Educational researcher, 33(7), 
pp.14-26. 
Johnson, R. B., Onwueguzie, A. J., & Turner, L. A. (2007). Toward a 
definition of mixed methods research. , 1 (2), 112-133. Journal of Mixed 
Methods Research, 1(2), 112-133.  
Joseph-Williams, N., Elwyn, G., & Edwards, A. (2014). Knowledge is not 
power for patients: A systematic review and thematic synthesis of patient-
reported barriers and facilitators to shared decision-making. Patient 
Education and Counseling, 94(3), 291-309.  
Katz, S.J., Lantz, P.M. & Zemencuk, J.K., 2001. Correlates of surgical 
treatment type for women with noninvasive and invasive breast cancer. 
Journal of women's health & gender-based medicine, 10(7), pp.659-670. 
Katz, S. J., Lantz, P. M., Janz, N. K., Fagerlin, A., Schwartz, K., Liu, L., ... & 
Morrow, M. (2005). Patient involvement in surgery treatment decisions for 
breast cancer. Journal of Clinical Oncology, 23(24), 5526-5533. 
Kenny, F. S., Robertson, J. F. R., Ellis, I. O., Elston, C. W., & Blarney, R. W. 
(1998).  Long-term follow-up of elderly patients randomized to primary 
tamoxifen or wedge mastectomy as initial therapy for operable breast cancer. 
The Breast, 7(6), 335-339.  
201 
 
Kerlinger, F. N., & Lee, H. (2000). Survey research. Foundations of 
Behavioral Research,  599-619.  
Krag, D. N., Anderson, S. J., Julian, T. B., Brown, A. M., Harlow, S. P., 
Ashikaga, T., et al. (2007). Technical outcomes of sentinel-lymph-node 
resection and conventional axillary-lymph-node dissection in patients with 
clinically node-negative breast cancer: Results from the NSABP B-32 
randomised phase III trial. The Lancet Oncology, 8(10), 881-888.  
Kreling, B., Figueiredo, M. I., Sheppard, V. L., & Mandelblatt, J. S. (2006). A 
qualitative study of factors affecting chemotherapy use in older women with 
breast cancer: Barriers, promoters, and implications for intervention. Psycho‐
oncology, 15(12), 1065-1076.  
Kuhn, T. (2000). The road since structure. University of Chicago press. 
Kunkler, I. H., Williams, L. J., Jack, W. J., Cameron, D. A., & Dixon, J. M. 
(2015). Breast-conserving surgery with or without irradiation in women aged 
65 years or older with early breast cancer (PRIME II): A randomised 
controlled trial. The Lancet Oncology, 16(3), 266-273.  
Kvale, S. (2007). Doing interviews.  . Thousand Oak. CA.: Sage.  
Kvale, S., & Brinkmann, S. (2009). Interviews: Learning the craft of 
qualitative research interviewing. Sage.  
Lange, M. M., Rogers, W., & Dodds, S. (2013). Vulnerability in research 
ethics: A way forward. , 27 (6), 333-340. Bioethics, 27(6), 333-340.  
Lantz, P. M., Janz, N. K., Fagerlin, A., Schwartz, K., Liu, L., Lakhani, I., ... & 
Katz, S. J. (2005). Satisfaction with surgery outcomes and the decision 
process in a population‐based sample of women with breast cancer. Health 
services research, 40(3), 745-768. 
Latty, D., Stuart, K. E., Wang, W., & Ahern, V. (2015). Review of deep 
inspiration breath‐hold techniques for the treatment of breast cancer. Journal 
of Medical Radiation Sciences, 62(1), 74-81.  
202 
 
Lavelle, K., Downing, A., Thomas, J., Lawrence, G., Forman, D., & Oliver, S. 
E. (2012). Are lower rates of surgery amongst older women with breast 
cancer in the UK explained by co-morbidity? British Journal of Cancer, 
107(7), 1175-1180.  
Lavelle, K., Moran, A., Howell, A., Bundred, N., Campbell, M., & Todd, C. 
(2007a). Older women with operable breast cancer are less likely to have 
surgery. British Journal of Surgery, 94(10), 1209-1215.  
Lavelle, K., Sowerbutts, A. M., Bundred, N., Pilling, M., Degner, L., Stockton, 
C., et al. (2014). Is lack of surgery for older breast cancer patients in the UK 
explained by patient choice or poor health?; A prospective cohort study. , (3), 
573-583. British Journal of Cancer, 110(3), 573-583.  
Lavelle, K., Todd, C., Moran, A., Howell, A., Bundred, N., & Campbell, M. 
(2007b). Non-standard management of breast cancer increases with age in 
the UK: A population based cohort of women ages; 65 years.  British Journal 
of Cancer, 96(8), 1197-1203.  
Legard, R., Keegan, J & Ward, K. Chapter 7 In Ritchie, J., Lewis, J., Nicholls, 
C. M., & Ormston, R. (2013). Qualitative research practice: A guide for social 
science students and researchers Sage. Thousand Oaks 
Lerner,  B. Bernard Fisher’s Battle Against the Radical Mastectomy Posted 
on August 9, 2013 theatlantic.com,   
http://drbarronlerner.com/2013/08/09/how-clinical-trials-saved-women-with-
breast-cancer-from-disfiguring-surgery/ 
Levin, B. H., & Clowes, D. A. (1991). From Positivism to Post-Modernism: 
Can Education Catch up with the Paradigm Shift?. 
Levinson, W., Kao, A., Kuby, A., & Thisted, R. (2005). Not all patients want to 
participate in decision-making - A national study of public preferences. 
Journal of General Internal Medicine, 20(6), 531-535.  
Liang, W., Burnett, C. B., Rowland, J. H., Meropol, N. J., Eggert, L., Hwang, 
Y. T., et al. (2002).  Communication between physicians and older women 
with localized breast cancer: Implications for treatment and patient 
203 
 
satisfaction. , 20(4), 1008-1016. Journal of Clinical Oncology, 20(4), 1008-
1016.  
Lieber, E. (2009). Mixing qualitative and quantitative methods: Insights into 
design and analysis issues. 3 (4) 2-18-227. Journal of Ethnographic & 
Qualitative Research, 3(4), 218-227.  
Lievesley, N., Hayes, R., Jones, K., Clark, A., & Crosby, G. (2009). Ageism 
and age discrimination in secondary health care in the United Kingdom: A 
review from the literature. Centre for Policy on Ageing, London. 
Lim, L., & Fisher, J. (1999). Use of the 12-item short-form (SF-12) health 
survey in an Australian heart and stroke population. Quality of Life Research, 
8(1-2), 1-8.  
Livaudais, J. C., Franco, R., Fei, K., & Bickell, N. A. (2013). Breast cancer 
treatment decision-making: Are we asking too much of patients? Journal of 
General Internal Medicine, 28(5), 630-636.  
Lievesly, N. (2009) Ageism and Age Discrimination in Secondary Healthcare 
in the United Kingdom, a Review from the Literature. London: Centre for 
Policy on Ageing. 
Lobb, E. A., Kenny, D. T., Butow, P. N., & Tattersall, M. H. (2001). Women’s 
preferences for discussion of prognosis in early breast cancer. Health 
Expectations, 4(1), 48-57.  
Lohr, K. N., & Zebrack, B. J. (2009). Using patient-reported outcomes in 
clinical practice: Challenges and opportunities. , 18(1), p.99. Quality of Life 
Research, 18(1), 99.  
Macmillan Cancer Support. Cancer in the UK 2014. 
www.macmillan.org.uk/Documents/AboutUs/WhatWeDo/CancerintheUK2014
.pdf. [Accessed February 2017] 
Mandelblatt, J. S., Edge, S. B., Meropol, N. J., Senie, R., Tsangaris, T., Grey, 
L., et al. (2003).  . Predictors of long-term outcomes in older breast cancer 
204 
 
survivors: Perceptions versus patterns of care. , 21(5), pp.855-863. Journal 
of Clinical Oncology, 21(5), 855-863.  
Mandelblatt, J. S., Hadley, J., Kerner, J. F., Schulman, K. A., Gold, K., 
Dunmore‐Griffith, J., et al. (2000). Patterns of breast carcinoma treatment 
in older women. Cancer, 89(3), 561-573.  
Marewski, J. N., Gaissmaier, W., & Gigerenzer, G. (2010). Good judgments 
do not require complex cognition. Cognitive Processing, 11(2), 103-121.  
Mastaglia, B., & Kristjanson, L. J. (2001). Factors influencing women’s 
decisions for choice of surgery for stage I and stage II breast cancer in 
western Australia. , 35(6), 836-847. Journal of Advanced Nursing, 35(6), 
836-847.  
Maxwell, J. A. (1998). Designing a qualitative study. Handbook of Applied 
Social Research Methods,  69-100.  
Mays, N., & Pope, C. (2000). Assessing quality in qualitative research. BMJ: 
British Medical Journal, 320(7226), 50.  
McArdle, J. J., Fisher, G. G., & Kadlec, K. M. (2007). Latent variable 
analyses of age trends of cognition in the Health and Retirement Study, 
1992-2004. Psychology and aging, 22(3), 525. demonstrate a linear decline 
in episodic memory with advancing age. 
McCarty, K. S.,Jr, Miller, L. S., Cox, E. B., Konrath, J., & McCarty KS, S. 
(1985). Estrogen receptor analyses. correlation of biochemical and 
immunohistochemical methods using monoclonal antireceptor antibodies. 
Archives of Pathology & Laboratory Medicine, 109(8), 716-721.  
McWhirter, R. (1948). V.the Value of Simple Mastectomy and Radiotherapy 
in the Treatment of Cancer of the Breast,  
Metzger, F. O., Saini, K. S., Azim, H. A., & Awada, A. (2012). Prevention and 
management of major side effects of targeted agents in breast cancer. 
Critical Reviews in oncology/hematology, 84, 79-85.  
205 
 
Michelson, B., Nystedt,M,. Bolund, C., Degner, L and  Wilking, N. (2000). 
Information needs and preferences for participation in treatment decisions 
among Swedish breast cancer patients. Acta Oncologica, 39(4), 467-476.  
Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: A 
sourcebook. Beverly Hills: Sage Publications. 
Minichiello, V., Browne, J., & Kendig, H. (2000). Perceptions and 
consequences of ageism: views of older people. Ageing & Society, 20(3), 
253-278.Molina-Azorin, J. F. (2010).  The use and added value of mixed 
methods in management research. Journal of Mixed Methods Research,  
Moller, H., Flatt, G., & Moran, A. (2011).  High cancer mortality rates in the 
elderly in the UK. Cancer Epidemiology, 35(5), 407-412.  
Moneypenny, I.J. UK audit of breast referrals and breast cancers occurring 
between April 2002 and March 2003. On behalf of Association of breast 
Surgery at BASO. Available through Lucy Davies at the Association of Breast 
Cancer Surgery at  BASO. 2004.  Unpublished work 
Moores, K. L., Jones, G. L., & Radley, S. C. (2012) Development of an 
instrument to measure face validity, feasibility and utility of patient 
questionnaire use during health care: The QQ-10. International Journal for 
Quality in Health Care. 
Morgan, D. L. (2007). Paradigms lost and pragmatism regained 
methodological implications of combining qualitative and quantitative 
methods. Journal of Mixed Methods Research, 1(1), 48-76.  
Morgan, J., Wyld, L., Collins, K. A., & Reed, M. W. (2014a). Surgery versus 
primary endocrine therapy for operable primary breast cancer in elderly 
women (70 years plus). The Cochrane Library,  
Morgan, J., Reed, M., & Wyld, L. (2014b). Primary endocrine therapy as a 
treatment for older women with operable breast cancer–a comparison of 
randomised controlled trial and cohort study findings. European Journal of 
Surgical Oncology (EJSO), 40(6), 676-684.  
206 
 
Morgan, J.L., Walters, S.J., Collins, K., Robinson, T.G., Cheung, K.L., 
Audisio, R., Reed, M.W. and Wyld, L., 2017. What influences healthcare 
professionals' treatment preferences for older women with operable breast 
cancer? An application of the discrete choice experiment. European Journal 
of Surgical Oncology (EJSO). 
Morrow, M., Jagsi, R., Alderman, A. K., Griggs, J. J., Hawley, S. T., Hamilton, 
A. S., et al. (2009). Surgeon recommendations and receipt of mastectomy for 
treatment of breast cancer. Jama, 302(14), 1551-1556.  
Morrow, M., White, J., Moughan, J., Owen, J., Pajack, T., Sylvester, J., et al. 
(2001). Factors predicting the use of breast-conserving therapy in stage I 
and II breast carcinoma. Journal of Clinical Oncology, 19(8), 2254-2262.  
Muss HB, Berry DA, Cirrincione C, et al. Toxicity of older and younger 
patients treated with adjuvant chemotherapy for node-positive breast cancer: 
the Cancer and Leukemia Group B Experience. J Clin Oncol 2007;25:3699-
3704 
Musselwhite, K., Cuff, L., McGregor, L., & King, K. M. (2007). The telephone 
interview is an effective method of data collection in clinical nursing research: 
A discussion paper. International Journal of Nursing Studies, 44(6), 1064-
1070.  
Mustacchi, G., Latteier, J., Milani, S., Bates, T., & Houghton, J. (1998). 
Tamoxifen versus surgery plus tamoxifen as primary treatment for elderly 
patients with breast cancer: Combined data from the “GRETA” and “CRC” 
trials. Proc Am Soc Clin Oncol, , 17. pp. 99a.  
Naeim, A., Hurria, A., Leake, B., & Maly, R. C. (2006). Do age and ethnicity 
predict breast cancer treatment received? A cross-sectional urban population 
based study: Breast cancer treatment: Age and ethnicity. Critical Reviews in 
oncology/hematology, 59(3), 234-242.  
NICE (National Institute for Health and Clinical Excellence). (2012). Methods 
for the development of NICE public health guidance (third edition) process 
and methods [PMG4]appendix H quality appraisal checklist – qualitative 
207 
 
studies. .Available at: 
https://www.nice.org.uk/process/pmg4/chapter/appendix-h-quality-appraisal-
checklist-qualitative-studies [Accessed: 16/01/17]  
NICE (National Institute for Health and Care Excellence ) (2017) Breast 
cancer (early) - intrabeam radiotherapy system [ID618]Draft Guidelines 
https://www.nice.org.uk/news/article/nice-recommends-controlled-use-of-
targeted-breast-cancer-radiotherapy-treatment-alongside-further-research 
[Date accessed 16/1/17] 
NHS Health Research Authority.  http://www.hra.nhs.uk/resources/applying-
to-recs/nhs-rec-proportionate-review-service/ 
Nold, R.J., Beamer, R.L., Helmer, S.D. and McBoyle, M.F., 2000. Factors 
influencing a woman’s choice to undergo breast-conserving surgery versus 
modified radical mastectomy. The American journal of surgery, 180(6), 
pp.413-418. 
North, M. S., & Fiske, S. T. (2012). An inconvenienced youth? Ageism and 
its potential intergenerational roots. Psychological Bulletin, 138, 982–997. 
doi: 10.1037/a0027843. 
O’Brien, M. A., Ellis, P. M., Whelan, T. J., Charles, C., Gafni, A., Lovrics, P., 
et al. (2013). Physician‐related facilitators and barriers to patient involvement 
in treatment decision-making in early stage breast cancer: Perspectives of 
physicians and patients. Health Expectations, 16(4), 373-384.  
O'Cathain, A., Murphy, E., & Nicholl, J. (2007). Why, and how, mixed 
methods research is undertaken in health services research in England: A 
mixed methods study. BMC Health Services Research, 7, 85.  
O'Cathain, A., Murphy, E., & Nicholl, J. (2008). The quality of mixed methods 
studies in health services research. Journal of Health Services Research & 
Policy, 13(2), 92-98.  
O'Cathain, A., Murphy, E., & Nicholl, J. (2010). Three techniques for 
integrating data in mixed methods studies. BMJ (Clinical Research Ed.), 341, 
c4587.  
208 
 
O’Donnell, M., & Hunskaar, S. (2007). Preferences for involvement in 
treatment decision-making generally and in hormone replacement and 
urinary incontinence treatment decision-making specifically. Patient 
Education and Counseling, 68(3), 243-251.  
ONS Office of National Statistics (2010). Breast Cancer Mortality and 
Survival. Retrieved from 
http://webarchive.nationalarchives.gov.uk/20160105160709/http://www.ons.g
ov.uk/ons/rel/cancer-unit/breast-cancer-in-england/2010/sum-1.html 
O’Leary, K. A., Estabrooks, C. A., Olson, K., & Cumming, C. (2007). 
Information acquisition for women facing surgical treatment for breast 
cancer: Influencing factors and selected outcomes. Patient Education and 
Counseling, 69(1), 5-19.  
Olivotto, I. A., Whelan, T. J., Parpia, S., Kim, D. H., Berrang, T., Truong, P. 
T., et al. (2013). Interim cosmetic and toxicity results from RAPID: A 
randomized trial of accelerated partial breast irradiation using three-
dimensional conformal external beam radiation therapy. Journal of Clinical 
Oncology : Official Journal of the American Society of Clinical Oncology, 
31(32), 4038-4045.  
Oppenheim, A. N. (1992). Questionnaire design, interviewing and attitude 
measurement Bloomsbury Publishing.  
Parkin, D. M., & Fernández, L. M. (2006). Use of statistics to assess the 
global burden of breast cancer. The Breast Journal, 12(s1), S70-S80.  
Partridge, A. H., Burstein, H. J., & Winer , E. P. (2001).  Side effects of 
chemotherapy and combined chemohormonal therapy in women with early-
stage breast cancer.. Journal of the National Cancer Institute Monographs, 
30, 135-142.  
Patey, D. H., & Dyson, W. H. (1948). The prognosis of carcinoma of the 
breast in relation to the type of operation performed. British Journal of 
Cancer, 2(1), 7-13.  
209 
 
Pfahler, G. E., & Parry, L. D. (1930). Results of roentgen therapy in 
carcinoma of the breast. Journal of the American Medical Association, 94(2), 
101-105.  
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, 
M., Smith, I., et al. (2005). Trastuzumab after adjuvant chemotherapy in 
HER2-positive breast cancer. New England Journal of Medicine, 353(16), 
1659-1672.  
Polacek, G. N. J., Ramos, M. C., & Ferrer, R. L. (2007). Breast cancer 
disparities and decision-making among US women. Patient Education and 
Counseling, 65(2), 158-165.  
Polgár, C., Fodor, J., Major, T., Sulyok, Z., & Kásler, M. (2013). Breast-
conserving therapy with partial or whole breast irradiation: Ten-year results 
of the budapest randomized trial. Radiotherapy and Oncology, 108(2), 197-
202.  
Pope, C., & Mays, N. (2000). Qualitative methods in health research. 
methods, 1, 2. 
Popper, K. R. (1934). 1959. The Logic of Scientific Discovery,  
Preece, P. E., Wood, R. A. B., Mackie, C. R., & Cushieri, A. 
(1982).   Tamoxifen as initial sole treatment of localised breast cancer in 
elderly women: A pilot study. ;284: 869–70. British Medical Journal, 284, 
869-870.  
Protière, C., Viens, P., Rousseau, F., & Moatti, J. P. (2010). Prescribers’ 
attitudes toward elderly breast cancer patients. discrimination or empathy? 
Critical Reviews in oncology/hematology, 75(2), 138-150.  
Ray, S., Sharp, E., & Abrams, D. (2006). Ageism: A benchmark of public 
attitudes in Britain. Age Concern. 
Reaby, L. L. (1998). Breast restoration decision-making: Enhancing the 
process.. Cancer Nurs., 21, 196-204.  
210 
 
Reed, M., Wyld, L., Ellis, P., Bliss, J., & Leonard, R. (2009). Breast Cancer in 
Older Women: Trials and Tribulations, Clinical Oncology   Volume 21, Issue 
2, 99–102 
Reyna, V. F. (2008). A theory of medical decision-making and health: Fuzzy 
trace theory. Medical Decision-making, 28(6), 850-865.  
Ring, A. (2010).  The influences of age and co-morbidities on treatment 
decisions for patients with HER2-positive early breast cancer. . Critical 
Reviews in oncology/hematology, 76(2), 127-132.  
Rippy, E., Ainsworth, R., Sathananthan, D., Kollias, J., Bochner, M., & 
Whitfield, R. (2014). Influences on decision for mastectomy in patients 
eligible for breast conserving surgery. The Breast, 23(3), 273-278.  
Ritchie, J., Spencer, L., & O’Connor, W. (2003). Carrying out qualitative 
analysis. Qualitative Research Practice: A Guide for Social Science Students 
and Researchers, 219-262.   
Ritchie, J., & Lewis, J. McNaughton Nicholls, C. and Ormston, R.(2014). 
Qualitative research practice: A guide for social science students and 
researchers. 
 
Robertson, L., & Hale, B. (2011). Interviewing older people: Relationships in 
qualitative research. The Internet Journal of Allied Health Sciences and 
Practice, 9(3), 1-8.  
Robson, C. (2002). Real word research Oxford: Blackwell.  
Rolstad, S., Adler, J., & Rydén, A. (2011). Response burden and 
questionnaire length: Is shorter better? a review and meta-analysis. Value in 
Health, 14(8), 1101-1108.  
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer Jr, C. E., 
Davidson, N. E., et al. (2005). Trastuzumab plus adjuvant chemotherapy for 
operable HER2-positive breast cancer. New England Journal of Medicine, 
353(16), 1673-1684.  
211 
 
Sackett, D. L., Straus, S. E., Richardson, W. S., Rosenberg, W., & Haynes, 
R. B. (2000). How to practice and teach EBM. Edinburgh: Churchill 
Livingstone,  
Salthouse, T. A. (1996). The processing-speed theory of adult age 
differences in cognition. Psychological Review, 103(3), 403.  
Salthouse, T. A. (2009). When does age-related cognitive decline begin?. 
Neurobiology of aging, 30(4), 507-514. 
Salvadori, B., Marubini, E., Miceli, R., Conti, A., Cusumano, F., Andreola, S., 
et al. (1999). Reoperation for locally recurrent breast cancer in patients 
previously treated with conservative surgery. British Journal of Surgery, 86(1), 
84-87.  
Sayer, A. (2000). Realism and social science. Sage. Thousand Oaks CA 
Schaie, K. W., Willis, S. L., & Caskie, G. I. (2004). The Seattle longitudinal 
study: Relationship between personality and cognition. Aging 
Neuropsychology and Cognition, 11(2-3), 304-324. 
Schmidt, H, Cohen, P., Mandeli, A.J., Weltz, C., & Port, E. R. (2016). 
Decision-making in breast cancer surgery: Where do patients go for 
information? The American Surgeon, 82(5), 397 
Schonberg, M. A., Silliman, R. A., McCarthy, E. P., & Marcantonio, E. R. 
(2012). Factors noted to affect breast cancer treatment decisions of women 
aged 80 and older. Journal of the American Geriatrics Society, 60(3), 538-
544.  
Schou, I., Ekeberg, Ø., Ruland, C. M., & Kåresen, R. (2002). Do women 
newly diagnosed with breast cancer and consulting surgeon assess decision-
making equally?. The Breast, 11(5), 434-441. 
Shapiro, C. L., & Recht, A. (2001). Side effects of adjuvant treatment of 
breast cancer. New England Journal of Medicine, 344(26), 1997-2008.  
212 
 
Sheffield Hallam University lone working policy: 
(https://staff.shu.ac.uk/HealthandSafety/documents/Lone%20working%20poli
cyv-1.pdf) 
Silliman, R. A., Dukes, K. A., Sullivan, L. M., & Kaplan, S. H. (1998). Breast 
cancer care in older women. Cancer, 83(4), 706-711.  
Simon, H. A. (1955). A behavioral model of rational choice. The Quarterly 
Journal of Economics, 69(1), 99-118.  
Simon, H. A. (1978). Rationality as process and as product of thought. The 
American Economic Review, , 1-16.  
Singh, J. A., Sloan, J. A., Atherton, P. J., Smith, T., Hack, T. F., Huschka, M. 
M., et al. (2010). Preferred roles in treatment decision-making among 
patients with cancer: A pooled analysis of studies using the control 
preferences scale. The American Journal of Managed Care, 16(9), 688-696.  
Singh-Manoux, A., Kivimaki, M., Glymour, M. M., Elbaz, A., Berr, C., Ebmeier, 
K. P., ... & Dugravot, A. (2012). Timing of onset of cognitive decline: results 
from Whitehall II prospective cohort study. Bmj, 344, d7622. 
Sivell, S., Edwards, A., Elwyn, G., & Manstead, A. S. (2011). Understanding 
surgery choices for breast cancer: how might the Theory of Planned 
Behaviour and the Common Sense Model contribute to decision support 
interventions?. Health Expectations, 14(s1), 6-19. 
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, 
A., et al. (2001). Use of chemotherapy plus a monoclonal antibody against 
HER2 for metastatic breast cancer that overexpresses HER2. New England 
Journal of Medicine, 344(11), 783-792.  
Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., 
et al. (2011). Adjuvant trastuzumab in HER2-positive breast cancer. New 
England Journal of Medicine, 365(14), 1273-1283.  
Smeeth, L., Fletcher, A. E., Stirling, S., Nunes, M., Breeze, E., Ng, E., et al. 
(2001). Randomised comparison of three methods of administering a 
213 
 
screening questionnaire to elderly people: Findings from the MRC trial of the 
assessment and management of older people in the community. BMJ 
(Clinical Research Ed.), 323(7326), 1403-1407.  
Smitt, M. C., & Heltzel, M. (1997). Women's use of resources in decision-
making for early-stage breast cancer: Results of a community-based survey. 
Annals of Surgical Oncology, 4(7), 564-569.  
Sowerbutts, A. M., Griffiths, J., Todd, C., & Lavelle, K. (2015). Why are older 
women not having surgery for breast cancer? A qualitative study. Psycho‐
oncology, 24(9), 1036-1042.  
Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., 
Hayes, D. F., et al. (2015). Prospective validation of a 21-gene expression 
assay in breast cancer. New England Journal of Medicine, 373(21), 2005-
2014.  
Spencer, L., Ritchie, J., & O'Connor, W. (2008). Analysis: Practices, 
principles and processes. In J. Ritchie, & J. Lewis (Eds.), Qualitative 
research practice: A guide for social science students and researchers (6th 
ed., pp. 199). London: Sage.  
Steginga, S., Occhipinti, S., Wilson, K., & Dunn, J. (1998). Domains of 
distress: The experience of breast cancer in Australia. Oncology Nursing 
Forum, 25(6), 1063-1070.  
Stevens, A., Abrams, K., Brazier, J., Fitzpatrick, R., & Lilford, R. (2001). The 
advanced handbook of methods in evidence based healthcare Sage.  
Stotter, A., Reed, M., Gray, L., Moore, N., & Robinson, T. (2015). 
Comprehensive geriatric assessment and predicted 3‐year survival in 
treatment planning for frail patients with early breast cancer. British Journal 
of Surgery, 102(5), 525-533.  
Strull, W. M., Lo, B., & Charles, G. (1984). Do patients want to participate in 
medical decision-making? Jama, 252(21), 2990-2994.  
214 
 
Sutherland, H. J., Llewellyn-Thomas, H. A., Lockwood, G. A., Tritchler, D. L., 
& Till, J. E. (1989). Cancer patients: their desire for information and 
participation in treatment decisions. Journal of the Royal Society of Medicine, 
82(5), 260-263. 
Tampubolon, G. (2015). O-059: Heterogeneity of cognitive ageing in older 
Britons: latent class trajectories of cognitive scores in ELSA 2002–2013. 
European Geriatric Medicine, 6, S22. 
Tang SW, Parker H, Winterbottom L, Hassell K, Ellis IO, Morgan DA, et al. 
(2011). Early primary breast cancer in the elderly - pattern of presentation 
and treatment. Surgical Oncology, 20(1), 7-12.  
Teddlie, C., & Tashakkori, A. (2009). Foundations of mixed methods 
research: Integrating quantitative and qualitative approaches in the social 
and behavioral sciences Sage Publications Inc.  
Tetley, J., Grant, G., & Davies, S. (2009). Using narratives to understand 
older people’s decision-making processes. Qualitative Health Research, 
19(9), 1273-1283.  
Tinker, A. (2003). Older people and ethics. Australasian Journal on Ageing, 
22(4), 206-210.  
Tod, A. Chapter 22 in Gerrish, K & Lacey, A (2006). The research process in 
nursing.5th Ed John Wiley & Sons.  
Tong, A., Flemming, K., McInnes, E., Oliver, S., & Craig, J. (2012). 
Enhancing transparency in reporting the synthesis of qualitative research: 
ENTREQ. BMC Medical Research Methodology, 12(1), 181.  
Travis, C. B., Howerton, D. M., & Szymanski, D. M. (2012). Risk, uncertainty, 
and gender stereotypes in healthcare decisions. Women & Therapy, 35(3-4), 
207-220. 
Vaidya, J. S., Wenz, F., Bulsara, M., Tobias, J. S., Joseph, D. J., Keshtgar, 
M., et al. (2014). Risk-adapted targeted intraoperative radiotherapy versus 
whole-breast radiotherapy for breast cancer: 5-year results for local control 
215 
 
and overall survival from the TARGIT-A randomised trial. The Lancet, 
383(9917), 603-613.  
Vogel, B. A., Helmes, A. W., & Hasenburg, A. (2008a). Concordance 
between patients' desired and actual decision‐making roles in breast cancer 
care. Psycho‐oncology, 17(2), 182-189.  
Vogel, B. A., Bengel, J., & Helmes, A. W. (2008b). Information and decision-
making: Patients’ needs and experiences in the course of breast cancer 
treatment. Patient Education and Counseling, 71(1), 79-85.  
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., 
Fehrenbacher, L., et al. (2002). Efficacy and safety of trastuzumab as a 
single agent in first-line treatment of HER2-overexpressing metastatic breast 
cancer. Journal of Clinical Oncology : Official Journal of the American 
Society of Clinical Oncology, 20(3), 719-726.  
Webster, J. D., Bohlmeijer, E. T., & Westerhof, G. J. (2010). Mapping the 
future of reminiscence: A conceptual guide for research and practice. 
Research on Aging, 32(4), 527-564.  
Whitbourne, S Krauss and Whitbourne, S B. (2010). Adult development and 
aging: Biopsychosocial perspectives. John Wiley & Sons. 
Wong, J. J., D’Alimonte, L., Angus, J., Paszat, L., Soren, B., & Szumacher, E. 
(2011). What do older patients with early breast cancer want to know while 
undergoing adjuvant radiotherapy? Journal of Cancer Education, 26(2), 254-
261.  
WHO (2017) Global incidence of breast cancer 
http://www.who.int/cancer/detection/breastcancer/en/ [Accessed 22/6/17] 
Wyld, L., Garg, D., Kumar, I., Brown, H., & Reed, M. (2004). Stage and 
treatment variation with age in postmenopausal women with breast cancer: 
Compliance with guidelines. British Journal of Cancer, 90(8), 1486-1491.  
Wyld, L., & Reed, M. (2007). The role of surgery in the management of older 
women with breast cancer. European Journal of Cancer, 43(15), 2253-2263. 
216 
 
Wylie, S. and Ravichandran, D., 2013. A UK national survey of breast 
surgeons on primary endocrine therapy of early operable breast cancer. The 
Annals of The Royal College of Surgeons of England, 95(5), pp.353-356. 
Zhang MM, Liu XM, Li J, He L, & Tripathy D. Chinese medicinal herbs to 
treat the side-effects of chemotherapy in breast cancer patients. Cochrane 
Database of Systematic Reviews 2007, Issue 2. [DOI: 
10.1002/14651858.CD004921.pub2] 
Zhu, X., Bensoussan, A., McNicol, E. D., Chen, H., & Lu, W. (2013). 
Acupuncture for treatment‐related side effects in women with breast cancer. 
The Cochrane Library,  
 
  
217 
 
 
 Appendices
 
  
218 
 
 
Appendix 1: Executive Summary of the parent 
study 'Bridging the Age Gap in Breast Cancer'
 
  
219 
 
Executive Summary 
The UK population is ageing with average life expectancy increasing from 50 
years, 100 years ago to over 80 today.  The level of fitness of older people is 
also increasing with many still healthy and fully independent in their 70s and 
80s.  Health technologies are also rapidly advancing with improvements in 
the survivability of health interventions such as surgery making them safe 
even for many people who would have been considered too frail 20 years 
ago. 
Despite this, there is still a perception that once a person crosses the age 
threshold of 65 or 70 years they are classed as ‘elderly’ and often subjected 
to age bias in their medical care.  These decisions are often non evidence 
based as little research has been done on older people to define optimal 
practice.  In addition, research done in the fairly recent past may no longer 
be valid today due to the rapid changes in technology and the rapidly 
improving health status and life expectancy of our population. 
In the field of breast cancer, age related practice variance is widespread.  
The gold standard of care for early breast cancer is surgical removal of the 
primary cancer, sentinel node biopsy of the axillary nodes and adjuvant 
therapies which may include chemotherapy, trastuzumab, anti-oestrogens 
and radiotherapy.  There is consistent evidence that older women are often 
denied surgery, chemotherapy, radiotherapy and trastuzumab based on the 
premise that there is no evidence of efficacy.  It is known that cancer specific 
outcomes in older women with breast cancer are significantly worse that 
those in younger women and can no longer be simply attributed to competing 
causes of death. 
In the case of surgery, up to 40% of older women do not get surgery for their 
breast cancer, with treatment being with anti-oestrogen tablets alone, known 
as primary endocrine therapy (PET).  This type of treatment was shown to be 
effective in several trials in the 1980s, with the trials showing no survival 
disadvantage although rates of local control were sub-optimal.  Life 
expectancy has moved on by almost 10 years since then and fitness levels 
have improved and surgical and anaesthetic techniques are much safer and 
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yet many clinicians continue to use non-surgical strategies in a significant 
proportion of women over 70.   
Undoubtedly there are some older women for whom surgery is associated 
with significant risks and many older women have a preference for minimalist 
treatment for a variety of reasons.  It is therefore appropriate to use anti-
oestrogens in this way in some older women.  The problem we have is that 
there is no guidance on the characteristics of older women which suggest 
they will do better with surgery or PET.   
In a similar vein, chemotherapy is part of the gold standard of care for many 
women with aggressive, oestrogen receptor (ER) negative and/or Her 2 
positive, breast cancer.  However the rate of chemotherapy usage in older 
women is very low, with a lack of research evidence to support its use and 
concerns about its safety in older women.  Older women with these more 
aggressive cancers are often denied this treatment.  Clearly there will be 
some women for whom chemotherapy will be inappropriate and others for 
whom benefit may be gained. 
The BTAG study will use state of the art statistical and modelling techniques 
to determine the age, comorbidity, frailty and disease characteristics of 
women over 70 with early breast cancer to provide guidance on 2 primary 
questions: 
1. What are the personal and cancer characteristics of women who can be 
safely advised that surgery is unlikely to confer any advantage for them? 
2. What are the personal and cancer characteristics of women who should 
be advised to have adjuvant chemotherapy after surgery? 
 
A preliminary disease and outcome statistical model will be derived using 
pre-existing data from the UK primary breast cancer registry held by the 
West Midlands Cancer Intelligence Unit (WMCIU) and the NHS Hospital 
Episode Statistics data.  These data have certain recognised areas of 
weakness, in particular relating to the completeness of and quality of 
comorbidity data.  In addition, staging and co-morbidity data may be less 
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accurate in women treated non surgically as there will be no post-operative 
pathology data returns.  To overcome these limitations a UK wide data 
collection exercise to gather detailed data on older women, their primary 
disease, health status and treatment details and medium term outcomes will 
be performed.  Initial 2 year direct follow up via direct data collection for the 
study will be supplemented by longer term follow-up via cancer registry 
returns for up to 10 years of follow up. 
The study will also explore the underlying reasons for practice variance 
across the UK by analysis of variance between UK breast units.  These new 
data will be used to revise and validate the preliminary statistical model.  The 
statistical models will also be used to develop a health economic model to 
estimate long-term health outcomes and costs for different intervention 
strategies. 
The final stage of the project will be to use the model to develop a web-
based algorithm to support clinicians in decision-making related to older 
women with breast cancer which will be responsive to their personal and 
cancer characteristics. 
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Study Algorithm 
 
Local Control Overall survival
Disease specific 
survival
Quality of life
Outcomes
Age
Comorbidity
Frailty
Disease Biology
Cognitive ability
Independence
Treatment type
Treatment related side effects
Age
Hospital Episode data
Disease Biology
Treatment type
Registry 
(Section 7)
Retrospective data
10 year follow up
Cohort Study
(Section 9)
Prospective data
2 year follow up
Health 
Economic 
Modelling
(sections 8 )
Web Based 
Clinician Decision 
Aid for PET versus 
Surgery choice 
(section 11)
Web Based 
Clinician Decision 
Aid for adjuvant 
chemotherapy 
(section 11)
Health 
Economic 
Modelling
(sections 10 )
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Literature review Search Strategy 
This review addressed the research aim: 
To establish the information needs and preferences of older women with 
early breast cancer when faced with a choice of surgery or primary endocrine 
therapy (PET). 
The type of review undertaken was 'Systematic search and review' 
Eligibility criteria 
Studies were selected according to the criteria listed below. 
Study design 
A study was eligible for inclusion in the review if it reported primary data 
using either qualitative, quantitative or mixed methods. Review papers were 
not eligible for inclusion in the review, but were used to cross-check for 
relevant primary studies. Editorials and opinion pieces were excluded.  
Population 
Eligible studies needed to focus on older women, defined as: ≥65 years of 
age with a primary diagnosis of early operable breast cancer. Studies which 
included studies which had a proportion of participants ≥65 years of age and 
those with mixed cancer cohorts were included. Studies addressing 
metastatic breast cancer or male breast cancer were excluded. 
Intervention 
Studies were eligible for inclusion if the intervention reported was surgery or 
PET.  
Comparator 
Studies were not required to include a comparator to be eligible for inclusion.  
Outcomes 
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A study was eligible for inclusion if it reported the information needs of older 
patients, the media or format of information and patient experience of the 
decision-making process.  
Setting 
Studies were eligible for inclusion irrespective of their setting.  
Information sources 
The bibliographic databases as follows were searched from their inception to 
present: CINAHL (EBSCO), Cochrane Library (Wiley), MEDLINE (EBSCO), 
PsycINFO (ProQuest), Scopus (Elsevier), Web of Science (Thomson 
Reuters).  
Author, citation and reference searches were undertaken on papers included 
in the review.  
Search strategy 
The search strategy comprised four facets and used terms related to: (1) 
older people, and (2) terms to describe breast cancer, and (3) terms to 
describe surgery or primary endocrine therapy, and (4) terms related to 
health literacy. The full search strategy as written up for MEDLINE is 
included in Appendix 1. The searches were undertaken in January 2013. The 
searches were updated in February 2017. 
All search terms were looked for in the title and abstract fields and controlled 
vocabulary terms were used where available. The Boolean operators AND 
and OR were used, alongside truncation, phrase searching and proximity 
operators. Only papers published from1980 onwards and in the English 
language were sought.  
RefWorks, a bibliographic management tool, was used to organise the 
literature yielded for this review and to remove duplicate bibliographic 
records.  
Selection process 
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Using the stated eligibility criteria, all literature was assessed by one 
reviewer (MB) for inclusion in the review. In the first instance this took place 
at title and abstract level. Following the initial screen of titles, a second 
reviewer (KC) checked the inclusions for appropriateness and accuracy. This 
was followed by a screening of the full-text of all remaining papers to 
determine their eligibility.  During the screening process, the reviewer was 
not blinded to the author/s or journal title.  
Data collection process 
All papers included in the review were subjected to a structured information 
abstraction process. Data was extracted by one reviewer (MB) using the data 
extraction form 
Data synthesis 
The data were synthesised using a thematic approach. The themes were 
pre-derived based on each element of the research aim. 
Results 
The literature searches yielded 3190 results in the original search and 1367 
in the re-run. After the removal of duplicates and screening for relevancy 275 
and 111 papers respectively were included in this review.  
Search strategy for older women, breast cancer, PET / Surgery and 
information needs 
All searches have been written up for MEDLINE using the EBSCO interface. 
Explanation of search terms used: / = MeSH Heading; exp = exploded MeSH 
Heading; * = denotes any character/s; ti = title word; ab = abstract word; pt = 
publication type; N = adjacency of words; N3 = adjacency within 3 words; "" = 
phrase search 
English language filters were applied where available. 
1. "older people*".ti,ab. 
2. "older women*".ti,ab. 
3. "older woman*".ti,ab. 
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4. geriatric*.ti,ab. 
5. elderly.ti,ab. 
6. "older old".ti,ab. 
7. sevent*.ti.ab 
8. aged.ti,ab. 
9. frail elderly/ 
10. geriatrics/ 
11. aged/ 
12. aged, 80 and over/ 
13. or/1-12 
 
14. "breast cancer*".ti,ab. 
15. "breast neoplasm*".ti,ab. 
16. "breast carcinoma*".ti,ab. 
17. breast neoplasms/ 
18. carcinoma, ductal, breast/ 
19. or/14-18 
 
20. surger*.ti,ab. 
21. "primary endocrine therap*".ti,ab. 
22. pet.ti,ab. 
23. general surgery/ 
24. mastectomy/ 
25. mastectomy, segmental/ 
26. or/20-25 
 
27. choice*.ti,ab. 
28. preference*.ti,ab. 
29. communicat*.ti,ab. 
30. decision N3 mak*.ti,ab. 
31. role*.ti,ab. 
32. educat*.ti,ab. 
33. knowledg*.ti,ab. 
34. understand*.ti,ab. 
35. pathway*.ti,ab. 
36. "patient choice*".ti,ab. 
37. "patientparticipat*".ti,ab. 
38. comprehen*.ti,ab. 
39. health N3 litera*.ti,ab. 
40. handout*.ti,ab. 
41. hand-out*.ti,ab. 
42. factsheet*ti,ab. 
43. fact-sheet*.ti,ab. 
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44. information* N3 sheet*.ti,ab. 
45. leaflet*.ti,ab. 
46. pamphlet*.ti,ab. 
47. patientpreference/ 
48. communication/ 
49. consumer participation/ 
50. decision-making/ 
51. health services accessibility/ 
52. communication barriers/ 
53. or/27-52 
54. 13 and 19 and 26 and 53  
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Table to show details of new articles 
Author & Article Title 
Country of study  
Aim of the study Sample & age Key findings  
FRONGILLO, M., 
FEIBELMANN, S., BELKORA, 
J., LEE, C. and SEPUCHA, K., 
2013. Is there shared 
decision-making when the 
provider makes a 
recommendation? Patient 
education and counseling, 
90(1), pp. 69-73. 
 
 
USA 
Hypotheses:  
• when providers made a 
treatment recommendation, 
patients would report less 
Involvement in the interaction 
compared to no 
recommendation was made 
• that patients who received a 
lumpectomy recommendation 
would have lower involvement 
scores compared to those who 
received other 
recommendations 
440 patients 
completed the 
surgery survey 
(response rate 
58%).Patients were 
on average 56.9 
years old (SD 11.3), 
This study found an association 
between the type of treatment 
recommendation regarding breast 
cancer surgical decisions and the 
amount of shared decision-making in 
the interaction.  
Patients are not getting a balanced 
view of the options, or being asked 
their preferences, particularly when 
providers recommend a lumpectomy. 
Providers are not discussing the 
option to have a mastectomy or 
eliciting patients’ treatment 
preferences often enough to ensure 
shared decision-making in these 
interactions.  
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Author & Article Title 
Country of study  
Aim of the study Sample & age Key findings  
LIVAUDAIS, J.C., FRANCO, 
R., FEI, K. and BICKELL, 
N.A., 2013. Breast Cancer 
Treatment Decision-Making: 
Are We Asking Too Much of 
Patients? Journal of General 
Internal Medicine, 28(5), pp. 
630-636. 
 
 
USA 
Explored the associations between 
breast cancer patients’ perceived 
degree of responsibility for 
treatment decision-making and a) 
knowledge of the benefit of 
surgical and adjuvant treatments 
discussed with the physician and 
b) regret of decisions after 6 
months.  
368 women aged 28–
89 
Too much perceived responsibility 
for breast cancer treatment decisions 
was associated with poor baseline 
treatment knowledge and 6-month 
decision regret. Health literacy 
problems were common, suggesting 
that health care professionals find 
alternative ways to communicate 
with low health literacy patients, 
enabling them to assume the desired 
amount of decision-making 
responsibility, thereby reducing 
decision regret. 
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Author & Article Title 
Country of study  
Aim of the study Sample & age Key findings  
O'BRIEN, M.A., CHARLES, 
C., WHELAN, T.J., ELLIS, 
P.M., GAFNI, A. and 
LOVRICS, P., 2013. Women's 
perceptions of their 
involvement in treatment 
decision-making for early 
stage breast cancer. 
Supportive Care in Cancer, 
21(6), pp. 1717-1723. 
 
 
Canada 
This study aimed to describe the 
perceptions of women with early 
stage breast cancer regarding 
their involvement in treatment 
decision-making (TDM). 
Nineteen women 
(median age, 61 
years; range, 40–74 
years) with early 
stage breast cancer 
considering surgery 
(n = 6) or adjuvant 
therapy (n = 13) 
participated in semi-
structured interviews.   
Women described being involved in 
various stages of TDM and 
interacting with informal networks 
and specialists. Women’s 
descriptions suggest that 
(1) the concept of involvement in 
TDM may have a broader meaning 
for patients than strictly their 
decisional role   
(2) inclusion of significant others in 
TDM contributes to the patient’s 
sense of involvement.   
Raises questions about what 
involvement means to these patients 
and suggest that the focus on patient 
involvement in TDM within the clinic 
setting may be too narrow to capture 
the meaning of involvement from the 
patient’s perspective. 
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Author & Article Title 
Country of study  
Aim of the study Sample & age Key findings  
SOWERBUTTS, A.M., 
GRIFFITHS, J., TODD, C. and 
LAVELLE, K., 2015. Why are 
older women not having 
surgery for breast cancer? A 
qualitative study. Psycho-
oncology, 24(9), pp. 1036-
1042. 
 
UK 
This study explores reasons why 
older women are not having 
surgery. 
28 women, 76–99 
years (mean 86 
years) participated in 
semi-structured 
interviews. 
 Group 1 - Patients who declined’ 
absolutely ruled out surgery. These 
patients were not interested in 
maximising their survival and 
rejected surgery citing their age or 
concerns about impact of treatment 
on their level of functioning.  
Group 2 - Patient considered surgery 
but chose to have PET most 
specifying if PET failed then they 
could have the operation. Patients 
viewed this as offering them two 
options of treatment. Group 3 - 
Surgeon decided these patients were 
started by the surgeon on PET. 
These patients had comorbidities 
and in most cases the surgeon 
asserted that the comorbidities were 
incompatible with surgery. 
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NICE Quality appraisal checklist – qualitative studies 
Study identification: Include author, 
title, reference, year of publication 
Crooks, D. L. (2001). Older women with breast cancer: New 
understandings through grounded theory research. Health Care 
for Women International, 22(1-2), 99-114. 
Guidance topic: This article reported 
the use of grounded theory in 
understanding breast cancer in older 
women. 
Key research question/aim: To study how older women live with 
breast cancer, integrate cancer into their lives and understand 
their experiences. 
Checklist completed by:  MB 
Theoretical approach  
1. Is a qualitative approach 
appropriate?  
For example: 
Does the research question seek to 
understand processes or structures, or 
illuminate subjective experiences or 
meanings? 
Could a quantitative approach better 
have addressed the research 
question? 
Appropriate 
Inappropriate 
Not sure 
Comments: 
The author went to great lengths to 
explain why a qualitative methodology 
was used. 
2. Is the study clear in what it seeks 
to do?  
For example: 
Is the purpose of the study discussed 
– aims/objectives/research question/s? 
Is there adequate/appropriate 
reference to the literature? 
Are underpinning 
values/assumptions/theory discussed? 
Clear 
Unclear 
Mixed 
Comments: 
The context of the study and the reason 
for it are discussed with reference to 
relevant literature. The aim of the study is 
not overtly stated but as part of the 
context and literature review.  
Values and theories are discussed. 
Study design  
3. How defensible/rigorous is the 
research design/methodology?  
Defensible 
Indefensible 
Comments: 
This article was an exploration of the use 
of grounded theory and therefore 
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For example: 
Is the design appropriate to the 
research question? 
Is a rationale given for using a 
qualitative approach? 
Are there clear accounts of the 
rationale/justification for the sampling, 
data collection and data analysis 
techniques used? 
Is the selection of cases/sampling 
strategy theoretically justified? 
Not sure included significant discussion of the 
methodology and data collection. 
No justification was given of the sample 
Data collection  
4. How well was the data collection 
carried out?  
For example: 
Are the data collection methods clearly 
described? 
Were the appropriate data collected to 
address the research question? 
Was the data collection and record 
keeping systematic? 
Appropriately 
Inappropriately 
Not 
sure/inadequately 
reported 
Comments: 
The author does not report details of 
where the interviews took place. The 
topics addressed were only identified in 
the findings section. Record keeping was 
not addressed 
Trustworthiness  
5. Is the role of the researcher 
clearly described?  
For example: 
Has the relationship between the 
researcher and the participants been 
adequately considered? 
Does the paper describe how the 
research was explained and presented 
to the participants? 
Clearly described 
Unclear 
Not described 
Comments: 
The researcher appears to be a nurse 
undertaking a PhD. She describes the 
bond she developed with the 
participants.  The process of recruitment 
not described. 
 
6. Is the context clearly described?  
For example: 
Clear 
Unclear 
Comments: 
Minimum amount of information given 
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Are the characteristics of the 
participants and settings clearly 
defined? 
Were observations made in a sufficient 
variety of circumstances 
Was context bias considered 
Not sure about the participants.  
As this was purely a grounded theory 
study only interviews would be used. 
7. Were the methods reliable?  
For example: 
Was data collected by more than 1 
method? 
Is there justification for triangulation, or 
for not triangulating? 
Do the methods investigate what they 
claim to? 
Reliable 
Unreliable 
Not sure 
Comments: 
The method is appropriate and fulfils the 
study aims.  
Analysis  
8. Is the data analysis sufficiently 
rigorous?  
For example: 
Is the procedure explicit – i.e. is it clear 
how the data was analysed to arrive at 
the results?  
How systematic is the analysis, is the 
procedure reliable/dependable? 
Is it clear how the themes and 
concepts were derived from the data? 
Rigorous 
Not rigorous 
Not sure/not 
reported 
Comments: 
Very limited information on how themes 
were derived or their analysis. No one 
else reported to be involved. 
 
9. Is the data 'rich'?  
For example: 
How well are the contexts of the data 
described? 
Has the diversity of perspective and 
content been explored? 
How well has the detail and depth 
been demonstrated? 
Rich 
Poor 
Not sure/not 
reported 
Comments: 
Detailed reporting of the findings. 
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Are responses compared and 
contrasted across groups/sites? 
10. Is the analysis reliable?  
For example: 
Did more than 1 researcher theme and 
code transcripts/data? 
If so, how were differences resolved? 
Did participants feed back on the 
transcripts/data if possible and 
relevant? 
Were negative/discrepant results 
addressed or ignored? 
Reliable 
Unreliable 
Not sure/not 
reported 
Comments: 
None of these items were addressed 
11. Are the findings convincing?  
For example: 
Are the findings clearly presented? 
Are the findings internally coherent? 
Are extracts from the original data 
included? 
Are the data appropriately referenced? 
Is the reporting clear and coherent? 
Convincing 
Not convincing 
Not sure 
Comments: 
Details of the findings were reported and 
examined in the light of the literature. No 
quotes were given.  
12. Are the findings relevant to the 
aims of the study?  
Relevant 
Irrelevant 
Partially relevant 
Comments: 
The aims of the study were addressed 
13. Conclusions  
For example: 
How clear are the links between data, 
interpretation and conclusions? 
Are the conclusions plausible and 
coherent? 
Have alternative explanations been 
explored and discounted? 
Adequate 
Inadequate 
Not sure 
Comments: 
Limited acknowledgement of the 
limitations. Limited discussion and 
exploration. More could have been done 
with the findings.  
In line with the aim of the article the 
conclusions were largely around  the use 
of grounded theory.   
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Does this enhance understanding of 
the research topic? 
Are the implications of the research 
clearly defined? 
Is there adequate discussion of any 
limitations encountered?  
Ethics  
14. How clear and coherent is the 
reporting of ethics?  
For example: 
Have ethical issues been taken into 
consideration? 
Are they adequately discussed e.g. do 
they address consent and anonymity? 
Have the consequences of the 
research been considered i.e. raising 
expectations, changing behaviour? 
Was the study approved by an ethics 
committee? 
Appropriate 
Inappropriate 
Not sure/not 
reported 
Comments: 
Although no direct statement about 
receiving a favourable ethical approval 
was made reference was made to 
'doctoral committee' raising concerns 
about the burden of the interviews which 
she defended.   
Overall assessment  
As far as can be ascertained from the 
paper, how well was the study 
conducted? (see guidance notes)  
++ 
+ 
− 
Comments: 
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Quality appraisal checklist – qualitative studies 
Study identification: Include author, 
title, reference, year of publication 
Ciambrone, D. (2006). Treatment decision-making among 
older women with breast cancer. Journal of women & aging, 
18(4), 31-47. 
Guidance topic: Rx DM among older 
women BrCa 
Key research question/aim: To identify factors associated 
with older women's breast cancer treatment decisions, their 
adherence to breast cancer surveillance and to ascertain 
how the women's primary support persons influence those 
decisions. 
Checklist completed by:  MB 
Theoretical approach  
1. Is a qualitative approach 
appropriate?  
For example: 
• Does the research question seek 
to understand processes or 
structures, or illuminate subjective 
experiences or meanings? 
• Could a quantitative approach 
better have addressed the 
research question? 
Appropriate 
Inappropriate 
Not sure 
Comments: 
This was an exploratory study and 
therefore a qualitative approach was 
the most appropriate.  
2. Is the study clear in what it seeks to 
do?  
For example: 
• Is the purpose of the study 
discussed – 
aims/objectives/research 
question/s? 
• Is there adequate/appropriate 
reference to the literature? 
• Are underpinning 
values/assumptions/theory 
discussed? 
Clear 
Unclear 
Mixed 
Comments: 
The case to undertake this study was 
clearly made with reference to the 
literature.  
The aims of the study are stated early 
in the paper. 
The underlying theories around the 
sub-optimal treatment women 
received are raised and discussed. 
Study design  
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3. How defensible/rigorous is the 
research design/methodology?  
For example: 
• Is the design appropriate to the 
research question? 
• Is a rationale given for using a 
qualitative approach? 
• Are there clear accounts of the 
rationale/justification for the 
sampling, data collection and data 
analysis techniques used? 
• Is the selection of cases/sampling 
strategy theoretically justified? 
Defensible 
Indefensible 
Not sure 
Comments: 
Implied justification for sample. No 
rationale for the use of qual approach 
- but based on my knowledge this is 
appropriate. 
 
 
Data collection  
4. How well was the data collection 
carried out?  
For example: 
• Are the data collection methods 
clearly described? 
• Were the appropriate data 
collected to address the research 
question? 
• Was the data collection and 
record keeping systematic? 
Appropriately 
Inappropriately 
Not 
sure/inadequately 
reported 
Comments: 
There were no details about where 
interviews took place or whether there 
was a choice of venue.  
Did not collect data on surveillance as 
this was not an issue for this group of 
women. 
 
Trustworthiness  
5. Is the role of the researcher clearly 
described?  
For example: 
• Has the relationship between the 
researcher and the participants 
been adequately considered? 
• Does the paper describe how the 
research was explained and 
presented to the participants? 
Clearly described 
Unclear 
Not described 
Comments: 
Nothing about researcher-participant 
relationship.   
Description given of the process of 
recruitment and this seems to be at a 
distance from the researcher.   
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6. Is the context clearly described?  
For example: 
• Are the characteristics of the 
participants and settings clearly 
defined? 
• Were observations made in a 
sufficient variety of circumstances 
• Was context bias considered 
Clear 
Unclear 
Not sure 
Comments: 
Details of the where and how the 
women were recruited. Some details 
given of the women's characteristics 
and the recruitment rate. 
7. Were the methods reliable?  
For example: 
• Was data collected by more than 
1 method? 
• Is there justification for 
triangulation, or for not 
triangulating? 
• Do the methods investigate what 
they claim to? 
Reliable 
Unreliable 
Not sure 
Comments: 
No information as to why only one 
method of data collection was 
undertaken and therefore no 
triangulation. 
Analysis  
8. Is the data analysis sufficiently 
rigorous?  
For example: 
• Is the procedure explicit – i.e. is it 
clear how the data was analysed 
to arrive at the results?  
• How systematic is the analysis, is 
the procedure 
reliable/dependable? 
• Is it clear how the themes and 
concepts were derived from the 
data? 
Rigorous 
Not rigorous 
Not sure/not 
reported 
Comments: 
Very limited information on how 
themes were arrived at. No one else 
reported to be involved. 
Process of analysis was described. 
9. Is the data 'rich'?  
For example: 
• How well are the contexts of the 
Rich 
Poor 
Not sure/not 
Comments: 
Detailed reporting of the findings with 
quotes. 
Difficult to explore the perspectives as 
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data described? 
• Has the diversity of perspective 
and content been explored? 
• How well has the detail and depth 
been demonstrated? 
• Are responses compared and 
contrasted across groups/sites? 
reported the women are from a similar 
background.  
10. Is the analysis reliable?  
For example: 
• Did more than 1 researcher theme 
and code transcripts/data? 
• If so, how were differences 
resolved? 
• Did participants feed back on the 
transcripts/data if possible and 
relevant? 
• Were negative/discrepant results 
addressed or ignored? 
Reliable 
Unreliable 
Not sure/not 
reported 
Comments: 
None of these items were addressed 
11. Are the findings convincing?  
For example: 
• Are the findings clearly 
presented? 
• Are the findings internally 
coherent? 
• Are extracts from the original data 
included? 
• Are the data appropriately 
referenced? 
• Is the reporting clear and 
coherent? 
Convincing 
Not convincing 
Not sure 
Comments: 
All items addressed 
12. Are the findings relevant to the 
aims of the study?  
Relevant 
Irrelevant 
Partially relevant 
Comments: 
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13. Conclusions  
For example: 
• How clear are the links between 
data, interpretation and 
conclusions? 
• Are the conclusions plausible and 
coherent? 
• Have alternative explanations 
been explored and discounted? 
• Does this enhance understanding 
of the research topic? 
• Are the implications of the 
research clearly defined? 
Is there adequate discussion of any 
limitations encountered?  
Adequate 
Inadequate 
Not sure 
Comments: 
Limited acknowledgement of the 
limitations. Limited discussion and 
exploration. More could have been 
done with the findings.  
However does 'Ring true' when in the 
context of my own research.  
Ethics  
14. How clear and coherent is the 
reporting of ethics?  
For example: 
• Have ethical issues been taken 
into consideration? 
• Are they adequately discussed 
e.g. do they address consent and 
anonymity? 
• Have the consequences of the 
research been considered i.e. 
raising expectations, changing 
behaviour? 
• Was the study approved by an 
ethics committee? 
Appropriate 
Inappropriate 
Not sure/not 
reported 
Comments: 
No reference to any ethics approval 
or issues 
Overall assessment  
As far as can be ascertained from the 
paper, how well was the study 
conducted? (see guidance notes)  
++ 
+ 
Comments: 
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Quality appraisal checklist – qualitative studies 
Study identification: Include 
author, title, reference, year of 
publication 
Kreling, B., Figueiredo, M. I., Sheppard, V. L., & Mandelblatt, J. S. 
(2006). A qualitative study of factors affecting chemotherapy use in 
older women with breast cancer: barriers, promoters, and 
implications for intervention. Psycho‐Oncology, 15(12), 1065-1076. 
Guidance topic: Barriers to older 
women with BrCa affecting chemo 
uptake. 
Key research question/aim:  To understand factors involved in 
older women's use or non-use of indicated adjuvant non-hormonal 
chemotherapy. 
Checklist completed by:  MB 
Theoretical approach  
1. Is a qualitative approach 
appropriate?  
For example: 
Does the research question seek to 
understand processes or structures, 
or illuminate subjective experiences 
or meanings? 
Could a quantitative approach 
better have addressed the research 
question? 
Appropriate 
Inappropriate 
Not sure 
Comments: 
The qualitative approach was appropriate.  
 
 
 
2. Is the study clear in what it 
seeks to do?  
For example: 
Is the purpose of the study 
discussed – 
aims/objectives/research 
question/s? 
Is there adequate/appropriate 
reference to the literature? 
Are underpinning 
values/assumptions/theory 
discussed? 
Clear 
Unclear 
Mixed 
Comments: 
Each of these items was addressed. 
Study design  
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3. How defensible/rigorous is the 
research design/methodology?  
For example: 
Is the design appropriate to the 
research question? 
Is a rationale given for using a 
qualitative approach? 
Are there clear accounts of the 
rationale/justification for the 
sampling, data collection and data 
analysis techniques used? 
Is the selection of cases/sampling 
strategy theoretically justified? 
Defensible 
Indefensible 
Not sure 
Comments: 
Full details were given of the study design, 
sample selection, data collection procedures 
and the analysis.  
Data collection  
4. How well was the data 
collection carried out?  
For example: 
Are the data collection methods 
clearly described? 
Were the appropriate data collected 
to address the research question? 
Was the data collection and record 
keeping systematic? 
Appropriately 
Inappropriately 
Not 
sure/inadequately 
reported 
Comments: 
Data collection was described in great detail. 
The topics addressed were given and the 
style of the focus groups was described.  
There was no mention of data storage. 
Trustworthiness  
5. Is the role of the researcher 
clearly described?  
For example: 
Has the relationship between the 
researcher and the participants 
been adequately considered? 
Does the paper describe how the 
research was explained and 
presented to the participants? 
Clearly described 
Unclear 
Not described - 
fully 
Comments: 
It was clear how the participants were 
recruited and that they provided ' written 
informed consent' but no details as to how 
they were informed. No information of the 
researchers/participant relationship  
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6. Is the context clearly 
described?  
For example: 
Are the characteristics of the 
participants and settings clearly 
defined? 
Were observations made in a 
sufficient variety of circumstances 
Was context bias considered 
Clear 
Unclear 
Not sure 
Comments: 
Clear rationale given for the use of focus 
groups as opposed to individual interviews. 
The FGs were undertaken in a variety of 
settings to address the particular needs of the 
participants. Bilingual researchers were 
employed to conduct a group of Latino 
women. 
7. Were the methods reliable?  
For example: 
Was data collected by more than 1 
method? 
Is there justification for 
triangulation, or for not 
triangulating? 
Do the methods investigate what 
they claim to? 
Reliable 
Unreliable 
Not sure 
Comments: 
The method does address the question.   
Analysis  
8. Is the data analysis sufficiently 
rigorous?  
For example: 
Is the procedure explicit – i.e. is it 
clear how the data was analysed to 
arrive at the results?  
How systematic is the analysis, is 
the procedure reliable/dependable? 
Is it clear how the themes and 
concepts were derived from the 
data? 
Rigorous 
Not rigorous 
Not sure/not 
reported 
Comments: 
Clear and detailed report given of data 
analysis including how and who was involved 
in theme development. 
9. Is the data 'rich'?  
For example: 
How well are the contexts of the 
Rich 
Poor 
Not sure/not 
Comments: 
Very thorough and balanced reporting of the 
findings.  
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data described? 
Has the diversity of perspective and 
content been explored? 
How well has the detail and depth 
been demonstrated? 
Are responses compared and 
contrasted across groups/sites? 
reported 
10. Is the analysis reliable?  
For example: 
Did more than 1 researcher theme 
and code transcripts/data? 
If so, how were differences 
resolved? 
Did participants feed back on the 
transcripts/data if possible and 
relevant? 
Were negative/discrepant results 
addressed or ignored? 
Reliable 
Unreliable 
Not sure/not 
reported 
Comments: 
The process of theme development, 
procedure for transcription and data analysis 
was given.  
There was no mention of participants feeding 
back on the transcription.  
  
11. Are the findings convincing?  
For example: 
Are the findings clearly presented? 
Are the findings internally coherent? 
Are extracts from the original data 
included? 
Are the data appropriately 
referenced? 
Is the reporting clear and coherent? 
Convincing 
Not convincing 
Not sure 
Comments: 
Each of the items listed is addressed.  
The findings are clear to follow and are 
supported by the literature. 
12. Are the findings relevant to 
the aims of the study?  
Relevant 
Irrelevant 
Partially relevant 
Comments: 
13. Conclusions  Adequate Comments: 
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For example: 
How clear are the links between 
data, interpretation and 
conclusions? 
Are the conclusions plausible and 
coherent? 
Have alternative explanations been 
explored and discounted? 
Does this enhance understanding 
of the research topic? 
Are the implications of the research 
clearly defined? 
Is there adequate discussion of any 
limitations encountered?  
Inadequate 
Not sure 
Good discussion which explores the findings. 
Study limitations fully acknowledged. 
Ethics  
14. How clear and coherent is the 
reporting of ethics?  
For example: 
Have ethical issues been taken into 
consideration? 
Are they adequately discussed e.g. 
do they address consent and 
anonymity? 
Have the consequences of the 
research been considered i.e. 
raising expectations, changing 
behaviour? 
Was the study approved by an 
ethics committee? 
Appropriate 
Inappropriate 
Not sure/not 
reported 
Comments: 
Favourable ethical approval reported.  
There is acknowledgment that the issue 
under discussion is potentially sensitive with 
women being asked to consider whether they 
are the subject of ageism. 
Overall assessment  
As far as can be ascertained from 
the paper, how well was the study 
conducted? (see guidance notes)  
++ 
+ 
− 
Comments: 
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Quality appraisal checklist – qualitative studies 
Study identification: Include 
author, title, reference, year of 
publication 
 Husain, L. S., Collins, K., Reed, M., & Wyld, L. (2008). Choices in 
cancer treatment: a qualitative study of the older women's (> 70 
years) perspective. Psycho‐Oncology, 17(4), 410-416 
Guidance topic: Choices in 
cancer treatment 
Key research question/aim: Factors that influenced older women's 
Rx choice 
Checklist completed by: MB 
Theoretical approach  
1. Is a qualitative approach 
appropriate?  
For example: 
Does the research question seek 
to understand processes or 
structures, or illuminate subjective 
experiences or meanings? 
Could a quantitative approach 
better have addressed the 
research question? 
Appropriate 
Inappropriate 
Not sure 
Comments: 
Study explores the factors that influence 
treatment decision making. 
2. Is the study clear in what it 
seeks to do?  
For example: 
Is the purpose of the study 
discussed – 
aims/objectives/research 
question/s? 
Is there adequate/appropriate 
reference to the literature? 
Are underpinning 
values/assumptions/theory 
discussed? 
Clear 
Unclear 
Mixed 
Comments: 
Aims of the study are clearly identified. 
Literature is used to make the case for the 
study and discuss the theories surrounding 
treatment decision making in older women. 
Study design  
3. How defensible/rigorous is the 
research design/methodology?  
Defensible Comments: 
Rationale clearly articulated for the use of 
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For example: 
Is the design appropriate to the 
research question? 
Is a rationale given for using a 
qualitative approach? 
Are there clear accounts of the 
rationale/justification for the 
sampling, data collection and data 
analysis techniques used? 
Is the selection of cases/sampling 
strategy theoretically justified? 
Indefensible 
Not sure 
qualitative approach, the sample used and the 
technique of data analysis. 
  
Data collection  
4. How well was the data 
collection carried out?  
For example: 
Are the data collection methods 
clearly described? 
Were the appropriate data 
collected to address the research 
question? 
Was the data collection and record 
keeping systematic? 
Appropriately 
Inappropriately 
Not 
sure/inadequately 
reported 
Comments: 
Detailed information was given about the 
conduct of the interviewing.  
An interview guide was used to ensure 
appropriate data were collected to answer the 
research questions. 
 
Trustworthiness  
5. Is the role of the researcher 
clearly described?  
For example: 
Has the relationship between the 
researcher and the participants 
been adequately considered? 
Does the paper describe how the 
research was explained and 
presented to the participants? 
Clearly described 
Unclear 
Not described 
Comments: 
No reference is made regarding the 
researcher/participant relationship. 
Full details given of the invitation and 
recruitment of the participants..  
6. Is the context clearly 
described?  
Clear Comments: 
The context was clearly set with details of the 
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For example: 
Are the characteristics of the 
participants and settings clearly 
defined? 
Were observations made in a 
sufficient variety of circumstances 
Was context bias considered 
Unclear 
Not sure 
participants and the setting being given. 
Although only interviews were undertaken bias 
was acknowledged.   
7. Were the methods reliable?  
For example: 
Was data collected by more than 1 
method? 
Is there justification for 
triangulation, or for not 
triangulating? 
Do the methods investigate what 
they claim to? 
Reliable 
Unreliable 
Not sure 
Comments: 
The findings from interviews are not expected 
to be transferable or generalisable. The 
findings could therefore be considered either 
as a as an initial phase which unearths issues 
for further investigation or used to inform the 
population from which they came. They do set 
fulfil the aims of the study.  
Analysis  
8. Is the data analysis 
sufficiently rigorous?  
For example: 
Is the procedure explicit – i.e. is it 
clear how the data was analysed to 
arrive at the results?  
How systematic is the analysis, is 
the procedure 
reliable/dependable? 
Is it clear how the themes and 
concepts were derived from the 
data? 
Rigorous 
Not rigorous 
Not sure/not 
reported 
Comments: 
Within the bounds of the word count imposed 
by the journal full details the data analysis 
procedure is given.  
9. Is the data 'rich'?  
For example: 
How well are the contexts of the 
data described? 
Has the diversity of perspective 
Rich 
Poor 
Not sure/not 
reported 
Comments: 
Detailed reporting of the findings that included 
quotes form the participants.  
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and content been explored? 
How well has the detail and depth 
been demonstrated? 
Are responses compared and 
contrasted across groups/sites? 
10. Is the analysis reliable?  
For example: 
Did more than 1 researcher theme 
and code transcripts/data? 
If so, how were differences 
resolved? 
Did participants feed back on the 
transcripts/data if possible and 
relevant? 
Were negative/discrepant results 
addressed or ignored? 
Reliable 
Unreliable 
Not sure/not 
reported 
Comments: 
Two other researchers independently verified 
the codes and the themes. 
No conflicts were reported.  
Member checking was not reported. 
11. Are the findings convincing?  
For example: 
Are the findings clearly presented? 
Are the findings internally 
coherent? 
Are extracts from the original data 
included? 
Are the data appropriately 
referenced? 
Is the reporting clear and 
coherent? 
Convincing 
Not convincing 
Not sure 
Comments: 
Findings are clearly presented and evidenced 
with extract from the transcriptions given.  
Findings are discussed with reference to the 
literature.  
12. Are the findings relevant to 
the aims of the study?  
Relevant 
Irrelevant 
Partially relevant 
Comments: 
13. Conclusions  
For example: 
Adequate 
Inadequate 
Comments: 
Limited acknowledgement of the limitations. 
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How clear are the links between 
data, interpretation and 
conclusions? 
Are the conclusions plausible and 
coherent? 
Have alternative explanations been 
explored and discounted? 
Does this enhance understanding 
of the research topic? 
Are the implications of the research 
clearly defined? 
Is there adequate discussion of 
any limitations encountered?  
Not sure Good discussion exploring the findings.  
Ethics  
14. How clear and coherent is 
the reporting of ethics?  
For example: 
Have ethical issues been taken 
into consideration? 
Are they adequately discussed e.g. 
do they address consent and 
anonymity? 
Have the consequences of the 
research been considered i.e. 
raising expectations, changing 
behaviour? 
Was the study approved by an 
ethics committee? 
Appropriate 
Inappropriate 
Not sure/not 
reported 
Comments: 
Ethical approval was reported. To obtain a 
favourable ethical approval it is necessary to 
consider the possibility of raising sensitive 
issues and the need to obtain informed 
consent so although not explicitly stated it is 
'known' that these will have been addressed. 
 
Overall assessment  
As far as can be ascertained from 
the paper, how well was the study 
conducted? (see guidance notes)  
++ 
+ 
− 
Comments: 
No all addressed but very close. Limitation 
could be assigned to a lack of word count in 
the journal. 
Notes on the use of the qualitative studies checklist 
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Quality appraisal checklist – qualitative studies 
Study identification: Include author, 
title, reference, year of publication 
Wong, J. J. W., D’Alimonte, L., Angus, J., Paszat, L., Soren, 
B., & Szumacher, E. (2011). What do older patients with early 
breast cancer want to know while undergoing adjuvant 
radiotherapy?. Journal of Cancer Education, 26(2), 254-261. 
Guidance topic: Experience of older 
women with Br Ca. 
Key research question/aim:  to investigate the information 
needs of women 70 years and older with early stage breast 
cancer in relation to adjuvant treatment post-lumpectomy. 
Checklist completed by:  MB 
Theoretical approach  
1. Is a qualitative approach 
appropriate?  
For example: 
Does the research question seek to 
understand processes or structures, or 
illuminate subjective experiences or 
meanings? 
Could a quantitative approach better 
have addressed the research question? 
Appropriate 
Inappropriate 
Not sure 
Comments: 
Clear rational given for the use of 
qualitative methodology.  
 
 
 
2. Is the study clear in what it seeks 
to do?  
For example: 
Is the purpose of the study discussed – 
aims/objectives/research question/s? 
Is there adequate/appropriate reference 
to the literature? 
Are underpinning 
values/assumptions/theory discussed? 
Clear 
Unclear 
Mixed 
Comments: 
The case is strongly made for the need of 
the study. Literature used address the 
underpinning values and make the case 
for the study.  
Study design  
3. How defensible/rigorous is the 
research design/methodology?  
For example: 
Is the design appropriate to the 
Defensible 
Indefensible 
Not sure 
Comments: 
Clear rational given for the use of 
qualitative methodology and the study 
design.  
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research question? 
Is a rationale given for using a 
qualitative approach? 
Are there clear accounts of the 
rationale/justification for the sampling, 
data collection and data analysis 
techniques used? 
Is the selection of cases/sampling 
strategy theoretically justified? 
Full eligibility criteria were given. 
It was explained women were asked to 
complete a demographics questionnaire 
which seem to include more than 
demographic information e.g. whether 
they had received sufficient emotional 
and or physical support.  
Data collection  
4. How well was the data collection 
carried out?  
For example: 
Are the data collection methods clearly 
described? 
Were the appropriate data collected to 
address the research question? 
Was the data collection and record 
keeping systematic? 
Appropriately 
Inappropriately 
Not 
sure/inadequately 
reported 
Comments: 
Data collection methods are described 
but there is no information about storage. 
All data collected were appropriate to 
answer the research question. 
Trustworthiness  
5. Is the role of the researcher 
clearly described?  
For example: 
Has the relationship between the 
researcher and the participants been 
adequately considered? 
Does the paper describe how the 
research was explained and presented 
to the participants? 
Clearly described 
Unclear 
Not described - 
fully 
Comments: 
Although all those involved in the data 
collection are identified there is no 
mention of the relationship between the 
researcher and the participant.  
No report is given of the how the 
participants were informed or whether 
informed consent was obtained. 
6. Is the context clearly described?  
For example: 
Are the characteristics of the 
participants and settings clearly 
Clear 
Unclear 
Not sure 
Comments: 
The context is clearly defined with the 
setting and the groups being described. 
The procedure for summarising the 
discussion was given - it is possible that 
this was an attempt to allow feedback for 
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defined? 
Were observations made in a sufficient 
variety of circumstances 
Was context bias considered 
the group. 
7. Were the methods reliable?  
For example: 
Was data collected by more than 1 
method? 
Is there justification for triangulation, or 
for not triangulating? 
Do the methods investigate what they 
claim to? 
Reliable 
Unreliable 
Not sure 
Comments: 
The methods (FGs & demographics 
questionnaire) do address the question. 
There is no justification for not using 
another form of data collection by which 
triangulation could be undertaken.  
 
Analysis  
8. Is the data analysis sufficiently 
rigorous?  
For example: 
Is the procedure explicit – i.e. is it clear 
how the data was analysed to arrive at 
the results?  
How systematic is the analysis, is the 
procedure reliable/dependable? 
Is it clear how the themes and concepts 
were derived from the data? 
Rigorous 
Not rigorous 
Not sure/not 
reported 
Comments: 
The process of dealing with the data and 
development of themes was described.  
 
9. Is the data 'rich'?  
For example: 
How well are the contexts of the data 
described? 
Has the diversity of perspective and 
content been explored? 
How well has the detail and depth been 
demonstrated? 
Are responses compared and 
contrasted across groups/sites? 
Rich 
Poor 
Not sure/not 
reported 
Comments: 
Detailed reporting and discussion of the 
findings.  
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10. Is the analysis reliable?  
For example: 
Did more than 1 researcher theme and 
code transcripts/data? 
If so, how were differences resolved? 
Did participants feed back on the 
transcripts/data if possible and 
relevant? 
Were negative/discrepant results 
addressed or ignored? 
Reliable 
Unreliable 
Not sure/not 
reported 
Comments: 
Themes were developed by one 
researcher but they were validated by 
two other researchers.  
More detail of the theme development 
could have been given. 
 
11. Are the findings convincing?  
For example: 
Are the findings clearly presented? 
Are the findings internally coherent? 
Are extracts from the original data 
included? 
Are the data appropriately referenced? 
Is the reporting clear and coherent? 
Convincing 
Not convincing 
Not sure 
Comments: 
The findings are easy to read and clearly 
and logically presented.  
A number of pertinent quotes are given.  
12. Are the findings relevant to the 
aims of the study?  
Relevant 
Irrelevant 
Partially relevant 
Comments: 
The study provides useful and relevant 
information 
13. Conclusions  
For example: 
How clear are the links between data, 
interpretation and conclusions? 
Are the conclusions plausible and 
coherent? 
Have alternative explanations been 
explored and discounted? 
Does this enhance understanding of 
the research topic? 
Are the implications of the research 
Adequate 
Inadequate 
Not sure 
Comments: 
Good discussion exploring the findings 
with good use of the literature.   
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clearly defined? 
Is there adequate discussion of any 
limitations encountered?  
Ethics  
14. How clear and coherent is the 
reporting of ethics?  
For example: 
Have ethical issues been taken into 
consideration? 
Are they adequately discussed e.g. do 
they address consent and anonymity? 
Have the consequences of the 
research been considered i.e. raising 
expectations, changing behaviour? 
Was the study approved by an ethics 
committee? 
Appropriate 
Inappropriate 
Not sure/not 
reported 
Comments: 
Favourable ethical was obtained. 
Informed consent was obtained but no 
description of how they were informed of 
the study.  
Participants were given contact 
information at the end of the FG should 
they have concerns or require support.  
Overall assessment  
As far as can be ascertained from the 
paper, how well was the study 
conducted? (see guidance notes)  
++ 
+ 
− 
Comments: 
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NICE Quality appraisal checklist – qualitative studies 
Study identification: Include author, 
title, reference, year of publication 
Burton, M., Collins, K. A., Lifford, K. J., Brain, K., Wyld, 
L., Caldon, L., Gath, J., Revell, D & Reed, M. W. 
(2015). The information and decision support needs of 
older women (> 75 yrs) facing treatment choices for 
breast cancer: a qualitative study. Psycho‐Oncology, 
24(8), 878-884. 
Guidance topic: Information and 
Decision-making preferences in older 
women with breast cancer. 
Key research question/aim: 
To investigate the information needs of older women 
(>75 years) regarding the use of surgery or primary 
endocrine therapy (PET) for the treatment of operable 
primary breast cancer; 
2. to identify the preferred format and media for the 
presentation of this information; 
3. to establish the preference of older women (>75 
years) for involvement in treatment decision-making 
regarding the use of surgery or PET for the treatment 
of operable primary breast cancer  
Checklist completed by: MB 
Theoretical approach 
1. Is a qualitative approach 
appropriate?  
For example: 
• Does the research question 
seek to understand processes 
or structures, or illuminate 
subjective experiences or 
meanings? 
• Could a quantitative approach 
better have addressed the 
research question? 
Appropriate 
Inappropriate 
Not sure 
Comments: 
Yes. Purpose of the study is to 
explore and establish views.  
 
 
 
2. Is the study clear in what it seeks 
to do? 
Clear 
Unclear 
Comments: 
The aim of the study was clear.  
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For example: 
• Is the purpose of the study 
discussed – 
aims/objectives/research 
question/s? 
• Is there adequate/appropriate 
reference to the literature? 
• Are underpinning 
values/assumptions/theory 
discussed? 
Mixed Literature is used throughout. 
Underpinning assumptions are 
discussed. 
Study design 
3. How defensible/rigorous is the 
research design/methodology? 
For example: 
• Is the design appropriate to the 
research question? 
• Is a rationale given for using a 
qualitative approach? 
• Are there clear accounts of the 
rationale/justification for the 
sampling, data collection and 
data analysis techniques used? 
• Is the selection of 
cases/sampling strategy 
theoretically justified? 
 
Defensible 
Indefensible 
Not sure 
Comments: 
The design is appropriate to 
address the research question 
but rationale given for a 
qualitative approach.  
Rationale for sampling, and data 
collection and analysis given. 
Data collection 
4. How well was the data collection 
carried out? 
For example: 
• Are the data collection methods 
clearly described? 
Appropriately 
Inappropriately 
Not 
sure/inadequately 
reported 
Comments: 
Appropriate data was collected 
and the methods clearly 
reported. No information is given 
about data storage. 
263 
 
• Were the appropriate data 
collected to address the 
research question? 
• Was the data collection and 
record keeping systematic? 
Trustworthiness 
5. Is the role of the researcher 
clearly described? 
For example: 
• Has the relationship between 
the researcher and the 
participants been adequately 
considered? 
• Does the paper describe how 
the research was explained and 
presented to the participants? 
Clearly described 
Unclear 
Not described - 
fully 
Comments: 
Although a description is given of 
how the women were 
approached and recruited the 
researcher / participant 
relationship is not addressed. 
6. Is the context clearly described? 
For example: 
• Are the characteristics of the 
participants and settings clearly 
defined? 
• Were observations made in a 
sufficient variety of 
circumstances 
• Was context bias considered 
Clear 
Unclear 
Not sure 
Comments: 
The setting was partially 
described but more detail would 
have helpful.  
Only interviews were undertaken 
and it was not made clear to the 
reader that this was part of a MM 
study.  
7. Were the methods reliable? 
For example: 
• Was data collected by more 
than 1 method? 
• Is there justification for 
triangulation, or for not 
triangulating? 
Reliable 
Unreliable 
Not sure 
Comments: 
No information on why no 
triangulation or only 1 method 
used. See comment above.  
Methods do address the question 
and investigate the research 
aims. 
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• Do the methods investigate 
what they claim to? 
Analysis 
8. Is the data analysis sufficiently 
rigorous? 
For example: 
• Is the procedure explicit – i.e. is 
it clear how the data was 
analysed to arrive at the 
results?  
• How systematic is the analysis, 
is the procedure 
reliable/dependable? 
• Is it clear how the themes and 
concepts were derived from the 
data? 
Rigorous 
Not rigorous 
Not sure/not 
reported 
Comments: 
Theme development and data 
analysis were reported to be 
undertaken in accordance with 
framework analysis. Framework 
is known for its rigorous structure 
and procedure. 
9. Is the data 'rich'? 
For example: 
• How well are the contexts of the 
data described? 
• Has the diversity of perspective 
and content been explored? 
• How well has the detail and 
depth been demonstrated? 
• Are responses compared and 
contrasted across groups/sites? 
Rich 
Poor 
Not sure/not 
reported 
Comments: 
Detailed reporting of the findings.  
10. Is the analysis reliable? 
For example: 
• Did more than 1 researcher 
theme and code 
transcripts/data? 
• If so, how were differences 
Reliable 
Unreliable 
Not sure/not 
reported 
Comments: 
Two researchers developed the 
themes and double coded 10% 
of the transcripts. 
No report of participants 
reporting back on the transcripts 
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resolved? 
• Did participants feed back on 
the transcripts/data if possible 
and relevant? 
• Were negative/discrepant 
results addressed or ignored? 
11. Are the findings convincing? 
For example: 
• Are the findings clearly 
presented? 
• Are the findings internally 
coherent? 
• Are extracts from the original 
data included? 
• Are the data appropriately 
referenced? 
• Is the reporting clear and 
coherent? 
Convincing 
Not convincing 
Not sure 
Comments: 
Items underlined addressed.  
12. Are the findings relevant to the 
aims of the study? 
Relevant 
Irrelevant 
Partially relevant 
Comments: 
The findings directly address the 
research aims.  
13. Conclusions 
For example: 
• How clear are the links between 
data, interpretation and 
conclusions? 
• Are the conclusions plausible 
and coherent? 
• Have alternative explanations 
been explored and discounted? 
• Does this enhance 
understanding of the research 
Adequate 
Inadequate 
Not sure 
Comments: 
Full discussion in which the 
findings are explored with 
reference to the literature.  
Limitations are acknowledged 
and discussed. 
The findings contribute 
significantly to the current body 
of knowledge. 
Possible use of the findings is 
explored in the discussion.  
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topic? 
• Are the implications of the 
research clearly defined? 
Is there adequate discussion of any 
limitations encountered? 
Ethics 
14. How clear and coherent is the 
reporting of ethics? 
For example: 
• Have ethical issues been taken 
into consideration? 
• Are they adequately discussed 
e.g. do they address consent 
and anonymity? 
• Have the consequences of the 
research been considered i.e. 
raising expectations, changing 
behaviour? 
• Was the study approved by an 
ethics committee? 
Appropriate 
Inappropriate 
Not sure/not 
reported 
Comments: 
Since a favourable ethical 
opinion was obtained it is safe to 
assume ethical issues were 
considered as the process is a 
detailed one.    
Overall assessment 
As far as can be ascertained from 
the paper, how well was the study 
conducted? (see guidance notes) 
++ 
+ 
− 
Comments: 
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THE UNIVERSITY OF SHEFFIELD 
Academic Surgical Oncology Unit 
Ms Lynda Wyld, MBChB, BMed.Sci, PhD, FRCS 
(Eng)  
 
Floor E 
Royal Hallamshire Hospital 
Sheffield S10 2JF 
 
Senior Lecturer: 0114 271 2936 
Personal Assistant : 0114 271 2510 
Fax : 0114 271 3314 
Email:l.wyld@sheffield.ac.uk 
  
       25
th
 October 2012  
Miss Stephanie Ellis 
Acting Chair 
NRES Committee London-Surrey Borders 
Research Ethics Committee (REC) 
London Centre, Ground Floor                                 
Skipton House 
80 London Road 
London  
SE1 6LH 
 
 
Dear Miss Ellis 
 
Study Title: Bridging the Age Gap in Breast Cancer: Improving Outcomes for Older Women. 
Helping older women choose.  
 
REC reference:  12/LO/1722 
 
 
Many thanks for reviewing our research study and for your letter informing us of the favourable 
ethical opinion.  
 
Please find below details of the study that the subcommittee wished to know more about 
 
1. How quickly would support be available for participants in the study, if the interview 
would cause them distress? 
 
The researcher undertaking the interviews has substantial experience and expertise in undertaking 
qualitative interviews with this age group. However, in the unlikely event that a participant 
becomes distressed during the interview, the interview would cease and the researcher would offer 
appropriate support within the remit of her role as a researcher. She would also call the participant 
later on in the day to offer further support and advice as necessary. The participant also has the 
name and contact details of the lead PI for the study (within the Patient Information Sheet) that 
would become immediately available should the participant wish to discuss specific issues relating 
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to the study. If the participant required more clinical specialist input and support, the researcher 
will advise the participant to contact either their GP or a member of their hospital clinical team.   
 
2. If any concerns surfaced during the study, how would these be dealt with?  
 
In the unlikely event that concerns surfaced during the study the lead PI (Lynda Wyld) would be 
alerted immediately. Depending on the concern surfacing, the PI would take the decision as to the 
most appropriate course of action. This might be to contact the NRES Committee London-Surrey 
Borders to ask for specific advice or to liaise with the Trust(s) with regard to any R & D concern.    
 
3. It was noted the name of the REC was wrong under the heading “Who has reviewed the 
study” – page 3 of the Participant Information Sheet.  
 
Please find attached an amended version of the Patient Information Sheet (version 2) 
 
In addition to the above I would like to submit our Interview Topic Guide document as a minor 
amendment.  This was previously embedded in the protocol but to make it clear to all involved we 
have created this as a stand-alone document. The content of this document is a 'copy and paste' of 
the text in the protocol. Please find topic guide attached. 
 
 
We hope these are satisfactory. 
 
Many thanks and best wishes 
 
Lynda 
 
Ms Lynda Wyld, (on behalf of the Study Team) 
 
 
Senior Lecturer in Surgical Oncology and Honorary Consultant Surgeon 
Academic Unit of Surgical Oncology, University of Sheffield Medical School, 
E Floor, Royal Hallamshire Hospital, Glossop Road, Sheffield 
 
Tel: 0114 2268640 
e-mail: l.wyld@sheffield.ac.uk 
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Research Passport Application Form – Version 3 01/09/2012 
 
Please refer to the guidance notes before completing the form. 
Section 1 - Details of Researcher To be completed by Researcher 
1.  Surname: BURTON Prof  Dr  Mr  
MrsX  
Miss  Ms  Other  Forename(s): RITA MARIA (KNOWN AS MARIA) 
Home Address: 6 HIGH GROVE, BESSACARR, DONCASTER, DN4 6LU 
Work Tel:  0114 225 5498                          Mobile:  07919400781                   Email:  
      
2. Date of birth: 29/04/1957     Gender: Male   Female X  
Ethnicity: WHITE BRITISH         National Insurance number:             
3. Professional registration details, if applicable (Doctors undertaking any form of medical 
practice should confirm they have a licence to practise).          N/A  
                           
4. Employer: SHEFFIELD HALLAM UNIVERSITY                        or place of study:       
Work Address/Place of Study:  CENTRE FOR HEALTH AND SOCIAL CARE RESEARCH, 
32 COLLEGIATE CRESCENT, SHEFFIELD, S10 2BP 
Post or status held: SENIOR RESEARCH FELLOW 
Section 2 - Details of Research  To be completed by Researcher 
5. What type of Research Passport do you need?       Project-specific         Multi-project X
 
If you will be conducting one project only please complete the details below. If you 
anticipate that you will be undertaking more than one project at any one time, please give 
details in the Appendix. 
Project Title: Bridging the Age Gap in Breast Cancer: Improving outcomes for older women. 
Project Start Date: July 01/07/12                                     End Date: 31/08/2017 
Proposed start and end-date of 3-year Research Passport:    
Start Date: January 2016         End Date: January 2019 
NHS organisation(s): Dept(s): Proposed research Manager in NHS 
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activities: organisation: 
See attached list                   
Section 3 – Declaration by Researcher  To be completed by Researcher 
6. Have you ever been refused an honorary research contract? Yes  No x  
Have you ever had an honorary research contract revoked? Yes  No x  
If yes to either question, please give details:       
I consent to the information provided as part of this Research Passport and attached documents 
being used, recorded and stored by authorised staff of the NHS organisations where I will be 
conducting research.   
Signed: Date: 
When Sections 1-3 have been completed, the researcher should forward the form to the 
appropriate person to complete Section 4. 
  
281 
 
Section 4 - Suitability of Researcher  
To be completed by researcher’s substantive employer, e.g. line manager, or academic 
supervisor 
7.a Will this person’s research activity mean that they may be undertaking 
regulated activity with children and/or adults as defined in the 
Safeguarding Vulnerable Groups Act 2006, as amended (in particular by 
the Protection of Freedoms Act 2012)? (please use the Research Passport 
algorithm to make this judgement) 
 
Yes  No x   
7. b I am satisfied that the above named individual is suitably trained and experienced to 
undertake the duties associated with the research activities outlined in this Research 
Passport form. 
Signed:  Date: 20 Jan 2016 
Name:   Karen Collins           Job Title: Professor of Health Services 
Research 
Department and Organisation: Centre for Health and Social Care Research, Sheffield 
Hallam University 
Address: 32 COLLEGIATE CRESCENT, SHEFFIELD, S10 2BP 
Tel No:0114 2255732 Email:k.collins@shu.ac.uk 
Managerial responsibility for the applicant: Day to day line management of work. Project 
lead for the current project. 
When Section 4 has been completed, the researcher should forward the form to the appropriate 
person to complete Section 5. 
Section 5 - Pre-engagement checks    To be completed by the HR department of the 
researcher’s substantive employer  or registry at place of study 
8. Does the above named individual’s research involve Regulated 
Activity with children and/or adults as defined in the Safeguarding 
Vulnerable Groups Act 2006, as amended (in particular by the 
Protection of Freedoms Act 2012)?  
 Yes   No 
If yes to the above, has the above named individual been checked 
against ISA barred lists for adults and/or children, as appropriate and 
have you received confirmation via the criminal record disclosure that 
the person is not barred from working with adults and/or children? (NB 
individuals who are barred from working with adults or children must 
not undertake a regulated activity in the NHS with the vulnerable group 
from which they are barred, and you must not submit a Research 
Checked against: 
 ISA Adults List? 
Yes  No  N/A 
 
ISA Children’s List? 
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Passport form in such cases). Yes  No  N/A 
 
Can you confirm that a clear criminal record disclosure has been 
obtained for the above-named individual, with no subsequent reports 
from the individual of changes to this record? NB for Regulated Activity 
this must be an enhanced level criminal record check.  For non-
regulated activity, ensure the criminal record check is at the mandated 
level.  
Yes  No  N/A 
 
If yes, please provide details of the clear disclosure: 
Date of disclosure: Type of disclosure:    
Disclosure No.: Organisation that requested disclosure: 
9. Have the pre-engagement checks described below been carried out with regard to the 
above-named individual and is confirmation of the necessary checks, including any 
required satisfactory documentary evidence, available in the employing 
organisation’s/place of study’s records? 
 Employment/student screening:  
o ID with photograph  Yes  No  
o two references Yes  No  
o verification of permission to work/study in the UK Yes  No  
o exploration of any gaps in employment Yes  No  
 Evidence of current professional registration Yes  No  N/A  
 Evidence of qualifications Yes  No  
 Occupational health screening / clearance Yes  No   
Is the named individual on a fixed term contract or is the contract end imminent?  
Yes  No  
Please indicate current contract end-date           Date: 
Signed:  Date:  
Name:              Job Title:  
Organisation:       Department:  
Address: 
Tel No: Email: 
Please return the form to the researcher. 
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Section 6 - Instructions to applicants 
To be completed by Researcher 
Please indicate which of the following documents are attached to this Research Passport: 
Current curriculum vitae, including details of qualifications, training and 
professional registration (please use the template C.V. at 
http://www.rdforum.nhs.uk/docs/template_cv.doc)  
Yes  No  
 
Researcher’s copy of criminal record disclosure. NB where research 
involves regulated activity with children and/or adults as defined in the 
Safeguarding Vulnerable Groups Act 2006, as amended (in particular by 
the Protection of Freedoms Act 2012), the disclosure must include 
confirmation of a check against the appropriate ISA barred list(s).    
Yes  No   N/A  
 
 
Evidence of occupational health screening / clearance Yes  No   N/A  
Appendix – List of projects and amendments Appendix numbers:  
 
 
N/A  
 
 
Please send the completed form and original documents to the Lead R&D office.  The 
completed form and original documents will be returned to you. This package of documents will 
be used to validate your completed Research Passport form. You may then, and where 
relevant, provide the Research Passport to other NHS organisations. 
 
You must inform all NHS organisations that have received this Research Passport of any 
changes to the information supplied above. Failure to do so may result in withdrawal of 
your honorary research contract or letter of access. As part of the quality control 
procedures for the Research Passport, random checks on the accuracy of the 
information held on this Research Passport may be made. 
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Section 7 
This section should be completed by HR in the Lead NHS organisation, only if additional 
checks are undertaken 
The following additional checks have been completed: 
 
 
 
 
 
Having confirmed that the necessary additional pre-engagement checks have been completed, I 
am satisfied that the above named researcher is suitable to carry out the duties associated with 
their research activity outlined in this Research Passport.  
Signed:  Date:  
Name:              Job Title:  
Organisation:       Department:  
Email:  
Section 8 - For Office Use Only 
This section should be completed by the NHS R&D office that received the initial application. 
The NHS R&D office must countersign and date retained photocopies of the documents. The 
grey section must be completed before the form is returned to the applicant. 
CV reviewed? Yes  No  Training? Yes  No  
Evidence of qualifications? Yes  No  Appendix pages 
reviewed? Numbers:  
Professional registration details 
reviewed? 
Yes  No  N/A 
 
Occupational health 
clearance reviewed? 
Yes  No  N/A 
 
Criminal record disclosure 
reviewed? 
Yes  No  N/A 
 
Date of disclosure: 
Disclosure No: 
For regulated activity as defined in the Safeguarding Vulnerable Groups 
Act 2006, as amended (in particular by the Protection of Freedoms Act 
2012), did the criminal record disclosure confirm a satisfactory check 
against the appropriate ISA barred list(s) 
Yes  No  N/A 
 
Enter Electronic Staff Record Number (if issued):  
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Confirmation of valid Research Passport: 
Project specific       Three-year      Other End date  Date:                                                
Signed:   Date:  
Name:   
NHS Organisation Name and contact details 
 
 
 
 
 
 
Date Honorary Research Contract/letter of access issued (delete as 
appropriate)  
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If required, this section should be added to the Research Passport Form and 
completed by each NHS R&D office receiving the valid Research Passport. 
The original Research Passport form and documents should be returned to 
the applicant. 
Has the Research Passport been validated by a Lead NHS organisation and 
is this validation acceptable to this NHS organisation?  Yes  No    
CV reviewed? Yes  No  Training? Yes  No  
Evidence of 
qualifications? Yes  No  
Appendix 
pages 
reviewed? 
Numbers:  
Professional Registration 
details reviewed? 
Yes  No  
N/A  
Occupational 
health 
clearance 
reviewed? 
Yes  No  
N/A  
Criminal record disclosure 
reviewed? 
Yes  No  
N/A  
Date of disclosure: 
Disclosure No: 
For regulated activity as defined in the Safeguarding 
Vulnerable Groups Act 2006, as amended by the 
Protection of Freedoms Act 2012, did the criminal 
record disclosure confirm a satisfactory check against the 
appropriate ISA barred list(s) 
Yes  No  
N/A  
Checked Electronic Staff Record: Yes  No  N/A  
Signed:  Date:  
Name:  
NHS organisation name and contact details: 
 
 
 
Date honorary research contract/letter of access issued (delete as 
appropriate) 
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Passport Appendix.  List of projects and amendments 
 
Appendix Number:  
 
 
If you are applying for a three-year Research Passport, please use this 
section to enter details of projects and activities that will be covered by this 
Research Passport. Once you have a validated Research Passport, you may 
add details of subsequent projects during the three years that this Research 
Passport is valid.  
 
If you are applying for a project-specific Research Passport, but need to add 
further sites to the project, please enter the details below. 
 
Whenever you add further details, the full Research Passport and 
accompanying documents must be submitted to the relevant NHS 
organisations. 
 
Title: Bridging the Age Gap in Breast Cancer, 
Improving Outcomes. Helping Older Women 
 
Start Date: End Date: 
NHS organisation(s): Dept(s): Proposed 
research 
Manager in 
NHS 
organisation: Sheffield Teaching Hospitals 
NHS FT 
General 
Surgery 
Interviews 
with 
Matthew 
Winter 
University Hospitals of 
Morecambe Bay NHS 
Foundation Trust  
Breast Surgery  Interviews 
with 
patients 
 
 
University Hospitals of 
Leicester 
Breast Surgery Interviews 
with 
 
Hull and East Yorkshire 
Hospitals NHS Trust 
Breast Surgery  Interviews 
with 
 
Nottingham University 
Hospitals NHS Trust 
Breast Surgery  Interviews 
with 
Miss Lisa 
Whisker 
Mid Yorkshire Hospitals NHS 
Trust 
Breast Surgery  Interviews 
with 
 
 
1 
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Title: Bridging the Age Gap in Breast Cancer, 
Improving Outcomes. Helping Older Women 
 
Start Date: End Date: 
Chesterfield Royal Hospital 
NHS Foundation Trust 
Breast Surgery  Interviews 
with 
 
Rotherham NHS Foundation 
Trust 
Breast Surgery  Interviews 
with 
 
Tameside Hospital NHS 
Foundation Trust 
Breast Surgery  Interviews 
with 
Stephanie 
Ridgeway 
Milton Keynes Hospitals NHS 
Foundation Trust 
Breast Surgery  Interviews 
with 
 
University Hospitals Coventry 
& Warwickshire NHS Trust 
Breast Surgery  Interviews 
with 
 
Royal Marsden NHS 
Foundation Trust 
Breast Surgery  Interviews 
with 
 
Mid Essex Hospital Services 
NHS Trust 
Breast Surgery  Interviews 
with 
 
Wrightington, Wigan and 
Leigh NHS Foundation Trust 
Breast Surgery  Interviews 
with 
 
 
Amendments to the Research Passport  
Please state what these are, e.g. they might be a change in name or 
employment details, or a change in research activities.  
Please check with the NHS organisation where you are undertaking your 
research if you are unsure whether you will need to submit new evidence of 
pre-engagement checks on a new Research Passport form, which will need 
to be validated by the NHS organisation(s) hosting your research. 
 
Date Old Details New Details 
Office use only 
NHS R&D 
contact details 
and signature 
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To add more projects please copy this page or download further blank 
pages. Each appendix page should be numbered. 
For office use only:  
A photocopy of the appendix should be retained whenever any amendments 
or additions to the appendix are made. 
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 Appendix 9: Participant Invitation Letter 
(Interviews) 
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Helping older women make informed choices about treatment for breast 
cancer. 
Participant Invitation Letter  
 
Dear [insert name here ] 
We would like to invite you to participate in a research study.  The study is 
being carried out by researchers from The University of Sheffield and 
Sheffield Hallam University.  We have invited you to take part because we 
are interested in hearing the views and opinions of women over the age 
of 75 years who have had treatment for breast cancer. 
The aim of the study is to find out the views of 
older women about different types of treatment 
for breast cancer. We would also like to know 
what information and support they would like to 
help them decide what type of treatment they 
would prefer.  The information we get from this 
study will be used to support older women in 
the future who are given a choice of treatment. 
We would like to interview you, at a time and place convenient to you, 
to ask your views on breast cancer treatment and how you would like to 
hear about the options for its treatment. 
We have enclosed an information sheet for you to read and help you to 
think about whether you would like to take part.  Taking part or not is 
entirely up to you.  
Whether you decide to take part or not, please complete the Study Reply 
Form and return it in the FREEPOST envelope provided. You do not need a 
stamp.  
If you decide not to take part, please tick the box beside ‘No, I do not wish to 
take part in this study’ and return the form to us. You do not need to fill in any 
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other details on the form. The research team will not make any further 
contact with you about the study. 
If you wish to take part in the study, please tick ‘Yes, I would like to take 
part in this study’, fill in the contact details section on the Study Reply 
Form, and the consent form provided, and then return the form to us in 
the FREEPOST envelope provided.  
Once we receive the form, a member of our research team will contact you to 
arrange an interview at a time and place most convenient to you. If you do 
not want to be interviewed at present, but have no objections to being 
contacted in the future please tick ‘I do not want to be interviewed but am 
interested in participating in other parts of the study at some time in the 
future’. 
If you would like to find out more about the study before deciding whether or 
not to take part please contact Mrs Maria Burton at the Sheffield Hallam 
University on 0114 225 5498 or NAME OF RESEARCH SITE CONTACT & 
DETAILS TO BE INSERTED.  
Yours sincerely 
 
 
Ms Lynda Wyld 
Consultant Breast Surgeon 
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 Appendix 10: Patient Information Sheet   
 (Interviews) 
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Patient Interview Information Sheet 
To be printed on Hospital Headed notepaper  
 
 
 
 
 
Helping older women make informed choices about 
treatment for breast cancer    
Participant Information Sheet - Interview 
Invitation to participate in the study 
We would like to invite you to take part in a research study. Before 
you decide you need to understand why it is being done and what 
it would involve for you. Please read the following information 
carefully and talk to others about the study to help you decide if 
you wish to take part. Ask us if there is anything that is not clear or 
if you would like more information.  
What is the purpose of the study? 
For some women with breast cancer there are several different 
treatment options, all of which work well.  Some chose to have an 
operation to remove it, while others chose to have tablets to 
prevent it growing and make it shrink.  The decision about what 
treatment to have can be complex, with pros and cons for each 
option.  The purpose of this study is to get a better understanding 
of what women think about the treatments offered, and what 
doctors and nurses can do to help women make their decisions.   
Why have you been invited to take part? 
You have been invited to take part in the study because you are a 
woman age 75 or older who has previously had treatment for 
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breast cancer, either with surgery or tablets (for example, 
Tamoxifen, Arimidex, Letrozole).  
 
Do you have to take part?  
No. Taking part is entirely voluntary.  If you do not want to take 
part you do not have to give a reason.  If you decide to take part 
but later change your mind, you can do and you do not have to 
give a reason.  No one will be upset and your treatment or 
care would not be affected. 
What will happen to you if you take part? 
If you decide to take part, a member of the study team will contact 
you to arrange an interview at a time and place convenient to you.  
The interview could be at the hospital, in your own home or 
elsewhere if you prefer. If being interviewed meant you had to 
travel, we would refund your travel costs.  If you would like a 
friend or relative to be at your interview, that is fine and we will 
refund reasonable travel costs.  Interviews will take about an hour.  
The interview will be recorded with your consent. Recordings will 
be stored anonymously in a secure place. 
In the interview, you will be asked to tell us your views on your 
breast cancer treatment and how you decided on which type to 
have.  We will also ask you about the information and support you 
received that helped you make your decision about which 
treatment.  In addition, we will ask you about the different ways 
this information can be presented – for example leaflets, videos, 
booklets etc.  There are no right or wrong answers to the 
questions in this study.  We want to know YOUR opinions.  
What are the possible risks and disadvantages of taking 
part? 
There are no specific risks associated with taking part in this study.  
You do not have to talk about any issues you don’t want to 
discuss.  If you find the interview upsetting (which we do not 
expect) it can be stopped at any time.  Specialist help and support 
is available if you feel any part of the study has upset or affected 
you in any way. 
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What are the possible benefits of taking part? 
This research study will not directly benefit you, but it will give us a 
better understanding of the views and support needs of older 
women making decisions about their breast cancer treatment.  
This should help us to provide better guidance for women facing 
similar decisions in the future. 
 
Will your taking part in the study be kept confidential? 
Yes. All information that is collected about you during the course 
of the research will be kept strictly confidential.  
What will happen to the results of the research study? 
The results of the study will be presented at conferences and 
published in scientific journals. A copy of the research findings will 
be available to you at the end of the study if you would like it. It 
may be several years before this is available. 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of 
people, called a Research Ethics Committee to protect your safety, 
rights, well-being and dignity.  This has been done by the NRES 
Committee London - Surrey Borders.  Some of the information 
from the study will be used as part fulfilment of an educational 
qualification (Doctor of Philosophy).  
 
What if you are harmed or unhappy about any aspect of the 
study? 
If you have any concerns or complaints about any aspect of the 
study please contact Ms Lynda Wyld (Senior Lecturer and 
Consultant Breast Surgeon), E Floor, Royal Hallamshire Hospital, 
Sheffield S10 2JF. Telephone 0114 2712510. 
If you remain unhappy and wish to complain formally, you can go 
through the NHS Complaints Procedure by contacting Dr David 
Throssell, Medical Director, Sheffield Teaching Hospitals NHS 
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Foundation Trust, 8 Beech Hill Road, Sheffield, S10 2SB. 
Telephone: 0114 271 2178. 
Who is organising the study? 
The study is being run by the University of Sheffield and Sheffield 
Hallam University.  It has been funded by the UK Government’s 
main research funding body, the National Institute for Health 
Research (NIHR) 
Contact for further information 
If you would like any further information, or have any questions 
concerning this study, please contact Mrs Maria Burton 0114 22 
55 498 or NAME OF RESEARCH SITE CONTACT & DETAILS 
TO BE INSERTED.  
 
What do I need to do now? 
If you WISH TO take part please tick “Yes, I would like to take 
part in this study”, fill in the contact details on the Study 
Reply Form and return the form in the FREEPOST envelope 
provided. 
If you do not want to be interviewed but you may be interested in 
participating in other parts of the study (for example a 
questionnaire and/or a discussion with other patients called a 
focus group) please tick “I do not want to be interviewed but 
am interested in participating in other parts of the study at a 
later date”.  Please also fill in the contact details on the Study 
Reply Form and return the form in the FREEPOST envelope 
provided. 
Feel free to call us with any queries you may have and/or talk the 
study over with anyone else.    
Please keep this information leaflet for future reference. 
Thank you for reading this information sheet and for taking 
an interest in the research study. 
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Helping older women make informed choices about treatment for breast 
cancer.    
Participant Study Reply Form  
 
฀ Yes, I would like to take part in this study  
฀ I do not want to be interviewed but I may be interested in 
participating in other parts of the study at a later date. 
If you have ticked 'Yes, to either of the above statements please also 
give contact details (IN BLOCK CAPITALS): 
 
Name: ____________________________________________ 
Address: ___________________________________________ 
___________________________________________________ 
___________________________________________________ 
Tel. No. (inc. Code): ___________________________________ 
I would like to receive a copy of the research findings YES/NO 
Please return this form in the FREEPOST envelope provided. 
You do not need a stamp. 
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Helping older women make informed choices about treatment 
for breast cancer. 
 
  
Interview Consent Form    Please initial if 
you agree 
I confirm I have read and understood the information 
leaflet dated ………….. Version ……….. for the above 
study.  I have had the opportunity to consider the 
information and ask questions, and have had these 
answered satisfactorily. 
 
 
I understand that my participation is voluntary and that I 
am free to withdraw at any time, without giving any 
reason, without my medical care or legal rights being 
affected. 
 
I give permission for the interview to be audio recorded. 
 
I understand and agree that quotes from my interview 
may be used within written reports or publications, and 
that any quotes would be completely anonymous and 
could not be linked to me in any way.   
 
I agree to take part in the above study. 
 
Name of Person taking consent:         
Signature:                                                                                  Date: 
 
Name of Participant: 
 
Signature:                                                                                   Date:     
302 
 
 
 Appendix 13: Interview Topic Guide
 
  
303 
 
Bridging the Age Gap in Breast Cancer:  Improving outcomes 
for older women.  Helping Older Women Choose 
The interviews will specifically explore the following areas: 
• beliefs about the risks and benefits of treatment options in 
relation to cancer survival/recurrence rates and quality of life outcomes 
• Timeline (beliefs about the duration of breast cancer and treatment 
options),  
• Cure/control (beliefs about the efficacy of treatment options; 
perceived control over the treatment decision-making process and 
personal confidence in treatment decision-making) 
• factors they have found positive or negative about their breast cancer 
treatment 
• factors they have found positive or negative about the treatment decision-
making process 
• how specific treatments were decided upon 
• which factors influenced their decision or the treatment undergone 
• their decision-making preference 
• sources of information they used, desired or would have preferred 
• satisfaction with treatment and the treatment decision-making process 
• whether they feel comfortable with computers/the internet 
• barriers to use of different media (visual or auditory impairment, memory 
impairment) 
• facilitators to the use of different media (family/BCN assistance, provision 
of equipment) 
• preferred design and media of DSI to support decision-making 
• discussion of the pros and cons and personal preferences for a range of 
demonstrated media tools 
• views on the possible usefulness of DSI's 
• Info needs - survival rates, chance of cure, Rx options, post-op state, side 
effects (drugs & surgery), surgery scarring pictures, 
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• Did you have enough, too much or too little info to make a decision. 
• Check  
o Age,  
o time from diagnosis 
o PET / Surgery 
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Helping older women make informed choices about treatment 
for breast cancer. 
Participant Invitation Letter  
Dear [insert name here ] 
You were recently invited to take part in a research study called 
‘Helping older women make informed choices about treatment for 
breast cancer’ which is trying to find out the views of older women 
about different types of treatment for breast cancer and the 
information and support they would like to help them decide what 
type of treatment they would prefer.  The information from this 
questionnaire will also be used as part fulfilment of an educational 
qualification (Doctor of Philosophy - a PhD). 
At the time, you said you would be 
interested in taking part in another part of 
the study.  We would now like to invite 
you to fill in a questionnaire.  The 
information sheet you were given before 
contains more detail.  Taking part or not 
is entirely up to you.  
If you wish to take part in this part of the study, please fill in 
the questionnaire provided, and return it in the FREEPOST 
envelope provided.  
If you would like to find out more before deciding whether or not to 
take part please contact Mrs Maria Burton at the Sheffield Hallam 
University on 0114 225 5498 or NAME OF RESEARCH SITE 
CONTACT & DETAILS TO BE INSERTED. 
Yours sincerely 
Ms Lynda Wyld, Consultant Breast 
Surgeon  
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Development of the QQ-10 
 
QQ-10 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
QQ-10 Please circle the answers below each of the following 10 statements 
that best fit your feelings about the questionnaire that you recently completed 
Please use the boxes at the bottom of the next page to make additional 
comments.  
 
The questionnaire helped me to communicate about my condition 
 
Strongly agree Mostly agree Neither agree or disagree Mostly disagree 
Strongly disagree 
 
The questionnaire was relevant to my condition 
Strongly agree Mostly agree Neither agree or disagree Mostly disagree 
Strongly disagree 
 
The questionnaire was easy to complete 
Strongly agree Mostly agree Neither agree or disagree Mostly disagree 
Strongly disagree 
 
The questionnaire included all the aspects of my condition that I am 
concerned about 
Strongly agree Mostly agree Neither agree or disagree Mostly disagree 
Strongly disagree 
 
I enjoyed filling in the questionnaire 
Strongly agree Mostly agree Neither agree or disagree Mostly disagree 
Strongly disagree 
 
I would be happy to complete the questionnaire again in the future as 
part of my routine care 
Strongly agree Mostly agree Neither agree or disagree Mostly disagree 
Strongly disagree 
 
The questionnaire was too long 
Strongly agree Mostly agree Neither agree or disagree Mostly disagree 
Strongly disagree 
 
The questionnaire was too embarrassing 
Strongly agree Mostly agree Neither agree or disagree Mostly disagree 
Strongly disagree 
 
The questionnaire was too complicated 
Strongly agree Mostly agree Neither agree or disagree Mostly disagree 
Strongly disagree 
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The questionnaire upset me 
Strongly agree Mostly agree Neither agree or disagree Mostly disagree 
Strongly disagree 
 
Do you have any comments or suggestions on how the questionnaire 
you used could be improved (e.g. its structure, appearance or design)? 
 
Were any of your important symptoms, problems or concerns missed 
out by the questionnaire you used? 
 
Do you feel that any areas or problems in the questionnaire you used 
were over-represented? 
 
 
 
